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Unlike other regenerative organs such as the liver, the adult mammalian heart does not 
regenerate tissue lost following injury such as myocardial infarction (MI). Instead a 
non-contractile fibrous scar develops that in the longer term leads to the development 
of heart failure (HF). In contrast to the adult, neonatal mammals, including mice and 
man, retain potent cardiac regenerative capacities and can replace myocardium lost 
following injury. Understanding the mechanisms underlying scar free repair in the 
neonate may help in development of new approaches to reduce the impact of 
myocardial injury in adults. In this thesis MI was induced by coronary artery ligation 
in mice at post-natal day 1 (P1). Novel electrocardiogram gated high resolution cardiac 
ultrasound was developed to permit non-invasive confirmation of injury 1 day later 
and regeneration 21 days later by loss, then restoration, of contractile function.  
Macrophages (MФ) play important roles in organ growth and homeostasis, and are 
required for scar-free regeneration of the neonatal mouse heart following MI. WNTs 
are secreted lipophilic proteins with multiple roles in development. MФ-derived 
WNTs are essential for scar free tissue regeneration following injury in the kidney, 
liver, and gut, but their role in the heart is unknown. The primary aim of this thesis 
was to investigate the role of MФ, and in particular MФ-derived WNTs in determining 
normal growth of the myocardium from neonate to adult and also in regeneration of 
the neonatal heart following injury.  
In wild-type neonatal mouse hearts, Csf1r-expressing cells density (mostly 
macrophages) was consistent across all time points studied. Three populations of 
resident cardiac mononuclear phagocytes were identified by flow cytometry: F4/80hi, 
CD11blo, Ly6C-ve - F4/80lo, CD11bhi, Ly6C-ve - F4/80lo, CD11bhi, Ly6C+ve.  F4/80hi, 
CD11blo, Ly6C-ve cells were hypothesised to correspond to yolk-sac derived 
mononuclear phagocytes and F4/80lo, CD11bhi, Ly6C-ve - F4/80lo, CD11bhi, Ly6C+ve 
to foetal liver/bone marrow derived mononuclear phagocytes. Three phases of 
myocardial growth were identified by ultrasound and histological techniques: 
hyperplastic (P2-P8, with increased Ki67 and cardiac troponin immunopositive cells), 
hypertrophic/reorganisation (P8-P21, with increasing cardiomyocyte size and no 




increasing cardiomyocyte size and left ventricle wall thickness). Average coronary 
vessel size was shown to decrease between P2 and P8 whilst vessel density was 
increased. The number of -smooth muscle actin (SMA) coated vessels greatly 
increased between P8 and P42, indicating vessel maturation.  Throughout all phases 
cardiac systolic function was maintained at steady state. Diastolic function was 
however shown to mature from a foetal to an adult pattern between P2 and P8, with 
reversal of the E:A wave ratio on Doppler ultrasound. 
In mice globally deficient in MФ due to a germline knock-out of the Csf1r gene (Csf1r-
null mice), both body and heart weights were decreased from P7 onwards. The number 
of proliferating (Ki67+ve) cardiomyocytes at P1 and P7 was unchanged in Csf1r-null 
mice but there was a trend towards decreased cardiomyocyte size at P7, suggesting an 
influence on hypertrophic rather than hyperplastic growth of the myocardium. There 
was also a trend for slowed vascular network maturation, with a delay in the shift from 
large to smaller vessels in hearts from Csf1r-null mice. In mice with MФ-directed 
(Csf1r-icre mediated) depletion of Porcupine (Porcn), a gene encoding an enzyme 
required for WNT acylation and secretion cardiac growth, vascularisation, fibrosis and 
function were all similar in Cre-ve and Cre+ve animals until P41, when cardiomyocyte 
size and cardiac systolic function were both significantly increased in Cre+ve animals. 
However, the underlying mechanism is unknown.  
In the neonatal mice, Csf1r expressing cells, mostly MФ, were identified in association 
with regenerating myocardium after induction of MI at P1. Flow cytometry data 
showed that by P7 the putative resident yolk-sac derived population had mostly 
disappeared from the heart and was replaced by F4/80lo cells, similar to the pattern 
reported in the adult. In the regenerating myocardium, Axin2 expression was increased 
consistent with activation of canonical Wnt signalling. Expression of Wnt5b and Fzd2 
receptor, both associated with fibrosis, was significantly increased relative to age 
matched uninjured hearts. MФ-directed depletion of Porcn did not influence either the 
functional decrease at day 1 or recovery at day 21 following induction of MI at P1. 
Coronary re-vascularisation was also unaffected by the genotype. However, retention 
of intra-myocardial fibrosis (picrosirius red staining) was significantly increased in 




WNTs are therefore required for scar-free wound healing in the heart, as they are in 
the liver and the kidney where they regulate matrix metalloproteinase activity.  
In summary, novel ECG-gated high-resolution in vivo ultrasound developed in this 
project has allowed characterisation of cardiac structure and function during early 
post-natal growth and following injury and regeneration in neonatal mice. The resident 
MФ population of the heart is established pre-natally, and may play a role in 
determining maturation of the developing vascular network, although this does not 
involve MФ-derived Wnt signalling. Following MI, the MФ population may expand 
from bone marrow cells and MФ accumulate around the regenerating tissue. MФ 
derived WNTs are not required for regeneration of the neonatal myocardium but do 




















A heart attack is caused by a blood clot forming in one of the vessels supplying the 
heart muscle with oxygen. Because of the lack of oxygen, the heart muscle dies. Unlike 
other organs such as the liver, the adult human and mouse heart does not repair itself 
optimally. The dead muscle is replaced by a stiff scar. This forces the remaining of the 
heart muscle to adapt and work harder. Depending on how severe the heart attack is, 
the heart can then become tired of the extra work. This can lead to heart failure. 
Unlike the adult, new-born humans and mice are good at repairing their hearts with no 
scar after a heart attack. This is known to be dependent on white blood cells called 
macrophages. Those macrophages are also known to help repair other organs without 
a scar by producing a type of molecule called WNTs. This is true in the kidney, the 
gut, and the liver. 
In this PhD thesis we have aimed to understand whether WNTs produced by 
macrophages help repairing new-borns heart without scarring. Understanding this 
would help us identify potential drugs to favour scar-free repair of the adult heart after 
a heart attack. 
First we needed to understand if anything different in the way the new-borns’ heart 
work and are built could help scar-free repair. In order to achieve this goal we adapted 
a set-up of echocardiography made for adult mice to new-born mice. This and other 
techniques has allowed us to confirm what other researchers had found. The heart 
muscle cells are better at multiplying than those in an adult heart.  
We then identified the types of macrophages present in the new-born mouse heart. 
Removing them did not change the ability of heart muscle cells to multiply. Our results 
and others’ suggest that they may have very specific importance at certain times as the 
heart grows after birth. This is especially true for blood vessel formation within the 
heart which is essential to deliver nutrients and oxygen. Other methods to remove 





In order to understand how the new-born heart repairs scar-free, we used a method that 
induces a heart injury very similar to the one observed after a heart attack. This was 
done in new-born mice. We saw that macrophages gathered at the site of injury. We 
also saw that the heart contains more molecules important in the activity of WNTs 
when compared to a normal heart. 
We were then able to prevent production of WNTs from macrophages and to see 
whether it affected the way new-born mice are able to repair their hearts scar-free. 
Three weeks after injury the hearts of mice able to produce WNTs from macrophages 
were normal with normal function. On the other hand, the hearts of mice unable to 
produce WNTs from macrophages contained a scar although heart function was 
normal. 
Our results have showed that macrophages produce WNTs that in turn are able to 
promote scar-free repair of the new-born heart. If we can identify which WNT is the 
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1.1 Myocardial infarction and heart failure 
1.1.1 Adult MI and the development of heart failure, mechanisms. 
Myocardial infarction (MI) is most frequently caused by the rupture of an 
atherosclerotic plaque leading to the formation of a thrombus within the coronary 
vasculature. Blood flow is thereby interrupted in the myocardium distal to the clot 
leading to necrotic cardiomyocyte death (Thygesen et al., 2013). The adult mammalian 
heart lacks significant regenerative capacities; myocardial damage therefore 
eventually leads to the formation of a non-contractile scar. The loss of functional 
myocardium associated with scarring triggers adaptive remodelling of the remaining 
healthy myocardium (Cohn et al., 2000). This can become maladaptive and is a risk 
factor for the development of heart failure (HF) (Cohn et al., 2000).  The extent and 
severity of remodelling is determined by a combination of the degree of initial injury 
as well as the effectiveness of the repair (Frangogiannis, 2014). Due to the 
considerable improvement in reperfusion techniques the survival rate of patients 
following MI has been dramatically improved (Ezekowitz et al., 2009; Behfar et al., 
2014). However, HF is a frequent complication of MI. Indeed, within 5 years of first 
MI, 16% of men and 22% of women over 45 years of age will have heart failure 
(Mozaffarian et al., 2016). With increasing survival post-MI and an aging population, 
the prevalence of HF is expected to have risen 48% between 2012 and 2030 
(Mozaffarian et al., 2016). 
1.1.1.1 Overview of the immune response following MI in the adult 
Following myocardial damage, endogenous ‘danger signals’ are released by the 
necrotic cells. Those include the wide family of danger-associated molecular patterns 
(DAMPs) (Timmers et al., 2012). Release of DAMPs then activates innate immune 
cells thus starting the immune response associated with MI (Chan et al., 2012; 
Frangogiannis, 2012). The first immune cell to be recruited to the site of infarction in 
the adult heart are neutrophils. Their number thus peaks rapidly at day 1 post-MI and 
by day 6-7 is back to low levels (McSweeney et al., 2010). Neutrophil infiltration is 
rapidly followed by infiltration of blood circulating monocytes (K. Jung et al., 2013). 
There are two populations of circulating blood monocytes: Ly6Chi and Ly6Clo 
(Geissmann et al., 2003). Upon MI, the Ly6Chi population is preferentially recruited 
to the site of injury via the interaction of the chemokine/chemokine receptor couple 
CCL2/CCR2 (Dewald et al., 2005; Nahrendorf et al., 2007). Their number peaks in 
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the myocardium at day 3 post-MI. Their recruitment represents a hallmark of the 
inflammatory phase of MI as  they secrete inflammatory cytokines and matrix 
metalloproteinases (MMPs) (Nahrendorf et al., 2007; Frangogiannis, 2012). Ly6Clo 
monocytes were shown to dominate at a later stage between day 4 and 7 post-MI in 
the so called proliferative phase and to accumulate through CX3CR1 rather than 
CCR2. Those monocytes are considered anti-inflammatory; promoting matrix 
deposition and angiogenesis (Nahrendorf et al., 2007). 
Following tissue infiltration monocytes start differentiating into macrophages. 
Depending on the set of signals they receive, macrophages can adopt a wide range of 
phenotypes which allows them to acquire varied specific functions within a tissue 
(Davies et al., 2013; Wynn et al., 2013). Nevertheless, macrophages have been 
described as being able to broadly adopt two polarised phenotypes. Those were 
originally characterised by in vitro polarisation of bone-marrow derived macrophages 
using either LPS/TNF or IL-4 yielding respectively to the so called M1 and M2 
phenotypes (Stein et al., 1992; Mills et al., 2000; Gordon and Taylor, 2005). In vivo, 
due to the multitude of polarizing signals received by macrophages this nomenclature 
has been broaden to M1-like, pro-inflammatory, and M2 like, anti-inflammatory, 
macrophages. It is widely agreed that those two phenotypes are over simplified and do 
not take into account macrophage ontology (Wynn et al., 2013; Murray et al., 2014). 
They are nevertheless helpful in the description of macrophage function. 
In the context of MI, ‘M1-like’ macrophages predominate during the early 
inflammatory phase between day 1 and 3 post-MI; whereas ‘M2-like’ macrophages 
are the dominant macrophage subset from day 5 post-MI (Yan et al., 2013). This 
correlates with the changes between the inflammatory and proliferative/repair phases 
following MI described by Frangogiannis (2012). M1-like macrophages have been 
shown to be crucial in the phagocytosis of cell debris and matrix remodelling through 
the secretion of proteases; on the other hand, M2-like macrophages have pro-
angiogenic, pro-resolution and pro-fibrotic capacities (Nahrendorf et al., 2007; Murray 
and Wynn, 2011).  
It is clear that the immune system and more specifically macrophages play a crucial 
role following MI in the adult. The time-line and specific roles of each phases of the 
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immune response as well as the role of the different cell types involved has been the 
focus of extensive research (Frangogiannis, 2014). This has helped further our 
understanding of the mechanisms involved in cardiac repair following MI. 
Nevertheless, myocardial damage such as MI invariably leads to the formation of scar 
which can impede cardiac function. 
1.1.1.2 Scar formation and the development of heart failure 
During the inflammatory phase following MI (day 1-3), extra-cellular matrix (ECM) 
is actively degraded through the activity of MMPs (Zamilpa and Lindsey, 2010). 
MMP-9, which is present on neutrophils and macrophages, noticeably peaks during 
this phase (Vanhoutte et al., 2006). In the proliferative/repair phase post-MI (from day 
4), collagen is actively deposited within the infarcted area and remains high for at least 
3 weeks in rats (Holmes et al., 2005). Deposition of a scar helps maintain cardiac 
structural integrity following MI and is regulated by a tight balance of ECM-degrading 
and preserving signals that are likely to play key roles in successful cardiac repair. It 
is known that myofibroblasts actively lay down ECM following MI (Nahrendorf et al., 
2007; van den Borne et al., 2010; Murray and Wynn, 2011). Myofibroblasts are mainly 
thought to differentiate from cardiac fibroblasts although other cell types in the heart 
have been shown to trans-differentiate, e.g. endothelial cells, pericytes, epicardial cells 
(van den Borne et al., 2010) and ‘fibrocytes’ may be recruited from the bone marrow. 
Cardiac fibroblasts are present in the steady state within the myocardium (Camelliti et 
al., 2005; Porter and Turner, 2009). Following injury, disruption of tissue integrity 
triggers their activation and differentiation into myofibroblasts (Tomasek et al., 2002; 
Hinz and Gabbiani, 2003). Other signals contribute to their differentiation including 
TGF1 which stimulate their production of collagen (Petrov et al., 2002). 
Myofibroblasts have mostly been characterised based on their expression of -smooth 
muscle actin (SMA). In the context of MI, following their activation and 
differentiation, they are known to migrate within the infarcted area where they secrete 
both MMPs and collagen thereby increasing matrix turnover. This migratory process 
was notably shown in rats to be dependent on their expression of the Wnt signalling 
receptor Frizzled-2 (Blankesteijn et al., 1997). Following resolution of inflammation, 
the number of myofibroblasts decrease leaving an acellular mature scar in place mostly 
composed of collagen (Holmes et al., 2005). 
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Following MI in the adult mammal, there is therefore a pattern of structural 
remodelling involving removal of cell debris and formation of a non-contractile scar. 
This remodelling can be considered a beneficial event as it helps maintain structural 
integrity and even improve cardiac function following injury. The loss of contractile 
tissue and alteration in tissue architecture however puts stress on the remaining viable 
myocardium. These changes can lead to further remodelling that can become 
maladaptive with associated functional and structural detrimental changes leading to 
heart failure progression (Cohn et al., 2000; van den Borne et al., 2010; Frangogiannis, 
2014). 
Multiple strategies have been developed to promote better repair leading to improved 
outcome following MI. Those have included modulation of inflammation 
(Frangogiannis, 2012) or fibrosis (Gourdie et al., 2016). However, the most valuable 
goal is to promote cardiomyocyte replenishment whilst limiting fibrosis thereby 
achieving tissue regeneration. 
1.1.2 Regenerative strategies 
The adult mammalian heart was long considered as devoid of regenerative capacities 
with cardiomyocytes having exited the cell cycle. Nevertheless, in the recent years 
evidence for slow renewal of cardiomyocyte changed this perspective (Bergmann et 
al., 2009). This suggests that the adult mammalian heart does harbour regenerative 
capacities that may have the potential to be instructed over scar formation following 
MI (Porrello and Olson, 2014). It is however very clear that those capacities are not 
sufficient for cardiomyocyte replenishment following MI. Several approaches have 
been undertaken in an effort to favour cardiomyocyte replenishment over scar 
formation including cell-based therapies. 
The first reports of cell-based therapeutic strategies following MI started with the 
transplantation of autologous bone-marrow-derived mononuclear stem cells 
(BMMNCs). Those were shown to integrate within the myocardium and differentiate 
into cardiomyocytes and endothelial cells (Jackson et al., 2001; Orlic et al., 2001; Deb 
et al., 2003). Those initial results were disproved by fate mapping experiments 
showing no trans-differentiation of BMMNCs into cardiomyocytes. They were 
however able of promoting endogenous cardiomyocyte replenishment following MI 
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(Loffredo et al., 2011). Meta-analysis of original clinical trials suggested minor but 
beneficial effects of BMMNCs-based therapy on functional recovery following acute 
MI (Kuswardhani and Soejitno, 2011; Delewi et al., 2013). Those meta-analyses were 
however obtained from the collection of published summaries. A later meta-analysis 
using individual-patient data was unable to report the previous beneficial effects 
(Gyongyosi et al., 2015). In the recent years, translation to humans of the benefits 
originally observed following BMMNCs-based therapy in mice has therefore been 
controversial with poorly understood mechanisms.  
Human mesenchymal stem cells (MSCs) also yielded promising pre-clinical results as 
studies suggested that they could trans-differentiate into cardiomyocytes in vitro and 
in vivo (Toma et al., 2002; Xu et al., 2004). Following MI in a porcine model, MSCs 
were shown to integrate within the injured myocardium and to have a beneficial effect 
on functional recovery (Shake et al., 2002). Later a clinical trial showed a beneficial 
effect of MSCs transplantation in humans following MI (Hare et al., 2009). However, 
following injection, MSCs are known to mostly accumulate in the spleen, liver, and 
lung with only 0.44% to be found in the myocardium (Toma et al., 2002). Such low 
engraftment frequency has raised doubt on whether engraftment is the main 
mechanism of action of MSCs. Others have suggested that MSCs could exert their 
beneficial effect through the secretion of growth factors such as vascular endothelial 
growth factor (VEGF) or fibroblast growth factor (FGF) promoting proliferation of 
endothelial cells and smooth muscle cells thereby increasing blood flow in a hind limb 
ischaemia model (Kinnaird et al., 2004). Other mechanisms of action such as 
expansion of cardiac stem cells or differentiation into endothelial cells have been 
proposed but are still questioned (reviewed in Williams & Hare (2011)).   
Further cell-based therapies that are being investigated in clinical trials involve 
cardiopoeitic stem cells (reviewed by Behfar et al. 2014). Cardiopoietic stem cells are 
derived from MSCs and instructed towards a cardiac phenotype with a differentiation 
cocktail (Behfar et al., 2010). Those cells were shown preclinically to integrate the 
injured myocardium, differentiate into cardiomyocytes and endothelial cells, and 
improve cardiac function compared to animals that received regular MSCs (Behfar et 
al., 2010). Those cells are showing encouraging results by improving cardiac function 
in patients with chronic heart failure following an ischaemic insult (Bartunek et al., 
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2013). Whether differentiation of those cells into cardiomyocyte and endothelial cells 
is the sole mechanism of action is unclear. However, cardiac function does not return 
to normal following the treatment suggesting that cardiomyocyte replenishment is not 
complete.  
In 2003, Beltrami et al. showed that the adult mouse heart contained a population of 
KIT+ve, Lin-ve cells expressing markers of cardiomyocyte progenitors with clonogenic, 
self-renewing capacities and able to differentiate into cardiomyocytes, endothelial 
cells, and smooth muscle cells in vitro and in vivo. Those cells were argued to represent 
an adult cardiac stem cells population (Beltrami et al., 2003). The regenerative 
potential of KIT+ve cells is however controversial. A study by Ellison et al. (2013) 
showed, using a Cre-reporter mouse, that a population of KIT+ve cells could act as 
cardiomyocyte progenitors in the adult mouse following injury by injection of 
isoproterenol. Later, a study by (van Berlo et al., 2014) showed that following MI, 
KIT+ve cells differentiation into cardiomyocyte was extremely limited and that most of 
their contribution to the cardiomyocyte pool was through cell fusion.  However, KIT 
is expressed in a number of other cell types present in the adult myocardium (Santini 
et al., 2016) which may render precise cell lineage and tracking difficult. This may 
explain the discrepancies observed in the published work. Further work will be needed 
to determine the exact identity and origin of those cells and whether they have the 
capacity to sufficiently differentiate into cardiomyocyte to replenish the injured 
myocardium following MI in the adult.  
Promising in vivo and in vitro pre-clinical studies showed the potential of multiple 
stem-cell populations to differentiate into cardiomyocytes and to improve outcome 
following MI. Nevertheless, engraftment and differentiation efficiency are low and 
most of the effect of those cells seems mediated through paracrine effects and 
promotion of angiogenesis following MI in the adult (Santini et al., 2016).  
Another avenue involves the study of cardiac regeneration in models retaining such 
capacities. Indeed, understanding how an organism can spontaneously regenerate its 
myocardium following injury may provide tools of crucial importance to support 
promotion of myocardial regeneration following injury in the adult human. 
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1.2 Cardiac regeneration in lower vertebrates 
Organ regeneration has been the focus of scientific research for over a century. It is 
however only recently that formal investigation of cardiac regeneration was conducted 
in lower vertebrate models. Despite the first evidence of cardiac regeneration being 
reported in amphibian models (Rumyantsev, 1966; Oberpriller and Oberpriller, 1974), 
the zebrafish has imposed itself as the standard model for investigation of cardiac 
regeneration. This is partly due to its straightforward genetic manipulation and short 
generation time. 
Zebrafish (Danio rerio), a member of the teleost infraclass of bony fish, was first 
reported to harbour potent cardiac regenerative capacities by Poss et al. (2002). Their 
experiment consisted of surgically removing about 20% of the ventricular myocardium 
in adult fish. Following resection, a blood clot was rapidly formed. This was replaced 
by a fibrin cap by 9 days post-resection. Over the next 60 days the fibrin cap was 
shown to regress as cardiomyocytes replenished the resected area. By that time point 
the ventricular area had recovered to baseline levels. The authors were also able to 
show evidence of cm proliferation following resection and that cell proliferation was 
essential to scar-free regeneration of the adult zebrafish heart. Later, it was formally 
proven that cm replenishment of the resected myocardium in the adult zebrafish 
occurred through existing cm de-differentiation and subsequent proliferation using 
lineage tracing and electron microscopy techniques (Jopling et al., 2010).  
1.3 Mammalian cardiac regeneration: Lessons from 
development 
It is commonly believed that following injury, developmental pathways such as Wnt, 
Notch and Hedgehog are re-activated in an effort to restore tissue integrity (Oka et al., 
2007; Bollini et al., 2011; Bielefeld et al., 2013). It is however very clear that 
successful regeneration is both age-dependent and organ-specific (Poss, 2010; Porrello 
and Olson, 2014). For example, unlike other regenerative organs such as the liver 
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1.3.1 Age dependency of mammalian cardiac regeneration 
1.3.1.1 In humans 
There is evidence that the human heart exhibits potent regenerative capacity during 
early post-natal life. Minimal myocardial scarring along with normal function was 
observed in adults having had cardiac corrective surgery for anomalous origin of the 
left coronary artery from the pulmonary artery (ALPACA) as children (Fratz et al., 
2011). Moreover, full functional recovery was reported following thrombolytic 
therapy in a new-born child presenting with severe MI (Haubner et al., 2016). These 
observations have supported the concept that regenerative capacities could be re-
activated in the adult after injury.  
1.3.1.2 In mice 
Mammalian models of cardiac regeneration were non-existent until the description in 
2011 by Porrello et al. that 1 day old neonatal mice could fully regenerate their 
myocardium by 21 days following apical resection. Synchronously, Porrello et al. 
(2013) and Haubner et al. (2012) developed model of left anterior descending (LAD) 
coronary artery ligation in 1 day old mice, leading to MI. As with the resection model, 
neonatal mice could regenerate the injured myocardium by 21 days following MI. This 
was also accompanied by full recovery of cardiac function. Similarly to the zebrafish, 
neonatal mice were shown to achieve cardiac regeneration through de-differentiation 
and proliferation of cardiomyocytes, rather than through a stem-cell based 
mechanism(Porrello et al., 2011, 2013; Haubner et al., 2012). MI in neonatal mice was 
shown to be associated with increased markers of cell death such as cleaved caspase 
3, functional decrease in the days following surgery, and decreased proportion of 
viable myocardium (Haubner et al., 2012; Porrello et al., 2013). At day 3 post-MI, 
Porrello et al. (2013) observed extensive cm loss and immune cell infiltration. By day 
7, a scar had formed within the injured myocardium. This scar was then gradually 
removed as the myocardium regenerated leading to minimal interstitial fibrosis by day 
21 post-MI. A small area of fibrosis was noted by both Porrello et al. (2013) and 
Haubner et al. (2012) at the site of the suture which did not have any effect on the 
functional recovery observed by day 21. Importantly, those regenerative capacities 
were strictly limited to the first week after birth. Neonatal mice undergoing CAL at 
post-natal day 7 (P7) were unable to regenerate the lost myocardium and instead 
formed a scar, similar to the adult. 
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Studying what controls both cardiac development and regeneration during the 
regenerative window (P1-P7) therefore appears crucial in advancing our understanding 
of cardiac regeneration. This could in turn provide tools to favour regeneration over 
scar formation in the adult following MI 
1.3.2 Mammalian cardiac development and maturation 
1.3.2.1 Organogenesis 
The heart is the first organ to form in vertebrates. It originates from cardiogenic 
precursors within the epiblast on either side of the primitive streak (PS) (Wu et al., 
2008; Vincent and Buckingham, 2010). Those precursors then migrate through the PS 
to give rise to cardiogenic mesoderm which will subsequently migrate in a rostro-
lateral fashion to form the primitive heart tubes (~E6.5) (Buckingham et al., 2005). 
Following formation of a coelom the mesoderm is split into a dorsal (somatic) and 
ventral (splanchnic) section. The embryo’s folding then begins bringing the 2 heart 
tubes together. Those start fusing cranially thereby creating the cardiac crescent of first 
heart field (FHF) (Buckingham et al., 2005). In the early 2000s another source of 
cardiac precursors named the second heart field (SHF) was shown to be located 
posteriorly to the FHF in the developing embryo. Both FHF and SHF participate in 
embryonic cardiac organogenesis. Fusion of the cardiac crescent then extend caudally 
to form a single heart tube (E7.5) (Buckingham et al., 2005). Following a series of 
looping and segmentation a four-chambered heart composed of right and left atria (RA, 
LA) and ventricles (RV, LV) is formed in mammals. The FHF and SHF specifically 
give rise to the LV and outflow-tract (OFT) respectively. The rest of the myocardium 
is composed of a combination of cells originating from both heart fields.  
From E9.5 onwards a group of coelomic cells start proliferating on the pericardial side 
of the septum transversum to give rise to the pro-epicardium organ (PEO). The PEO 
then extends villi which migrate cranially to cover the myocardium. A subset of 
epicardial cells can then undergo epithelial to mesenchymal transition (EMT) and are 
the main source of vascular smooth muscle cells (Wilm et al., 2005). 
An illustration of this process can be found on Figure 1-1. 
By E14.5 the foetal heart has acquired most of its adult structural characteristics 
(Buckingham et al., 2005). The circulation is however slightly different. Most of the 
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blood is diverted away from the lungs and systemic and pulmonary circulations are 
not isolated. Following birth and interruption of maternal oxygenation, the lungs 
inflate and both circulations segregate.   
1.3.2.2 Cardiac structural maturation 
The adult mammalian heart is composed of three main cell types: cardiomyocytes, 
endothelial cells, and fibroblasts. The exact proportion of each cell type is likely to 
vary according to species, age, and in disease. Until recently fibroblasts had been 
considered the most numerically abundant cell type in the heart (Banerjee et al., 2007). 
This view was however challenged by a recent publication by Pinto et al. (2016) 
showing that in the adult mouse and human hearts endothelial cells are the most 
abundant cell type, followed by cardiomyocytes, and finally fibroblasts.   
(a) Cardiomyocytes 
As the foetus develops, the heart is faced with an increasing work load which in turn stimulates 
its growth. Cardiomyocyte growth can be achieved through hyperplasia (cell division), or 
hypertrophy (increased cell size) (Oparil et al., 1984). Hyperplastic growth was shown to be at 
its highest at foetal and early post-natal stages in mammals (Soonpaa and Field, 1998; Leu et al., 
2001). In the rodent, early post-natal cardiomyocyte cell division is acytokinetic and leads to bi-
nucleation of 80-90% of cells. Binucleated cardiomyocytes are mostly unable of completing 
cytokinesis in the highly regenerative newt (Matz et al., 1998) linking binucleation to the loss of 
regenerative capacities in the mouse (Porrello and Olson, 2014). In mice, hyperplastic growth 
was shown to stop around P4 (Leu et al., 2001).  Even though it is clear that cardiomyocyte 
growth is mostly hyperplastic at this stage it is important to note that cardiomyocytes do also 
increase in size. Hirschy et al. (2006) showed that cm length increased 3-fold between E8.5 and 
P4 whilst their width remained stable. From P4 onwards most of cm growth is described as 
hypertrophic; growing first mostly in length and from P24 mostly in width (Leu et al., 2001). 
Even though those studies have provided the field with a relatively good understanding of the 
different phases of cardiomyocyte growth some caveats are worth noting.  Leu et al. (2001) 
performed their experiments on isolated cardiomyocytes which does not provide information of 
their role in tissue architecture and interaction with other cell types. Whilst Hirschy et al. (2006) 
investigated cardiomyocyte growth pattern on heart sections thereby preserving tissue 
architecture, their study focused on foetal development with limited investigation during the 
neonatal stages and how it relates to other cell types. A comprehensive analysis of postnatal 
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cardiomyocyte growth patterns, focusing on the neonatal period, and how those relate to tissue 
architecture is therefore missing. An in-depth understanding of normal postnatal growth patterns 
of the neonatal mouse heart would provide a strong basis for interpretation of the mechanisms 
involved following injury and during regeneration. 
(b) Coronary vasculature 
Pioneering anatomical studies such as the one performed by Bennett (1936) in the pig heart  
recognised that the coronary vasculature sprouted from the aorta into the myocardium. Later, 
those observations would be questioned as a study on quail embryos suggested that coronary 
vessels grew into rather than out of the aorta (Bogers et al., 1989). Further experiments on avian 
models proposed a model by which the coronary vasculature was to originate from the pro-
epicardial organ (PEO) (Mikawa and Gourdie, 1996; Männer, 1999; Perez-Pomares et al., 
2002). This model was then itself challenged with lineage tracing studies showing that the PEO 
only gave rise to few cardiac endothelial cells whilst being the main source of smooth muscle 
cells (SMC) (Wilm et al., 2005). Red-Horse et al. (2010) elegantly settled this controversy 
regarding the origin of the coronary vasculature. Using a coronary endothelial specific LacZ 
reporter the authors were able to show the invasion of endothelial cells from the sinus venosus 
onto the dorsal side of the heart from E11.5. Those cells were then shown to migrate in a caudal-
ventral manner thereby wrapping around the developing heart (Figure 1-1). At the onset of this 
PhD, coronary vasculature growth in the post-natal mammal was thought to be achieved through 
angiogenesis of those existing vessels. Formal proof of this concept was however lacking. 
(c) Cardiac fibroblasts 
Cardiac fibroblasts (CF) play essential roles in the deposition and remodelling of extra-cellular 
matrix (ECM) both during development (Ieda et al., 2009) and disease (Porter and Turner, 2009; 
Turner and Porter, 2013). Due to the lack of specific markers of CF the field has been lacking a 
formal proof of their origin within the embryo at the onset of the PhD. It was however thought 








Figure 1-1: Cardiac organogenesis schematic. Cardiogenic precursors start migrating 
through the primitive streak (PS) at E6.5 to give rise to cardiogenic mesoderm which produces 
the primitive heart tubes. Those will then start fusing giving rise to the cardiac crescent or first 
heart field (FHF-green). The fusion of the primitive heart tubes starts then expands caudally from 
the cardiac crescent at E7.5 to form a single heart tube with the participation of a second 
progenitor population known as the second heart field (SHF-purple). After a series of looping 
the heart acquires 4 distinct regions; right and left atria (RA, LA) and ventricles (RV, LV) by 
E10.5 with the FHF giving rise to the LV whilst the SHF gives the outflow tract. The rest of the 
myocardium is made of a mixture of the two precursor populations. From E10.5 the pro-
epicardial organ (PEO) starts migrating rostrally to cover the heart (red arrows). This will give 
rise to vascular smooth muscle cells. From E11.5, cells from the sinus venosus start migrating in 
a caudal-ventral manner to wrap around the developing heart giving rise to endothelial cells (blue 
arrows). Adapted from Buckingham et al. (2005). 
 
1.3.2.3 Functional maturation of the heart 
During one cardiac cycle, the blood-filled ventricles start systole by a period of 
isovolumetric contraction (IVCT). It is during the IVCT that pressure within the 
ventricle rises until it reaches levels above that within the pulmonary artery and aorta. 
At this point the aortic and pulmonary valves open letting blood into the circulation. 
The ventricles then start relaxing thereby decreasing ventricular pressure. Once it has 
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reached levels below the arterial pressure the aortic and pulmonary valves close. This 
is followed by an isovolumetric relaxation time (IVRT) until the ventricular pressure 
drop induces the mitral and tricuspid valves to open leading to the passive filling (E-
wave) of the ventricle. The atria then contract ejecting the remainder of the blood into 
the ventricles performing the so called active filling (A-wave) (Godfrey et al., 2012). 
Passive and active filling of the ventricles can be measured by pulse-wave Doppler 
ultrasound (Godfrey et al., 2012) 
Cardiac systolic function, or the ability to eject blood within the circulation, is thought 
to be relatively stable throughout foetal development and to decline slightly after birth 
albeit within the physiological range (Corrigan et al., 2010). Those measurements were 
acquired using pulse-wave Doppler and motion-mode (M-mode) ultrasound which are 
1-dimensional (D) measurements of cardiac function. At the onset of this PhD, 2-D 
measurements of cardiac systolic function routinely performed in the adult mouse were 
not available for application to neonatal mice. Those not only provide functional 
readouts but also structural information such as cavity size and wall thickness.  
Cardiac diastolic function is drastically different in the foetus compared to the 
postnatal animal. In the foetus, most of the filling of the ventricle is due to the active 
filling or A wave; whereas in the adult the passive filling (E wave) predominates. 
Reversal of the E/A wave ratio occurs during the first post-natal week (Zhou et al., 
2003a; Corrigan et al., 2010).  
Altogether, thanks to advances in lineage tracing techniques the understanding of 
cardiac organogenesis has made considerable progress. Cellular origins and 
composition has indeed been scrutinised with a new light over the past 25 years. In 
comparison, characterisation of early post-natal cardiac structure and function has not 
received similar attention. Nevertheless, the recent discovery of the ability of the 
neonatal mouse to fully regenerate its myocardium has placed early post-natal growth 
in a new light. Characterisation of structural and functional changes of the neonatal 
heart could thus provide important clues regarding the mechanisms behind cardiac 
regeneration. 
High-resolution in-vivo ultrasound has been extensively used to characterise functional 
and structural maturation of the foetal heart in-utero (Phoon and Turnbull, 2003; Yu 
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et al., 2008). This was achieved through pulse-wave Doppler, a non-electrocardiogram 
(ECG)-gated visualisation method. In the post-natal heart, ultrasound is well described 
as a powerful method to investigate functional effects of MI in both adults and 
neonates (Haubner et al., 2012; Moran et al., 2013; Porrello et al., 2013). This is 
possible using M-mode visualisation. In the adult, the ultrasound set up allows ECG-
gated visualisation of the mouse heart, but this has not previously been achieved in the 
neonatal mouse. Establishing a set-up of ECG-gated visualisation in neonatal mice 
would therefore allow collection of novel information on the structural and functional 
maturation of the heart in that period. It would also allow quantification of the 
functional effect of MI on neonatal mice. 
 
1.4 Macrophages in development and regeneration 
1.4.1 Overview of the immune system 
The mammalian immune system has been classically divided into innate immunity, 
activated rapidly following exposure to a pathogen or after injury; and adaptive 
immunity which specifically targets pathogens with a stronger, more focused response. 
Leukocytes are primary effector cells of the immune system.  
Broadly, leukocytes originate in the bone marrow from pluripotent haematopoietic 
stem cells. Those then give rise to 2 main categories of multipotent stem cells: common 
lymphoid and myeloid progenitors. Common lymphoid progenitors yield all 
lymphocytes (B, T, and Natural Killer (NK) cells). On the other hand, the common 
myeloid precursors will give rise to all myeloid cells. These include platelet-producing 
megakaryocytes, erythrocytes, granulocytes (neutrophils, basophils, eosinophils), 
mast cells precursors, and monocytes. Monocytes are mostly found in the blood. They 
can however enter tissues where they differentiate into macrophages (MФ). MФ, from 
the Greek  (large) and  (to eat), are large phagocytic cells that sample 
the environment and are capable of activating other immune cells thereby participating 
in innate immunity. Resident MФ populations are found in all adult mammalian tissues 
where they exert non-immunological roles in homeostasis (Davies et al., 2013; Wynn 
et al., 2013). 
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1.4.2 Tissue resident macrophages origin 
Understanding how tissue resident MФ are established, their origins, as well as the 
pathways involved in their maintenance would provide tools for the manipulation of 
their function in a context such as cardiac injury.  
All tissue resident MФ populations were thought to be derived through the so-called 
mononuclear phagocytic system (MPS). The MPS established resident MФ as directly 
differentiated from bone marrow-derived blood monocytes that have entered the tissue 
(van Furth et al., 1972). However, this system was challenged with the evidence that 
some organs contain MФ populations established prior to the onset of definitive 
haematopoiesis within the bone-marrow that persists into adulthood.     
A first population of maternally-derived MФ arises in the yolk-sac as early as E7.5. 
This population does not however present haematopoietic capacities. Subsequently, 
two populations of myeloid cells precursors with haematopoietic capacities are 
established in the yolk-sac (Bertrand et al., 2005). The first population, described as 
‘primitive’ is thought to bypass the monocyte stage of differentiation and to only give 
rise to MФ. Between E8.5 and E10.5 a second population of erythro-myeloid 
precursors arises from the haemogenic endothelium. This population is able to give 
rise to erythrocytes and megakaryocytes thereby carrying a wide myeloid potential. 
Yolk-sac derived progenitors then populate the foetal liver making it the main source 
of definitive haematopoiesis by E12.5. They also seed the bone marrow where 
definitive haematopoiesis will be relocated postnatally. Following birth, 
haematopoiesis is relocated to the bone marrow where it will remain (Bertrand et al., 
2005; Pollard, 2009). 
Using a combination of lineage tracing and genome-wide expression arrays, Schulz et 
al. (2012) were able to show that YS derived MФ persist postnatally in organs such as 
the lung, the kidney, or the skin. They were also able to show that, depending on their 
origins, tissue MФ differentially express the canonical MФ marker F4/80 and 
leukocyte marker CD11b. Typically, YS derived MФ were shown to be mostly F4/80hi, 
CD11blo whereas macrophages derived from definitive haematopoiesis were F4/80lo, 
CD11bhi (Schulz et al., 2012). 
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The exact composition of tissue resident MФ in regards to their origins is thought to 
be organ specific. The brain is thought to mostly be populated prenatally by YS derived 
MФ prior to the closure of the blood-brain barrier (Alliot et al., 1999; Ginhoux et al., 
2013). Contrastingly, the gut contains a resident MФ population that is continuously 
replenished by bone marrow derived monocytes (Bain and Mowat, 2014; Bain et al., 
2014). Finally, the lung contains distinct macrophage populations originating in the 
yolk sac as well as through definitive haematopoiesis in the foetal liver or bone-
marrow (Kopf et al., 2015). The exact composition and origin of cardiac resident MФ 
as well as their function in the steady state was unclear at the onset of this PhD.  
1.4.3 The role of MФ in organ growth and regeneration 
Macrophages were historically described in non-sterile and sterile inflammation. Over 
the past 20 years it has become increasingly clear that MФ also play essential roles in 
tissue homeostasis, growth, and regeneration. 
1.4.3.1 MФ in organ growth 
The importance of MФ in growth has been in part demonstrated using a mouse model 
homozygous for a null mutation of the colony stimulating factor -1 (Csf1op/op) (Yoshida 
et al., 1990). CSF-1 and its receptor CSF1R are essential in the differentiation and 
survival of MФ. The Csf1op/op mouse lacks many tissue MФ populations and presents 
a range of developmental abnormalities, including growth retardation (Chitu and 
Stanley, 2006). Mice homozygous for an inactivating mutation of the Csf1r (Csf1r-
null) lead to a similar phenotype albeit more severe (Dai et al., 2002). IL-34 was 
proposed as an alternative ligand of the CSF1-R which would explain the phenotype 
discrepancies (Lin et al. 2007). 
(a) MФ and angiogenesis 
Angiogenesis is essential to support growth of all vertebrates. It has been clear for 
decades that MФ play important roles in both physiological and pathological 
angiogenesis (Sunderkötter et al., 1994; Pollard, 2009; James A. Stefater et al., 2011). 
MФ are indeed able to produce growth factors (Fantin et al., 2010; Rymo et al., 2011) 
and matrix remodelling proteins (Moldovan et al., 2000; Hiratsuka et al., 2002; 
Murdoch et al., 2008) thereby facilitating angiogenesis. In the retina, MФ  have also 
been shown to regulate regression of the hyaloid vasculature which is essential for 
normal retinal development (Lobov et al., 2005). Macrophages have also been shown 
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to associate with tip cells and promote anastomosis of newly formed vessels in the 
retina (Fantin et al., 2010). 
(b) MФ and the central nervous system 
In the brain, microglia depletion (Csf1op/op, or Csf1r-null) in the embryo leads to 
postnatal defects in brain development (Michaelson et al., 1996; Erblich et al., 2011). 
Microglia depletion was also shown to diminish neuronal pruning which is essential 
in adequate brain development (Pow et al., 1989; Paolicelli et al., 2011). 
(c) MФ in bone development 
The most striking phenotype of the Csf1op/op is osteopetrosis which is a defect of bone 
remodelling. This is due to bone resident MФ depletion which requires CSF-1 for 
development and maturation (Dougall et al., 1999; Pollard, 2009). Macrophage 
depletion also leads to a failure to develop  bone cavity and therefore haematopoiesis 
defects (Begg et al., 1993). 
(d) MФ and cardiac growth 
As described in section 1.1.1.1 MФ play critical roles following MI in the adult. 
Interestingly, morpholino-induced depletion of MФ in xenopus was shown to impair 
heart tube formation (Smith and Mohun, 2011). Pinto et al. published in 2012 the first 
formal report of cardiac resident MФ in the adult mouse. The authors proposed a role 
in immune regulation for those MФ which was supported by gene expression analysis. 
Since then resident cardiac macrophages have received considerable attention which 
will be discussed later in this thesis. At the onset of this PhD their origins and role 
during murine cardiac development, growth and homeostasis was however mostly 
unclear.  
1.4.3.2 MФ in regeneration 
MФ depletion using clodronate loaded liposomes completely abrogates limb 
regeneration in the adult salamander (Godwin et al., 2013). Interestingly, MФ 
depletion was associated with extensive fibrosis and increased expression of collagen 
I and IV at the site of amputation. This phenotype was completely reversible after 
macrophage replenishment. Using the same MФ ablation approach showed their 
requirement for neuron regeneration in a sciatic nerve injury model (Salegio et al., 
2011) as well as during hepatocyte regeneration in a chronic liver injury model 
(Boulter et al., 2012). At the onset of this PhD the role of macrophages in neonatal 
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cardiac regeneration following MI was suggested by the Olson lab based on the 
deleterious effect of clodronate-mediated macrophage ablation. This work was 
subsequently published by Aurora et al. (2014) showing complete abrogation of 
cardiac regeneration and extensive scar formation by 21 days following injury. A role 
for MФ in the angiogenic response following injury was proposed. These observations 
formed the basis for development of a hypothesis around the role of MФ derived WNT 
ligands in myocardial post-natal growth and neonatal regeneration.  
 
1.5 The Wnt signalling pathway in development and 
regeneration 
1.5.1 The Wnt signalling pathway 
Since the discovery of Wnt genes, over 30 years ago, Wnt signalling has been shown 
to play crucial roles in key biological phenomena such as development, regeneration 
and disease.  
The first Wnt gene, Wnt1, was discovered through the work of Dr Roel Nusse and 
Harold Varmus. Their work focused on elucidating the oncogenic mechanism of the 
retrovirus, Mouse Mammary Tumour Virus (MMTV) (Nusse and Varmus, 1982) in 
the hope of identifying new proto-oncogenes. These studies led to the discovery of 
integration site 1 (Int1) of the MMTV which proved to possess a great degree of 
conservation across species, notably with drosophila (Nusse and Varmus, 1982). Int1 
was eventually revealed to be the same gene as well-known segment polarity gene in 
drosophila; Wingless (Rijsewijk et al., 1987). 
Later on the int nomenclature was judged inadequate and the int family of genes was 
renamed: Wingless-related integration site ‘Wnt’ and Int1 became Wnt1. 
Since then, researchers have identified most of the protagonists of the Wnt signalling 
pathway. However, many aspects of their interactions and roles remain unclear.  
1.5.1.1 Overview of the pathway 
The Wnt signalling pathway has been classically divided into the ‘canonical’, -
catenin dependent, and ‘non-canonical’, -catenin independent pathways. 
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(a) Canonical Wnt signalling pathway 
 
Figure 1-2: Overview of the canonical Wnt signalling pathway.  Binding of WNT 
to a frizzled receptor (FZD) and its co-receptor, LRP5/6, leads to the stabilisation and 
cytosolic accumulation of -catenin. -catenin then translocates to the nucleus where 
it displaces Groucho from TCF/LEF transcription factor allowing activation of target 
genes’ transcription. (Adapted from Dawson et al. (2013)) 
 
In the absence of WNT (Figure 1-2, left panel),-catenin is targeted for ubiquitination 
and subsequent degradation by its destruction complex. The destruction complex is 
composed of Dishevelled, Casein Kinase 1 (CK1), Glycogen Synthase Kinase 3 
(GSK3), Adenomatous Polyposis Coli (APC) and Axin. It acts through a series of 
phosphorylation (Clevers and Nusse, 2012). 
Upon binding of a WNT (Figure 1-2, right panel) to its receptor, frizzled (FZD), and 
co-receptor, LRP5/6, the cytoplasmic tail of the latter is phosphorylated. This is 
mediated by interaction with CK1, GSK3 and Axin (Rao & Kühl, 2010). In this 
process FZD interacts with Dishevelled but is thought to mainly serve as an anchor for 
WNTs (MacDonald et al., 2009). -catenin destruction complex is thus disassembled 
leading to the stabilisation and accumulation of -catenin in the cytoplasm. -catenin 
then translocates to the nucleus were it interacts with TCF/LEF transcription factor 
displacing the corepressor Groucho leading to activation of transcription of target 
genes involved in cell proliferation and differentiation (Clevers and Nusse, 2012). 
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(b) Non-canonical Wnt signalling pathway 
Non-canonical or -catenin independent signalling is classically divided into two 
separate pathways; the Wnt/Ca2+, and the Wnt/planar cell polarity (PCP) pathway. 
Both pathways still involve the Frizzled receptor but not its co-receptor LRP5/6. 
In the Wnt/Ca2+ pathway (De, 2011), binding of a WNT ligand to its FZD receptor 
triggers activation of phospholipase C (PLC) and thereby accumulation of inositol 
1,4,5 triphosphate (IP3) and 1,2 diacylglycerol (DAG). IP3 triggers the release of Ca2+ 
from the ER and therefore activation of CaMKII while DAG activates PKC and both 
of these can lead to activation of the transcription factor nuclear factor of activated T 
cells (NFAT).  NFAT is involved in cardiac development as well as cardiac 
hypertrophy (Schulz and Yutzey, 2004; Komiya and Habas, 2008). 
The Wnt/PCP pathway, on the other hand, requires recruitment at the membrane of 
DVL, which then transduces the signal through the small GTPases, Rho and Rac. In 
the Rho branch, binding of a WNT ligand to its FZD receptor leads the recruitment of 
DVL and activation of dishevelled associated activator of morphogenesis 1 (Daam1) 
which itself activates Rho. Rho then activates Rho-associated kinase (ROCK) to 
modulate actin cytoskeleton stability and polarity. In the Rac branch, interaction 
between WNT and FZD leads to the activation of c-Jun-N-terminal kinase (JNK). The 
downstream effectors of WNT/FZD activated JNK are however less clear (Komiya 
and Habas, 2008; Rao and Kühl, 2010). 
1.5.1.2 WNT ligands post-translational modifications and secretion 
In mammals, the WNT ligand family is composed of 19 members. All 19 proteins 
possess common features such as a signal peptide at the N-terminus end targeting them 
for secretion, highly conserved cysteine residues, and numerous glycosylation sites. 
(a) WNT post-translational modifications 
Most of the research investigating the mechanisms of WNT post-translational 
modifications as well as secretion has been focused on WNT3a. Therefore, the 
following paragraphs refer mainly to this particular ligand. Nevertheless, the 
information is applicable to most WNT proteins. 
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WNTs glycosylation and acylation are essential for their secretion and activity.  
Regulation of these modifications permits control over their release into the 
extracellular medium. 
(i) Glycosylation 
Mutation of both Asn87 and Asn298, preferential glycosylation sites on WNT3a, into 
Gln led to extremely low levels of its secretion in the extracellular medium. The 
mutations also impaired WNT3a’s capacity to induce accumulation of -catenin 
(Komekado et al., 2007). Briefly, WNT3a binding to its appropriate receptor on a 
target cell leads to dissociation of the -catenin destruction complex and thereof its 
accumulation in the cytosol. How WNT3a stimulation leads to accumulation of 
cytosolic -catenin will be described in subheading 1.5.1.1(a). 
(ii) Acylation 
WNT3a was shown to be acylated on two different residues. A palmitic acid is added 
on Cys77 and a palmitoleic acid is attached on Ser209 as revealed by mass 
spectrometry (Takada et al., 2006). Acylation of Ser209 was shown to be mediated by 
the multi-pass transmembrane protein Porcupine (PORCN) of the membrane bound 
O-acyltransferase (MBOAT) family (Takada et al., 2006). PORCN was first described 
as many members of the Wnt signalling pathway in drosophila where it was known to 
be crucial for the maintenance of Wingless signalling (Mikels & Nusse, 2006). In mice 
deletion of Porcn is embryonic lethal. These mice failed to secrete functional WNTs 
and exhibited defective gastrulation (Herr et al., 2012). Moreover, anti-Porcn siRNA 
treatment led to abolished Ser209 acylation and abrogated secretion of WNTs along 
with their retention in the cytoplasm.  On the other hand, C77A mutation eradicated 
canonical Wnt signalling but had no impact on secretion of WNT (Willert et al., 
2003).Furthermore, treatment of WNTs with acyl protein thioesterase, an enzyme 
catalysing deacylation, leads to non-hydrophobic, inactive ligands (Willert et al., 
2003). Figure 1-3 recapitulates the succession of WNTs acylation modifications. 




Figure 1-3: WNT acylation. Following translation, the N-terminal signal sequence is 
removed. WNTs are subsequently glycosylated in the endoplasmic reticulum (ER). 
This step is required for acylation of Ser209 in the ER by porcupine and of Cys77 by 
a yet unknown enzyme. Adapted from Resh (2012) 
 
(b) Wntless and the retromer complex 
Wntless (Wls) is a relatively recently discovered multi-pass transmembrane protein. 
The extent of Wls participation in the Wnt signalling remains unclear, nevertheless it 
is widely accepted that it is essential in the secretion of WNTs. Indeed, deletion of Wls 
in the mouse leads to embryonic lethality (Herr et al., 2012). The interaction between 
Wls and WNT3a proved to be dependent of acylation of Ser209 but not Cys77 (Takada 
et al., 2006). Following delivery of WNT ligand to the cell membrane Wls is then 
recycled and shipped back to the Golgi by the Retromer complex (Herr et al., 2012). 
Figure 1-4 recapitulates the secretory steps of Wnt proteins. 




Figure 1-4: Secretion of Wnt ligands into the extracellular medium. Following 
post-translational modifications in the endoplasmic reticulum, glycosylated and 
acylated WNTs travel to the Golgi apparatus where they interact with wntless which 
escorts them to the cellular membrane where they are released into the extracellular 
medium. Wntless is then thought to be recycled by the retromer complex. Adapted 
from Herr et al. (2012) 
 
(c) WNT extracellular transport and delivery 
Due to their hydrophobicity, WNTs are thought to remain partly bound to the cellular 
membrane of the secretory cells. This would imply that activation of the Wnt signalling 
pathway in the target cell would require its close proximity to the secreting cell. 
However, in vitro studies on human cells showed that WNTs can also be secreted in 
association with exosomes which were able to induce Wnt signalling activation in 
target cells. Thus, WNTs are likely to have longer-range signalling capacity than 
previously thought (Gross et al., 2012). 
1.5.2 Wnt signalling and MФ-derived WNTs in development 
1.5.2.1 Wnt signalling in cardiac development 
As described in 1.3.2.1, the heart is the first organ to form during embryogenesis 
following a well described succession of events. WNTs and their receptor FZDs are 
expressed throughout cardiac development within the relevant tissues as reviewed by 
Gessert & Kühl (2010). Early during cardiac organogenesis, cardiac precursors arise 
from the mesoderm. Mesoderm formation, therefore a prerequisite of cardiac 
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organogenesis, has been shown to be highly dependent on the activity of the canonical 
Wnt signalling pathway. Deletion of -catenin and the canonical ligand WNT3a is 
associated with absence of mesodermal layer (Liu et al., 1999; Huelsken et al., 2000). 
Furthermore, down-regulation of -catenin within the SHF leads to a reduced number 
of progenitors whereas its overexpression leads to their expansion (Ai et al. 2007; 
Klaus et al. 2007; Cohen et al. 2007; Kwon et al. 2007; Lin et al. 2007). Altogether 
these studies highlight the importance of the canonical Wnt signalling pathway in the 
early formation of cardiogenic mesoderm through its ability to promote expansion of 
precursor populations.  
The canonical pathway was however shown to be detrimental to cardiac specification. 
Indeed, up-regulation of canonical Wnt pathway inhibitors was able to promote 
instruction of mesoderm to the cardiac lineage in a Notch signalling dependent 
manner. This was reversible with the addition of the canonical ligand WNT3a (Chen 
et al., 2008). On the other hand, non-canonical Wnt signals have been shown to 
promote cardiac specification. The non-canonical ligand WNT11 indeed promotes 
expression of cardiac specific genes as well as prevents cytoplasmic accumulation of 
-catenin thereby inhibiting the canonical pathway (Pandur et al., 2002; Abdul-Ghani 
et al., 2011). Other non-canonical WNTs are up-regulated in cardiac progenitors 
including the prototypical WNT5a which promotes formation of troponin positive 
cells, a key marker of cardiomyocytes (Chen et al., 2008). Both WNT5a and WNT11 
have then been shown to be important in cardiac organogenesis (Cohen et al., 2012). 
WNT11 was shown to act through a JNK/PKC dependent pathway during cardiac 
organogenesis (Pandur et al., 2002; Koyanagi et al., 2005). 
The literature highlights the importance of the Wnt signalling pathway during the 
various phases of cardiac organogenesis. In summary, it is widely accepted that in the 
foetal heart, canonical signals promote proliferation of cardiac progenitors whilst its 
inhibition in concert with non-canonical signals promotes their specification. The tight 
regulation of the series of Wnt signals regulating cardiac organogenesis is crucial to 
adequate outcome. The role of the Wnt signalling in the post-natal maturation of the 
mammalian heart is however less clear.  
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1.5.2.2 MФ-derived WNTs in development 
As previously mentioned (1.4.3.1) MФ play central roles in organ growth. MФ have 
also been shown to be a source of WNTs in injury and regenerative contexts as will be 
further detailed below.  
The roles of MФ-secreted WNTs in development remains poorly understood. 
Nevertheless, they have been shown to play critical roles during angiogenesis, a 
process crucial to the support of growth and development. This was shown in both 
models of wound repair and retinal angiogenesis (Stefater et al. 2013; Stefater et al. 
2011). In both cases, blockade of MФ secretion of WNTs with a targeted deletion of 
Wls using a Csf1r promoter driven Cre led to vasculature patterning defects. More 
precisely, release of WNTs from MФ induced tissue expression of Flt1, a VEGF-A 
receptor with limited signalling capacities, thereby titrating angiogenic signals 
necessary to promote adequate patterning of the vasculature.  
1.5.3 Wnt signalling and MФ-derived WNTs in regeneration 
1.5.3.1 Wnt signalling in regeneration 
The Wnt signalling pathway not only plays well described roles during development 
it is also known to be essential in the regeneration of some organs. In lower vertebrates, 
members of the canonical pathway were shown to be expressed during limb 
regeneration (Caubit et al., 1997; Poss et al., 2000) whilst its inhibition prevented 
regeneration (Kawakami et al., 2006). In mammals, the pathway is known to play a 
role in skeletal muscle (Otto et al., 2008), hair follicle (Ito et al., 2007), and intestinal 
crypt (Miyoshi et al., 2012) regeneration. As described in section 1.5.2.1 modulation 
of the Wnt signalling pathway is known to be crucial for cardiac organogenesis and is 
also known to promote formation of functional cardiomyocytes from human 
pluripotent stem cells (hPSC) (Lian et al., 2012). Nevertheless, its role in neonatal 
cardiac regeneration is unclear. The Hippo signalling pathway, which controls organ 
size and cell proliferation during development (Pan, 2010; Zhao et al., 2011),  was 
identified as a regulator of neonatal cardiac regeneration. Briefly, activity of the 
pathway leads to phosphorylation of Yes associated protein (YAP) thereby preventing 
its nuclear translocation and activation of genes controlling cell growth. Inhibition of 
the pathway was shown to promote cm proliferation in a Wnt signalling-dependent 
manner in the mouse embryo (Heallen et al., 2011), as well as promoting scar free 
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regeneration 21 days following LAD ligation in P7 and P28 mice (outside of the 
regenerative window) (Xin et al., 2013). These reports therefore suggest a potential 
role of the Wnt signalling pathway in neonatal cardiac regeneration. 
1.5.3.2 MФ -derived WNTs in regeneration 
In the kidney, ischaemia-reperfusion injury was shown, using Axin2-LacZ and 
BATGal reporter mouse lines, to induce a clear increase in canonical Wnt signalling 
activity. It was also shown that MФ were a major source of WNTs during the repair 
phase following injury and that they were able to robustly induce canonical Wnt 
activity in vitro in a reporter cell line. In the tissue, MФ ablation was associated with 
decreased Wnt activity following injury. Furthermore, MФ-specific deletion of Wnt7b 
was shown to impair kidney repair and regeneration by affecting progression of 
epithelial cells through the G2 phase of the cell cycle preventing advancement into 
mitosis (Lin et al., 2010). In the liver, following injury using a model of choline-
deficient, ethionine supplemented diet (CDE) known to specifically cause hepatocyte 
regeneration (Yang et al., 2008), MФ were shown to strongly up-regulate Wnt3a. 
Clodronate liposome mediated ablation of MФ was also shown to prevent hepatocyte 
regeneration in this model, a process that is known to depend on canonical Wnt activity 
(Boulter et al., 2012). 
At the onset of this PhD, these two studies had established role of MФ-secreted WNTs 
in tissue regeneration. Since then, further evidence of the involvement of this axis in 
regeneration has been provided, as discussed later in the thesis.  
It is therefore clear that modulation of the Wnt signalling pathway following injury 
can participate in tissue regeneration. More precisely, MФ-derived WNTs have been 
shown to promote scar-free regeneration of multiple organs. Whether they play a role 











Understanding how an organ grows can help identify factors to promote regeneration 
in the adult tissue. 
Hypothesis 1: New insights on structural and functional maturation of the murine heart 
will be provided by a combination of ECG-gated high-resolution in-vivo ultrasound 
and histological technique. Emphasis will be placed upon the neonatal period, when 
the heart is capable of regeneration 
 
MФ and the Wnt signalling pathway are known to play roles in normal organ growth. 
MФ are able of secreted WNT ligands. This secretion is dependent on the activity of 
the enzyme Porcupine. 
Hypothesis 2: Macrophage depletion and preventing secretion of WNTs from 
macrophages through specific deletion of Porcupine will impair normal cardiac 
functional and structural maturation. 
 
MФ have been shown to be essential in scar-free regeneration of the neonatal murine 
heart. MФ-derived WNTs are essential in the scar-free regeneration of the kidney, 
liver, and gut. 
Hypothesis 3: Preventing secretion of WNTs from macrophages through specific 
deletion of Porcupine will impair scar-free cardiac regeneration in neonatal mice. 
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A list of reagents, consumables and equipment can be found in Section 2.7 with their 
suppliers. Recipes for in-house buffers are in Section 2.8 
2.1 Animals 
All animals were mice aged post-natal day 1 (P1) to P42. Both males and females were 
used. Mice were kept under a 12-hour light/12-hour dark cycle mimicking circadian 
rhythm. Temperature of the environment was maintained at 21±2oC and humidity at 
50±10%. Animals had access to chow diet and water ad libitum. 
2.1.1 United Kingdom – Edinburgh 
Animal work was approved by the University of Edinburgh Preclinical Animal 
Welfare and Ethical Review Board, and by the UK Home Office, project licence 
60/4247 and 70/8933 and personal licence IC353799. 
2.1.1.1 C57BL/6J mice 
C57BL/6J mice were bred in-house from stock originally obtained from Harlan (UK). 
2.1.1.2 MacGreen mice 
(a) Colony 
Tg(Csf1r-Egfp), or ‘MacGreen’, mice express enhanced green fluorescent protein 
(EGFP) under the control of the colony-stimulating factor 1 receptor gene (Csf1r) 
promoter (Sasmono et al., 2003). CSF-1 and its receptor CSF1R are essential in the 
differentiation and survival of macrophages (Dai et al., 2002; Chitu and Stanley, 
2006). Csf1r is mostly expressed by monocytes and macrophages. Csf1r mRNA can 
also be found in neutrophils but is not translated (Sasmono et al., 2007). Nevertheless, 
this indicates an active Csf1r promoter in neutrophils which also express EGFP in 
Tg(Csf1r-Egfp) mice.  Animals containing the transgene were noted as GFP+ve and 
used for visualisation of Csf1r-expressing cells. Animals devoid of the transgene were 
noted as GFP-ve.  This mouse line is on an incomplete C57BL/6J background. Males 
positive for the transgene were kindly donated by Prof Philippa Saunders (MRC Centre 
for Inflammation Research, Edinburgh, UK) and crossed with WT C57BL/6J in-house 
females to establish a colony. A heterozygous breeding strategy was then applied for 
this colony by backcrossing GFP+ve males from each new generation to wild type (WT) 
C57BL/6JOla females. 
 




Ear clips were collected for identification and genotyping purposes of each MacGreen 
animal at weaning by the BRR-LF2 staff. DNA was extracted on column using a 
DNeasy blood and tissue kit according to manufacturer’s instructions.  
Genotyping of the MacGreen mouse was performed by PCR using the following 
primers: EGFP Forward 5’ GCA CGA CTT CTT CAA GTC CGC CAT GCC 3’, 
EGFP Reverse 5’ GCG GAT CTT GAA GTT CAC CTT GAT GCC 3’ and internal 
control primers: Fabpi Forward 5’ CCT CCG GAG AGC AGC GAT TAA AAG TGT 
CAG 3’, Fabpi Reverse 5’ TAG AGC TTT GCC ACA TCA CAG GTC ATT CAG 3’ 
(Final concentration: 1 M). This leads to 267 bp and 500 bp products for EGFP and 
Fabpi respectively. Each PCR reaction contained the following: 
• 5.0 L 2X Biomix 
• 1.0 L Forward Primer EGFP 
• 1.0 L Reverse Primer EGFP 
• L Forward Primer Fabpi 
• L Reverse Primer Fabpi 
• L DNA  
The PCR reaction was then run on a thermocycler using the following programme: 
1) 94oC, 3min 
2) 94oC, 30s 
3) 65oC, 30s 
4) 72oC, 1min 
5) 72oC, 7min 
6) 4oC, forever 
To the PCR product was added 5 L of sucrose gel-loading dye which was then run 
on a 1.5% agarose gel containing 1x gel-red dye in 1X TBE, for 1h at 100 V. The gel 
was then examined under an ultra-violet (UV) lamp and a picture of the result taken. 
Mice containing the transgene Tg(Csf1r-Egfp) produce a 267 bp product. Mice devoid 
of the transgene do not produce a 267 bp product. 
35 cycles 
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Ear clipping is not possible until the second post-natal week in mice. Neonatal 
MacGreen mice were therefore genotyped post mortem by crushing a small amount of 
spleen or skin between slide and coverslip in fluoromount G and assessing the presence 
of GFP+ve cells in the sample using an Axiovert200 fluorescent microscope. 
Figure 2-1 shows both genotyping methods and their correlation. 
 
Figure 2-1: Genotyping of MacGreen mice.  Spleens and skin were collected and 
mounted on a slide in Fluoromount G and observed under a fluorescent microscope 
for GFP detection (A). Egfp DNA was detected by PCR (B). Mouse 14-354 was 
identified as GFP-ve and 14-355 as GFP+ve with both methods. 
 
2.1.2 United States of America – New York 
Animal work was reviewed and approved by the Einstein College of Medicine’s 
Institutional Animal Care and Use Committee (IACUC) under animal protocol 
#20150408 and performed in accordance to the guide for the care and use of laboratory 
animals in line with the National Institute of Health (NIH) Office of Laboratory 
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2.1.2.1 Csf1r-null mice 
(a) Colony 
This mouse line was kindly provided by Prof J.W. Pollard. Mice homozygous for a 
targeted deletion of exon 5 of the Csf1r gene express a truncated Csf1r mRNA and 
lack functional CSF1R protein (Li et al., 2006). Those mice are referred to as Csf1r-
null. Mice lacking CSF1R had previously been shown to lack many tissue 
macrophages and to present a range of developmental abnormalities (Dai et al., 2002). 
Parents heterozygous for the deleted allele of Csf1r were used for breeding. Progeny 
contained homozygotes for the deleted allele (Csf1r-null), heterozygotes, and 
homozygotes for the wild-type (WT) allele (WT animals). Csf1r-null mice were 
compared to their aged matched WT littermates as control. Those mice were aged 
between P1 and P20 and were on a complete C57BL/6J background. 
(b) Genotyping 
Tail clips were collected for genotyping by Dr Liyin Zhu. Tails were digested in 180 
L of tail buffer and 20 L of proteinase K solution and placed at 55oC overnight. 
DNA was then precipitated by adding 2 volumes of 100% ethanol, samples spun at 
max speed for 10 min at 4oC. Supernatant was removed and pellet rinsed with 500 L 
of 70% ethanol. Supernatant was discarded and pellet air-dried and re-suspended in 30 
L of Milli-Q water. 
Deletion of exon 5 of the Csf1r gene was assessed by PCR by Mrs Liyin Zhu using the 
following primers: Csf1r-intron 4 Forward 5’ ATC CCA GCA TTA GGC AGC CT 
3’and Csf1r-intron 5 Reverse 5’ GCC ACC ATG TGT CCG TGC TT 3’. This leads to 
a 1.3 kb product for the WT allele and 600 bp for the deleted allele. Each PCR reaction 
contained the following: 
• 15.3 L H2O 
• 2.5 L   10 X Buffer with Mg 
• 2.0 L   dNTP (2.5 mM) 
• 1.5 L   Primer Csf1r-intron 4 Forward (1.0 M) 
• 1.5 L   Primer Csf1r-intron 5 Reverse (1.0 M) 
• 0.2 L   Takara Taq polymerase 
• 2 L      DNA 
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The PCR reaction was then run on a thermocycler using the following programme: 
1) 95oC, 4 min 
2) 95oC, 30 s 
3) 58oC, 30 s 
4) 72oC, 30 s 
5) 72oC, 7 min 
6) 4oC, forever 
To the PCR product was added 5 L of sucrose gel-loading dye which was then run 
on a 1.5% agarose gel containing 0.5% ethidium bromide in 1X TBE, for 1h at 100 V. 
The gel was then examined under a UV lamp and a picture of the result taken. Mice 
homozygous for the deleted allele of Csf1r (Csf1r-null) produced a single 600bp 
product. Mice homozygous for the WT allele produced a single 1.3kb fragment. Mice 
heterozygous for the deleted allele of Csf1r produced both 600bp and 1.3kb fragments. 
2.1.2.2 Porcupine mouse 
(a) Colony 
This mouse line was kindly provided by Prof J.W. Pollard. Mice homozygous for a 
floxed allele of the Porcupine gene (Porcnfl/fl) were used for breeding and generation 
of experimental animals. Those were originally generated from embryos kindly 
provided by Dr J. Rossant (Hospital for Sick Children Research Institute, Toronto, 
Canada) to Prof J.W. Pollard’s lab (Biechele et al., 2013). Here, the male breeders 
were also heterozygous for a transgene containing the improved Cre (iCre)-
recombinase under the control of the Csf1r promoter (Tg(Csf1r-iCre)) (Deng et al., 
2010). The off-spring of such breeding are homozygous for Porcnfl/fl, and a subset also 
express cre-recombinase in Csf1r-expressing cells (Saha et al., 2016). This mouse line 
is referred to as the Porcupine mouse. Animals expressing iCre were referred to as 
Cre+ve and compared to iCre-deficient (Cre-ve) animals as littermate controls. Those 
mice were aged between P1 and P41 and were on an incomplete FVB background. 
(b) Genotyping 
Tail clips were obtained by either Mr Mark Thompson or myself. DNA was obtained as 
described in 2.1.2.1(b) 
 
40 cycles 
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Homozygosity for the floxed allele of the Porcupine gene was assessed in the mice 
used for the breeding and generation of experimental animals by Mr Mark Thompson. 
The following primers were used: RecF1: 5’ CTG TTA AAC CAA GAC ATG ACC 
TTC A 3’, RecR1: 5’ TAA CTA GGA CGC TTT GGG ATA GGA T 3’ and RecR3: 
5’ GTT CTG CCT TCC TAA CCC ATA TAA C 3’. Primer combination RecF1 and 
RecR1 was used to determine the presence of the floxed allele. This leads to a 138 bp 
product for the WT allele and 248 bp for the floxed allele. Primers RecF1 and RecR3 
were used to confirm the deletion of Porcupine in cells expressing iCre. This produces 
a large fragment (> 1.4 kb) for the WT or floxed allele and 386 bp for the deleted allele. 
A schematic representation of the primers location can be found on (Figure 2-2). Each 
PCR reaction contained the following: 
 
• 13.8 L H2O 
• 2.5 L   10 X Buffer with Mg 
• 2.0 L   dNTP (2.5 mM) 
• 1.5 L   PorcnRecF1 (1.0 M) 
• 1.5 L   PorcnRecR1 (1.0 M) 
• 1.5 L   PorcnRecR3 (1.0 M) 
• 0.2 L   Takara Taq polymerase 
• 2 L      DNA 
The PCR reaction was then run on a thermocycler using the following programme: 
 
1) 95oC, 5 min 
2) 95oC, 45 s 
3) 60oC, 45 s 
4) 72oC, 45 s 
5) 72oC, 5 min 
6) 4oC, forever 
To the PCR product was added 5 L of sucrose gel-loading dye which was then run on a 1.5% 
agarose gel containing 0.5% ethidium bromide in 1X TBE, for 1 hour at 100V. The gel was then 
examined under a a UV lamp and a picture of the result taken. Mice homozygous for the floxed 
30 cycles 
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allele of Porcupine (Porcnfl/fl) produced a single 248bp product. Mice homozygous for the WT 
allele produced a single 138 bp fragment. Mice heterozygous for the floxed allele of the 
Porcupine gene produced both 248bp and 138 bp fragments.  
 
Females Porcnfl/fl; Cre-ve were crossed with males Porcnfl/fl; Cre+ve. Presence of iCre was assessed 
by Mr Mark Thompson and myself using the following set of primers: iCre779 Forward 5’ CAG 
GGC CTT CTC CAC ACC AG C 3’, and iCre386 Reverse 5’ CTG GCT GTG AAG ACC 
ATC 3’. Mice containing the transgene produce a 393bp product. Mice devoid of the transgene 
do not yield a 393bp product. 
 
It was reported by Prof J.W. Pollard’s lab that bone marrow derived macrophages (BMMФ) 
from Cre+ve animals of this mouse line contain 80% of the deleted allele of Porcupine by PCR 
using the RecF1 and RecR3 primers set (Figure 2-2) (Saha et al., 2016). The authors also showed 
that the culture medium from Cre+ve BMMФ was unable to activate the -catenin pathway in 
the TCF/LEF (TOPFLASH) reporter assay (Korinek et al., 1997). Culture medium from Cre-ve 
littermates BMM could induce activity. This indicates that the macrophage-targeted deletion of 




Figure 2-2: Porcupine floxed allele genotyping strategy. A set of three primers were 
used to determine the mice genotype for the floxed and wild-type (WT) allele of Porcupine gene 
(Porcn) as well as the deleted allele. RecF1, RecR1, and RecR3 are the primers used for this 
genotyping. The yellow triangle represents the flippase (Flp) recognition target (FRT) site left 
from the Flp-FRT site directed recombination to remove the neomycin cassette originally 
present in the construct used to introduced LoxP sites (red triangles) around exon 3 of Porcn. 
RecF1 and RecR1 primer combination was used for identification of the floxed and WT alleles. 
These lead to the amplification of a 248 bp fragment for the floxed allele and a 138 bp fragment 
for the WT as the FRT and LoxP site are absent. RecF1 and RecR3 primer combination was 
used to control for cell specific deletion. These leads to the amplification of a large fragment 
(>1.4 kb) for the WT or floxed allele and a 386 bp fragment for the deleted allele. Schematic 
taken from Biechele et al. (2013) 
 




Mice on the C57BL/6 back ground are easily sexed in the neonatal period as male mice 
present with a typical dark patch of skin on their scrotum. Mice on the FVB 
background do not present an easy external way of sexing in the neonatal period. 
Genotyping was therefore used to sex the Porcupine mouse as it was the only one on 
an FVB background. 
Tail clips were obtained by either Mr Mark Thompson or myself. DNA was obtained 
as described in 2.1.2.1(b). 
Sex was determined using a forward primer: 5’ TGA AGC TTT TGG CTT TGA G 3’ and a 
reverse primer: 5’ CCA CTG CCA AAT TCT TTG G 3’. This leads to the amplification of a 
single 300 bp fragment for females. Males lead to the amplification of a 280 bp and 300 bp 
fragment. Each PCR reaction contained the following: 
• 15.3 L H2O 
• 2.5 L   10 X Buffer with Mg 
• 2.0 L   dNTP (2.5 mM) 
• 1.5 L   Forward (1.0 M) 
• 1.5 L   Reverse (1.0 M) 
• 0.2 L   Takara Taq polymerase 
• 2 L      DNA 
The PCR reaction was then run on a thermocycler using the following programme: 
1) 95oC, 3 min 
2) 95oC, 30 s 
3) 50oC, 30 s 
4) 72oC, 30 s 
5) 72oC, 5 min 
6) 4oC, forever 
To the PCR product was added 5 L of sucrose gel-loading dye which was then run on a 2.5% 
agarose gel containing 0.5% ethidium bromide in 1X TBE, for approximately 5 hours. The gel 
was then examined under a UV lamp, a picture of the result taken, and sex identified. 
35 cycles 
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2.2 In vivo work 
2.2.1 Echocardiography from early postnatal to adult stages 
2.2.1.1 Procedure 
When imaging neonatal mice, all pups from a litter were taken away from the dams at 
the same time to prevent maternal cannibalisation (Mahmoud et al., 2014) . The mice 
were placed into a box lined with tissue and bedding which was placed onto a heat mat 
set between 37-40oC. Each animal was weighed and anaesthesia induced with 5% 
(neonates) or 2.5% (juvenile and adult) isoflurane in medical O2 for approximately 2 
min before being placed in a supine position onto a heated ultrasound table (40oC). 
Anaesthesia was maintained through a nose cone with 4-5% (neonates) or 2-3% 
(juvenile and adult) isoflurane during the procedure. When imaging neonatal mice, 
adapters were attached to the end of a standard nose cone (P2 & P4: Ø5 mm, P8: Ø8 
mm) as shown on Figure 2-3. This allowed adequate fitting of the nose cone around 
the neonatal mice airways and effective delivery of anaesthesia throughout the 
procedure. Thoracic hair was removed from juvenile and adult mice using 
commercially available electric shavers and depilatory cream. Conductive ultrasound 
gel was then applied to each paw that were then secured onto copper electrodes to 
allow recording of electrocardiogram (ECG) signals. As shown on Figure 2-3 the set 
up was adapted by Mr Adrian Thomson and myself to be able to record ECG signals 
from neonatal mice. Copper tape was wrapped twice around the body of a resized 
cotton bud and used to extend the ECG electrodes present on the ultrasound table to 
reach the neonatal mouse limbs. The animal’s body temperature was monitored 
throughout the procedure using rectal probes. A heating lamp was used to maintain the 
body temperature between 36.5-37.5oC. Pre-warmed Aquasonic® 100 ultrasound 
transmission gel was applied onto the abdomen avoiding bubble formation.  
 
 




Figure 2-3: Set-up for assessing neonatal cardiac function and structure using 
high-resolution in-vivo ultrasound imaging. 
Ultrasound acquisition was performed by Mr. Adrian Thomson (Chapter 3) or myself 
(Chapter 4 & 5) using a Visualsonics Vevo® 770 ultrasound biomicroscope. The 
details about the different ultrasound probes used in this thesis are listed in Table 2-1. 
Different probes were used to optimise the resolution of the acquired images. Animals’ 
cardiac function was assessed through analysis of standard pulse wave Doppler data 










E18.5 RMV 708 55 30 4.5 
P2, P4, P8 RMV 704 40 40 6 
P21, P42 RMV 707B 30 55 12.7 
Table 2-1: Ultrasound probes. 
 
2.2.1.2 Ultrasound traces acquisition and analysis 
(a) EKV PLAX B-mode 
This specific method allows for electrocardiogram (ECG) gated Kilo-Hertz 
Visualisation (EKV) of the parasternal long axis (PLAX) of the left ventricle (LV). 
Images were acquired with very high temporal resolution over a full cardiac cycle. 
This method allows identification of the LV endocardial and epicardial limits at the 
end of systole and diastole using the cardiac measurement- LV package of the 
Vevo770® software.  Representation of the measurements obtained with this method 
can be found in  Figure 2-4. The software allows calculation of the parameters listed 
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in Table 2-2. Notably, left ventricular end systole and diastole area (LVESA, LVEDA) 
were used to calculate the functional readout of fractional area change (FAC). 
 
 
Figure 2-4: Representative EKV PLAX B-mode still images.  Parasternal long axis 
(PLAX) view of the left ventricle (LV) was imaged throughout a cardiac cycle using 
electrocardiogram gated kilohertz visualisation (EKV) B-mode ultrasound. 
Representative images of a 1 day old mouse left ventricle (LV) at the end of systole 
(A) and diastole (B). The Vevo770 software was used to identify: left ventricular end 
systole and diastole areas of the endocardium (LVESA, endo (a) & LVEDA, endo (e)) 
and epicardium (LVESA, epi (b) & LVEDA, epi (f)), LV endocardial and epicardial 
majors at the end of systole (LV endo major, s (c) & LV epi major, s (d)) and at the 
end of diastole (LV endo major, d (g) & LV epi major, d (h)). Anatomical features are: 
(1) Aortic valve, (2) LV posterior wall, (3) Apex, (4) LV anterior wall, (5) LV cavity. 
A B 




























































































































Chapter 2: Methods 
42 
 
(b) PLAX M-mode 
From the PLAX B-mode view (Figure 2-4) the M-mode cursor was placed to span 
across the left ventricular anterior wall, cavity, and posterior wall (Figure 2-5A). This 
method allows visualisation of wall movement along a single line as shown on Figure 
2-5B which was obtained from a 1 day old mouse. Those traces were used to determine 
end diastolic and systolic distances (EDD & ESD). Those were used by the Vevo® 
770 software to calculate the functional readout of fractional shortening (FS). 
Description of this measurement can be found in Table 2-3. Importantly, note the 
electrocardiogram recording of the 1 day old mouse on Figure 2-5B (green line).  
 
Figure 2-5: Representative PLAX M-mode still image. Parasternal long axis 
(PLAX) view of the left ventricle (LV) wall movement was imaged using M-mode 
with the cursor (yellow dotted line) spanning across the left ventricular anterior wall, 
cavity, and posterior wall (A). Posterior and anterior endocardial wall movement along 
the cursor was traced as indicated by the blue lines on (B) across 3 cardiac cycles. End 
diastolic and systolic distances (EDD & ESD) are used to calculate the fractional 
shortening (FS). Those are representative images of a 1 day old mouse LV. 
 
(c) Standard pulse wave Doppler 
The ultrasound probe was placed to achieve an apical 4 chamber view of the heart and 
the Doppler cursor placed within the left ventricular cavity below the aortic and mitral 
valves Figure 2-6A. Representative Doppler traces can be found on Figure 2-6B, C 
A 
B 
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and schematic representation on Figure 2-6D. The E wave represents the velocity of 
the blood coming from the left atrium passively filling the left ventricle. This passive 
filling is due to a fall of pressure in the left ventricle at the end of systole as it relaxes 
during diastole. The A wave represents the velocity of the blood that is actively 
pumped out of the left atrium into the left ventricle due to the atrial kick. E/A ratios 
are used to identify diastolic dysfunction. On each Doppler trace, Myocardial 
Performance Index (MPI) of the left ventricle was obtained by measurement of 
isovolumic contraction and relaxation times (IVCT, IVRT) and ejection time (ET) 




Figure 2-6: Representative neonatal and adult transmitral pulse wave Doppler 
traces. Pulse wave Doppler traces were obtained from 4 chamber apical view of the 
left ventricle by placing the cursor within the left ventricle (LV) cavity under mitral 
and aortic valves (A). (B) shows a typical neonatal (postnatal day 1 -P1-) Doppler trace 
with A > E wave. (C) shows a typical adult (P42) Doppler trace with A < E wave. (D) 
Schematic representation of an adult transmitral Doppler trace with designation of the 
peak E wave velocity (E), peak A wave velocity (A), isovolumic contraction time 
(IVCT), ejection time (ET), and isovolumic relaxation time (IVRT). 
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2.2.2 Induction and evaluation of cardiac injury in neonatal mice 
2.2.2.1 Preparation for Coronary artery ligation (CAL) surgery in neonatal mice 
The surgical area was first cleaned with 70% ethanol. A sterile zone was created by 
laying of a sterile surgical sheet. A pre-cooled ice pack was then wiped thoroughly 
with 70% ethanol and placed onto the surgical sheet. A new, sterile surgical sheet was 
cut and secured onto the ice pack. 
The male breeder mouse was removed from the cage containing the females and post-
natal day 1 (P1) pups (maternal cage) and placed in a new clean cage. Material from 
the maternal cage was then collected into a petri dish for later use. The entire litter was 
placed into a separate box lined with tissue and placed onto a heat mat and under a 
regular lamp to ensure adequate warmth. Distance of the lamp was adjusted depending 
on the temperature of the room at the time of the surgery. The pups would be kept in 
this holding box for a maximum of ~ 3 h depending on litter size. 
2.2.2.2 CAL surgery in neonatal mice 
Anaesthesia was first induced using isoflurane (4-5%) in medical O2 for 2 min. The 
pup was then wrapped in tissue and placed in crushed ice for 5 min to induce 
hypothermia. Adequate anaesthesia was then checked by lack of movement, lack of 
toe-pinch reflex, and apnoea. The pup was placed and secured in a supine position onto 
the ice pack to maintain anaesthesia throughout the procedure. In a pilot study pups 
were maintained under hypothermia for approximately 15min and the following 
recovery assessed. 100% survival was confirmed at 30min following recovery from 
hypothermia. 
A 5 mm skin incision was placed over the left thorax above the 5th rib and the skin was 
blunt dissected to expose the pectoral muscle using blunt bent forceps. The 5th 
intercostal space was identified and a small opening was created laterally through the 
pectoral and intercostal muscles with sharp bent forceps. Straight forceps were then 
used to open the thorax and visualise the left pulmonary lobes and heart. Blunt bent 
forceps were then used to grab the 5th rib and lift it slightly to allow adequate 
visualisation of the left ventricle and atrium. The left anterior descending (LAD) 
coronary artery was then identified and ligated using 9-0 Ethilon suture. The ribs and 
pectoral muscles were then closed with 1 single stich using 8-0 Prolene suture. A first 
single stich was placed on the skin incision, analgesia was administrated with one drop 
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of 1/50 bupivacaine in saline onto the wound, a second single stich was placed to fully 
close the skin wound using 8-0 Prolene suture. 
The pup was then returned to the rest of the litter on the heat mat and under the lamp 
to stimulate recovery and raise body temperature. Full recovery was assessed by 
restoration of movements, regular breathing patterns, and return of pink colour. 
In order to be able to longitudinally follow individual animals each pup was tattooed 
by injecting a small quantity of dye under the skin of the paws using a 27G needle.  
Once the entire litter had undergone surgery and tattooing the pups were rolled in warm 
and rehydrated material from the maternal cage in an effort to avoid maternal 
cannibalisation. The entire litter was then returned at once to the maternal cage to the 
location of the nest. The litter was not checked again for a few hours to avoid maternal 
stress, which increases risks of cannibalisation (Mahmoud et al., 2014). In a pilot study 
pups were anaesthetised (isoflurane + hypothermia) and maintained under 
hypothermia for approximately 15min, recovered and then re-introduced to their 
mother. 100% survival was confirmed at 24h post-re-introduction. 
2.2.2.3 Confirmation of injury and assessment of regeneration 
To confirm the presence of injury, cardiac function was assessed the day following the 
surgery (day 1) using high-resolution in vivo ultrasound imaging as described in 2.2.1. 
Cardiac functional decrease in the first days following LAD ligation has previously 
been shown to  correlate with signs of myocardial injury (Haubner et al., 2012; Porrello 
et al., 2013). A pilot study was designed to confirm that, in our hands, functional 
decrease following LAD ligation correlated with signs of myocardial damage. As 
shown on Figure 2-7A reduced fractional area change (FAC) at day 1 was used to 
characterise successful LAD ligation leading to myocardial infarction (MI). This 
correlated with signs of myocardial injury on cardiac sections as shown on Figure 2-
7E (black outline) as well as raised plasma cardiac troponin I (cTnI) levels Figure 2-
7G. Plasma cTnI levels were measured as described in section 2.3.1 in blood collected 
from decapitation wounds at day 1 following MI. Functional recovery was also 
observed at day 21 following LAD ligation (Figure 2-7B) as previously described 
(Haubner et al., 2012; Porrello et al., 2013) which was associated with normal left 
ventricular morphology (Figure 2-7F) 




Figure 2-7: High-resolution in vivo ultrasound can be used to confirm presence of 
injury and regeneration following LAD ligation in P1 mice. Mice underwent left 
anterior descending (LAD) coronary artery ligation at postnatal day 1 (P1). At day 1 
(P2), cardiac function was assessed on parasternal long axis (PLAX) view of the left 
ventricle (LV) using M-mode and electrocardiogram gated kilohertz visualisation 
(EKV) B-mode. Functional decrease was used to characterise successful LAD ligation 
at day 1 (A). Functional recovery was also observed at day 21 as previously described 
in the literature (Haubner et al., 2012; Porrello et al., 2013) (B). Representative LV M-
mode traces at day 1 (C) and day 21 (D) showing absence and recovery of wall 
movement respectively in the MI group. Arrows represent End Diastolic and Systolic 
Distances (EDD, ESD) Functional decrease and recovery were respectively associated 
with signs of injury (black outline-E) and normal morphology (F) within the LV on 
H&E stained 4 m thick cardiac sections. Plasma cardiac troponin I (cTnI) were 
measured and showed increased levels at day 1 following LAD ligation compared to 
naïve animals indicative of cardiac injury (G). Data are shown as mean ± SEM. ***p 
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If the pups were to return to the maternal cage following ultrasound imaging, material 
from the maternal cage would be collected into a petri dish to use at the time of re-
introduction. The entire litter was then placed into a separate box lined with tissue and 
placed onto a heat mat and under a regular lamp to ensure adequate warmth. Distance 
from the lamp was adjusted depending on the temperature of the room at the time of 
the scanning. At the end of the imaging session the pups were returned as described in 
2.2.2.2 or culled using a schedule 1 method and relevant tissue collected.  
2.2.2.4 Blood sampling 
Blood was collected at day 1 following LAD ligation subsequently to ultrasound 
imaging for analysis of plasma cardiac troponin I levels as described in 2.3.1. Briefly, 
following decapitation, 50 L of blood was collected from the open wound from each 
neonatal mouse (P2) and placed into a 0.5 mL Eppendorf tube containing 50 L of 
3.2% sodium citrate solution to prevent coagulation. The blood sample was thoroughly 
mixed by pipetting up and down and kept on ice until centrifuged at 6000 g for 10 min 
at 4oC. The plasma was then collected and placed into a new 0.5 mL Eppendorf and 
the sample stored at -80oC until further processing. 
2.2.3 Termination and tissue harvesting 
At the end of each study, mice were weighed and culled using a schedule 1 method. 
The chest was then opened and the heart perfused with approximately 2 mL of 
heparinised saline through the right and left ventricle using a 27G needle. Efficiency 
of the perfusion could be assessed by discolouration of the liver and lungs. The heart 
and other relevant organs were harvested and further processed for fluorescence 
assisted cell sorting (FACS), snap frozen for later RNA extraction, or placed in 10% 
Formalin in phosphate buffered saline (PBS) for 24h at room temperature (RT) and 
then for at least another 24h in 70% ethanol before processing for histology. 
Organs from MacGreen animals were harvested in the same way but then placed in 
4% PFA over-night at 4oC on a roller. The organs were then rinsed 3 times for 5 min 
in PBS and placed in 10% sucrose for 1 hour at RT, 20% sucrose for 2 hours at RT, 
and 30% sucrose over-night at 4oC. Organs were then embedded in optimal cutting 
temperature (OCT) compound and stored at -80oC until further processing. 
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2.3 In vitro work 
2.3.1 Cardiac troponin I (cTnI) enzyme-linked immunosorbent assay (ELISA) 
Cardiac troponin I (cTnI) levels were measured in plasma samples obtained as 
described in section 2.2.2.4 using a high sensitivity kit following manufacturer’s 
instructions. Plasma cTnI levels have long been identified as a powerful marker of 
cardiac injury (Adams et al., 1993). Briefly, plasma was further diluted 1:2 with the 
provided plasma diluent. The sample was then incubated with two antibodies directed 
against cTnI: one attached to the microtiter wells for solid phase immobilisation and 
the second horseradish peroxidase (HRP)-conjugated. This result in a so-called 
sandwich ELISA, with cTnI being secured between the solid phase and HRP-
conjugated antibodies. Samples were then incubated at room temperature for 1 hour 
on a plate shaker, washed with wash solution, and incubated for 20 min with 
tetramethylbenzine, a substrate of HRP. This leads to the development of a blue colour 
stopped by the addition of 1N HCl turning the colour yellow. The absorbance of the 
samples at 405 nm was then obtained on a plate reader. A standard curve was used to 
quantitatively determine the concentration of plasma cTnI.  
This protocol is designed for adult mice which present with levels of plasma troponin 
above 10 ng/mL following MI. As the samples are diluted 1:4 overall, this falls within 
the usual standard curve done with the assay (Figure 2-8A). However, the optical 
density (OD) of the plasma samples from naïve and post-MI neonatal animals were 
lower than those usually obtained from adults and fell at the extremity of the standard 
curve where the linear regression is not most accurate (Figure 2-8A). A new standard 
curve was obtained from the OD values of the standards with the lowest concentrations 
(Figure 2-8B). The samples’ OD fell within the new standard curve’s linear regression 
which had a good coefficient of determination (R2) (Figure 2-8B). 




Figure 2-8: Determination of plasma cTnI levels in naïve and post-MI neonatal 
mice. Plasma samples were obtained and cTnI concentration measured using a high-
sensitivity kit. The original standard curve (A) presented with a good coefficient of 
determination (R2) but the samples fell at one extremity of the linear regression which 
had poor correlation. A new standard curve was made from the standards with the 
lowest concentration and a linear regression produced (B). Linear regressions’ 
equations and R2 are present on each graph. (C) is the list of optical density (OD) 
values obtained for each naïve and post-myocardial infarction (MI) samples. Linear 
regression was performed on GraphPad Prism 5. 
2.3.2 Fluorescence Assisted Cell Sorting (FACS) 
2.3.2.1 Cell suspension preparation from neonatal myocardium 
Unless stated otherwise, due to the amount of tissue available from a neonatal heart 
and according to previous work (Aurora et al., 2014) it was decided to pool multiple 
neonatal hearts in order to perform FACS. The hearts were harvested as described in 
2.2.3. The hearts would then be placed into cold Hank’s balanced salt solution (HBSS) 
in a 1.5 mL Eppendorf tube. All FACS experiments were performed on GFP+ve 
MacGreen mice. Expression of GFP was assessed prior to further processing as 
described in 2.1.1.2(b).  
Hearts were cut into small pieces and placed in a MACs tube C containing 7.5 mL of 
warm HBSS supplemented with 1.25 g/L collagenase D and 60 U/mL of DNase I. The 
tissue was consecutively processed on a gentleMACs dissociator and placed in an 
incubator for 30 min at 37oC. The tissue was then processed on the gentleMACs 
A B 
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dissociator once more and the digest was strained through a 70 m mesh filter into a 
50 mL falcon tube. 20 mL of cold PBS without calcium or magnesium (PBS-/-) was 
then used to rinse the MACs tube. The liquid was then used to flush the filter. The 
sample was centrifuged (300 g, 5 min, 4oC), re-suspended in 10 mL PBS-/-, and 
centrifuged again. The supernatant was discarded again and cells were re-suspended 
in 1 mL PBS -/-. 
2.3.2.2 Cardiac mononuclear phagocytes isolation from neonatal myocardium 
Cells were spun at 300g for 5 min at 4oC, supernatant was discarded and 10 L of 
mouse serum was added to each sample containing 100 L of PBS-/- for 20 min at 
4oC. 50 L of antibody solution was subsequently added to the stained sample and 
incubated for 30 min at 4oC in the dark. Antibody solution was as described in Table 
2-7. 
Antigen Fluorochrome Dilution 
CD45 PE/Cy7 1/100 
Ly6G Pacific Blue 1/100 
CD11b AF700 1/100 
F4/80 PE 1/100 
Ly6C PerCP Cy5.5 1/100 
Table 2-4: Antibody panel and dilution for cardiac mononuclear phagocyte 
isolation from neonatal hearts.  Fluorochrome labelled antibodies were used against 
the antigen listed above to identify cardiac mononuclear phagocyte population in the 
neonatal mouse heart. 
The cell suspension was consecutively rinsed with 1 mL of PBS-/- and cells re-
suspended in PBS-/-  supplemented with 2% foetal bovine serum (FBS). 
Cells were sorted on a FACSAria II or FACS fusion into 2 mL tubes containing 
complete DMEM medium supplemented with 10% FBS. Figure 2-9 shows the gating 
strategies used for extraction of cardiac mononuclear phagocytes from neonatal hearts. 
On Figure 2-10 are the fluorescence minus one (FMO) negative controls for F4/80, 
CD11b, and Ly6C. Cardiac mononuclear phagocytes were collected from naïve and 
post-MI neonatal hearts. F4/80lo, CD11bhi, Ly6C-ve and F4/80hi, CD11blo, Ly6C-ve 
populations were collected from naïve neonatal hearts. Following MI, the F4/80hi, 
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CD11blo, Ly6C-ve was mostly gone (Section 5.4.1), F4/80lo, CD11bhi, Ly6C-ve were 
collected. 
 
Figure 2-9: Gating strategy for cardiac mononuclear phagocytes from neonatal 
MacGreen mice. Cells were gated in the order indicated by the black arrows. SSC-A 
and FSC-A were used to exclude cell debris giving the gate named ‘Cells’. Single cells 
were then gated using FSC-H and FSC-A. From the single cells gate, live cells were 
identified as DAPI-ve. Leukocytes were then gated as CD45+ve. GFP and Ly6G were 
then used to identify neutrophils as GFP+ve, Ly6G+ve labelled N. The GFP+ve, Ly6G-ve 
population was then gated on CD11b and F4/80 in order to identify mononuclear 
phagocytes (labelled M) as (F4/80, CD11b)+ve. Mononuclear phagocytes could be 
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subdivided into F4/80lo, CD11bhi and F4/80hi, CD11blo subsets. Those were further 
characterised based on expression of Ly6C (Ly6C-ve and Ly6C+ve populations).  
Abbreviations; SSC-A: side scatter-area, FSC-A: forward scatter-area, SSC-H: side 
scatter-height, FSC-H: forward scatter-height. 
 
Figure 2-10: Fluorescence minus one (FMO) negative controls for F4/80, CD11b, 
and Ly6C.  Cells obtained from cardiac digests were stained with all antibodies listed 
in Table 2-4 and DAPI except anti-F4/80 (A), anti-CD11b (B), or anti-Ly6C (C). Cells 
were gated as shown on Figure 2-9 and the negative population for F4/80 (A), CD11b 
(B), or Ly6C (C) identified. 
2.4 Molecular biology 
2.4.1 RNA extraction 
Prior to any work involving RNA samples a designated area of the bench, as well as 
pipettes and any consumables required, was wiped clean with 70% ethanol followed 
by RNase Zap. RNase free filtered tips were used.  
2.4.1.1 From cardiac mononuclear phagocytes 
A cell suspension of cardiac mononuclear phagocyte subsets was isolated using FACS 
as described in 2.3.2. Cells were spun down at 1000 g for 5 min at 4oC and RNA was 
extracted using an RNeasy® Micro Kit. Briefly, supernatant was removed and cells 
lysed with 75 L of RLT buffer provided in the RNeasy® kit supplemented with 1% 
-mercaptoethanol.  One volume of 70% ethanol was added to the cell lysate. The mix 
was then loaded onto an RNeasy® Micro Kit column and processed according to 
manufacturer’s instructions. Total RNA was pulled down in 14 L of RNase free water 
and stored at -80oC until further processing. 
2.4.1.2 From whole heart 
Tissues were harvested as described in 2.2.3 and snap frozen until RNA extraction. 
Each whole heart (right and left ventricle) were placed in a labelled 2 mL tissue 
homogenizing tubes containing ceramic beads on dry ice and 1 mL of QIAzol® 
reagent added to the sample before placing it on wet ice. The samples were then 
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homogenised using a Precelly 24 tissue homogeniser 2 times at 6500 rpm for 30 s and 
immediately placed on wet ice to cool down. The homogenate was then transferred 
into an autoclaved 1.5 mL Eppendorf tube, incubated 5 min at RT, and 0.5 mL of 
chloroform added to the homogenate. Samples were shaken by hand for 15 s, incubated 
5 min at RT, and centrifuged at 12,000g for 15 min at 4oC. The upper, aqueous, phase 
was then transferred into a new autoclaved 1.5 mL Eppendorf , 0.5 mL of isopropanol 
added, samples vortexed, and incubated 5 min at RT. Samples were then centrifuged 
at 12,000g for 10 min at 4oC, supernatant discarded, and RNA pellet rinsed with 1 mL 
of 70% ethanol. Samples were then centrifuged at 7,500g for 5 min at 4oC, supernatant 
discarded, and RNA pellet air-dried. Once dry, RNA pellet was dissolved in 30 L of 
RNase free water and stored at -80oC until further use. 
2.4.2 mRNA expression evaluation 
2.4.2.1 In cardiac mononuclear phagocytes 
Total RNA concentration was evaluated on a Nanodrop 1000 but was below the 
detection limit in all samples tested. RNA samples from naïve animals were therefore 
pooled, precipitated with 7.5 M of lithium chloride solution, rinsed with 70% ethanol 
and re-suspended in 14 L of RNase free water to increase RNA concentration. RNA 
samples from post-MI animals were not pooled. Concentrations were however below 
the detection limit of the Nanodrop 1000. At this point, samples contained RNA of up 
to 18 neonatal hearts. 
The total RNA concentration of the samples was then obtained using an Agilent RNA 
6000 Nano kit. RNA concentrations were < 6 ng/L in a total volume of 
approximately 10 L (Figure 2-11A). The intention has been to run these sample on 
an RT2 Profiler™ PCR array specific to the mouse Wnt signalling, but the amount of 
RNA was below the minimum required (400 ng). Regular quantitative PCR (qPCR) 
was therefore performed on macrophage RNA from naïve and post-MI hearts to assess 
the presence of the Wnt5b and Gapdh transcripts. Briefly, cDNA was synthesised from 
10 L of RNA sample using the QuantiTect® reverse transcription kit according to 
manufacturer’s instruction including a genomic DNA wipe-out step. Freshly 
synthesised cDNA was used for qPCR of Wnt5b and Gapdh using Taqman gene 
expression assays and prepared as follows: 
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• Taqman Universal Master Mix II (2x) 5 L 
• Taqman Gene Expression Assay  2 L 
• cDNA      2 L 
• Nuclease Free H2O    1 L 
The following programme was used to run the qPCR on a 7900HT Fast Real-Time 
PCR system: 
1) 95oC, 1 min 20 s 
2) 95oC, 1 s 
3) 60oC, 20 s 
The amount of RNA obtained from cardiac mononuclear phagocytes was also too low 
for regular qPCR. As shown on Figure 2-11B, the house-keeping gene Gapdh had 
threshold cycle (Ct) values around 30 indicating low amount of the transcript due to 
the low quantity of total RNA. The transcript for Wnt5b did not yield any amplification 
within the 40-cycle limit indicating that regular qPCR is unable to detect its expression 




Figure 2-11: Total RNA concentration is insufficient to use on RT2 Profiler™ 
PCR array. Total RNA concentration of different cardiac mononuclear phagocyte 
populations was assessed on an Agilent nano chip (A). mRNA expression of Gapdh 
and Wnt5a was assessed using Taqman gene expression assays (B) 
[totalRNA] (ng/L) RIN total RNA (ng)
P2 (F4/80hi, CD11blo, Ly6C-ve) 0.29 N/A 2.9
P2 (F4/80lo, CD11bhi, Ly6C-ve) 1.38 N/A 13.8
P8 (F4/80hi, CD11blo, Ly6C-ve) 3.57 N/A 35.65489
P8 (F4/80lo, CD11bhi, Ly6C-ve) 3.36 N/A 33.56788
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2.4.2.2 In whole heart 
(a) Samples 
The expression levels of mRNA were assessed on a commercial RT2 Profiler™ PCR 
array specific to the mouse Wnt signalling pathway in whole heart samples assigned 
to the following experimental groups: 
• Naïve neonatal mice (P8), n=6 
• Neonatal mice at day 7 post-MI (P8), n=6 
• Adult mice at day 7 post-MI, n=4 (samples supplied by Dr Katie Mylonas) 
(b) cDNA synthesis 
Immediately after assessing whole heart total RNA quantity and quality using a 
Nanodrop 1000, cDNA was synthesised from each sample using the RT2 First Strand 
Kit provided with the RT2 Profiler™ PCR array specific to the mouse Wnt signalling 
pathway. Briefly, 400 ng of total RNA of each sample was incubated in a genomic 
DNA elimination mix at 42oC for 5 min in a thermocycler (reaction volume: 10 L). 
Reverse transcription mix was then added to each sample that were then incubated at 
42oC for 15 min (reaction volume: 20 L). The reaction was stopped by a step at 95oC 
for 5 min and 91 L of RNase free water was added to each sample. At this point 
cDNA samples were kept at -20oC for less than 48h. 
(c) mRNA expression 
To 102 L of each cDNA sample was added 650 L of 2x RT2 SYBR Green 
Mastermix and 548 L of RNase free water. Samples were then dispensed into RT2 
Profiler PCR Array plates pre-loaded with primers and probes for 84 genes related to 
the Wnt signalling pathway as well as controls. Figure 2-12 shows the RT2 Profiler 
PCR Array layout. A list of each gene can be found in Appendix. 




Figure 2-12: RT2 PCR profiler array template. Each 384-well plate had been pre-
plated with 84 genes of interest to the Wnt signalling pathway, 5 house-keeping genes 
(HKG), genomic DNA controls (GDC), reverse transcription controls (RTC), and 
positive PCR controls (PPC). Each number from 1 to 84 represent each of the 84 genes 
tested and listed in Appendix. The primers and probes for each gene was plated in 
quadruplets allowing analysis of 4 samples per plate.  
 
Each plate was then run onto a Roche Lightcycler 480 using the guidelines obtained 
from: http://www.sabiosciences.com/pcrarrayprotocolfiles.php. The following 
programme was used: 
1) Heat activation 
• 95oC, 10 min 
2) PCR Cycling 
• 95oC, 15 s 
• 60oC, 1 min 
3) Melt Curve 
• 60oC, 15 s 
• 95oC, 0.03oC/s 
(d) Analysis 
The threshold cycle (Ct) was calculated for each well using the second derivative 
method on the Roche Lightcycler software and an excel spread sheet was formatted as 
shown on Figure 2-13 to compare expression data between experimental groups.  
Quality controls were then run per manufacturer’s instructions. The Ct value for the 
genomic DNA (gDNA) contamination controls were above 35 for all samples studied. 
40 cycles 
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This indicates that the gDNA contamination is inexistent or too low to affect gene 
expression profiling. To assess efficiency of the reverse transcription the following 
formula was used for each plate: 
∆𝐶𝑡 = 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝐶𝑡𝑅𝑇𝐶 − 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝐶𝑡𝑃𝑃𝐶  
The value was below 5 for each RT2 Profiler™ PCR array plate indicating efficient 
reverse transcription. PCR reproducibility was assessed by comparing the Ct(PPC) 
values for each sample which should be 20 ± 2 on each RT2 Profiler™ PCR array plate 
and between each plate. One sample belonging to the day 7 adult MI group was 
discarded as its Ct(PPC) value was 25.27. All other samples passed this quality control 
indicating good reproducibility and allows comparison of the results between plates.  
 
Figure 2-13: Example formatted Excel spread sheet for gene expression analysis.  
Data from the RT2 Profiler™ PCR array plates were formatted as shown above. The 
first column on the left indicates each well number corresponding to a gene of interest 
or control as shown in Figure 2-12. The first row lists the different samples 
identification numbers into distinct columns. The second row identifies each sample 
to an experimental group. One group was always designated as ‘Control Group’ (green 
outline) and one group as ‘Test group 1’ (orange outline). For each sample, the 
threshold cycle (Ct) was listed against the corresponding well.   
 
The Ct value of the housekeeping genes (HKG) are used to normalise the Ct of each 
gene of interest (GOI) for each different sample using the following formula: 
∆𝐶𝑡(𝐺𝑂𝐼)𝑠𝑎𝑚𝑝𝑙𝑒 1 = 𝐶𝑡(𝐺𝑂𝐼)𝑠𝑎𝑚𝑝𝑙𝑒 1 − 𝐶𝑡(𝐻𝐾𝐺)𝑠𝑎𝑚𝑝𝑙𝑒 1 
Identification of a HKG that is stably expressed across all samples of the compared 
experimental groups was performed prior to analysis of the RT2 Profiler™ PCR array 
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results. Two comparisons were carried out. The first compared mRNA expression 
levels within whole heart at day 7 following induction of MI in neonatal mice to aged 
matched naïve samples as the reference. As shown on Figure 2-14 all five HKG 
displayed great stability between the two experimental groups. However, Gapdh 
presented with the closest match and was therefore chosen as the HKG for this 
comparison. The second comparison measured mRNA expression difference between 
whole hearts at day 7 following induction of MI in neonatal and adult mice. As shown 
on  Figure 2-15, the genes had a slightly greater variability between the two 
experimental groups, Gusb was selected as it had the closest match between the two 
groups.  
 
Figure 2-14: Identification of best-fit housekeeping gene for comparing gene 
expression changes following MI in the neonatal mouse. The Ct value of each 
housekeeping gene (HKG) for each experimental group were plotted and the HKG 
with the closest match between groups identified and selected for normalising 
expression data. Here Gapdh was selected. Data is mean ± SEM, n=6/group. 




Figure 2-15: Identification of best-fit housekeeping gene for comparing gene 
expression changes following MI between adult and neonatal mice. The Ct value 
of each housekeeping gene (HKG) for each experimental group were plotted and the 
HKG with the closest match between groups identified and selected for normalising 
expression data. Here Gusb was selected. Data is mean ± SEM, n=3-6/group. 
 
From the online data analysis centre of Qiagen (link below) the mouse RT2 Profiler™ 
PCR array specific to the Wnt signalling pathway was selected. The formatted Excel 
spread sheet was then uploaded onto the online data analysis centre and the Ct cut off 
set to 35. All samples were quality checked again by the online platform and passed.  
http://www.qiagen.com/shop/genes-and-pathways/data-analysis-center-overview-
page/ 
The pre-selected HKG was then used to perform the normalisation of the expression 
values on the online data analysis centre. The volcano representation of the data was 
preferred with a boundary set to 1.5-fold change and the p-value to 0.05. This method 
considers a gene to be significantly differentially regulated between the experimental 
groups if it is changed by at least 1.5-fold and the p-value for the comparison is ≤ 0.05.  
The volcano plot and the report created by the online data analysis centre were 
exported and saved.  
 
 




2.5.1 Immunohistochemistry and Immunofluorescence on formalin fixed - paraffin embedded 
tissue 
Paraffin embedded samples were cut into sequential 4 µm thick sections on a Leitz 
microtome with disposable blades. Sections were orientated to achieve a short axis, 2 
chamber view of the heart. Ribbons of sections were carefully transferred onto the 
surface of a 45oC water bath and placed onto electrostatic slides. The slides were then 
labelled and dehydrated overnight at room temperature.  
Prior to staining, slides were deparaffinised and rehydrated by sequential transfer into 
xylene (2 x 5 min), absolute ethanol (2 x 10 s), 90% ethanol (10 s), 80% ethanol (10 
s), 70% ethanol (10 s), and finally washed in distilled water for 5 min. 
2.5.1.1 Haematoxylin and Eosin (H&E) staining 
Staining. This staining was performed at the Queen’s Medical Research Institute 
(QMRI) shared university research facility (SuRF) histology department by myself 
using standardised protocol. Briefly, following deparaffinisation and rehydration 
slides were immersed in Harris Haematoxylin solution (5 min), rinsed under running 
water (20 s), immersed in 1% acid alcohol solution (5 s), dipped into Scott’s tap water 
(2 min), and placed in eosin solution (20s). Slides were finally rinsed under running 
water and dehydrated and cleared by sequential immersion in 70% ethanol (5s), 80% 
ethanol (5 s), 90% ethanol (5 s), absolute ethanol (2 x 5 s), and xylene (2 x 5 min). 
Slides were then mounted with coverslip and left to dry overnight at room temperature. 
Analysis. Images were acquired on a Zeiss slide scanner at magnification x40. 
2.5.1.2 Picrosirius Red (PSR) staining 
Staining. This staining was performed by Melanie McMillan at the QMRI’s SuRF 
histology department using a standard protocol. Briefly, following deparaffinisation 
and rehydration slides were immerged in commercially available picric acid solution 
containing 0.1% direct red (picrosirius red -PSR- solution) for 2-4 hours. Slides are 
then dehydrated and cleared (2.5.1.1). Slides were then mounted with coverslip and 
left to dry overnight at room temperature. 
Analysis. Pictures were then taken using either a Nikon Eclipse E800 microscope using 
a Prior proscan II stage at maginification x10 (Chapter 3) or using a Zeiss slide scanner 
at magnification x40 (Chapter 4 & 5). Analysis was either carried out in Adobe 
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Photoshop CS6 or Definiens software. When using Adobe Photoshop CS6, a region of 
interest (ROI) was selected encompassing the whole LV. A sample image was then 
used to create a colour range mask for the PSR+ve area and for the whole tissue area. 
This was done by identifying pixels falling into each category until a representative 
selection could be obtained and validated on multiple pictures. PSR+ve and whole tissue 
area were then exported into Excel for formatting before statistical analysis. 
When using Definiens software, images were grouped into dark, light, and medium 
subsets to obtain more accurate identification of the PSR staining considering 
variability in the strength of the staining. Each subset was exported into Definiens 
Tissue Studio v2.4 and ROIs manually selected encompassing the whole LV. Each 
ROI was then saved into a workspace and opened in Definiens Developer XD v2.4. 
The image with the widest colour variation within the subset was chosen for sample 
training. A chessboard segmentation was applied to each image creating 5 x 5 pixels 
squares for analysis. A schematic representation can be found on Figure 2-16A. 
PSR+ve, whole tissue, and background were assigned a class and the software trained 
on the sample image by selecting groups of pixels belonging to each class. The red-
green-blue (RGB) value of each selected group of pixel for each class was recorded 
by the software and plotted. Groups of pixels were selected until a smooth distribution 
of RGB values for each class could be discerned. Representative distribution for each 
class can be found on Figure 2-16B. Each group of pixel on the entire image would 
then be assigned a class using built-in features of the software. This was then done 
automatically for all the images of the subset and total PSR+ve and whole tissue area 
exported into excel. This above protocol was designed in close collaboration with 









Figure 2-16: Picrosirius red analysis using Definiens Developer XD v2.4 software.  
Following region of interest selection in Definiens Tissue Studio v2.4 images a 
workspace was created and opened in Definiens Developer XD v2.4. A chessboard 
segmentation was applied to each image. (A) is a simplified representation of this 
method. Groups of 5 x 5 pixels were created from the original image for further 
analysis. Black squares are the original pixels and the red squares represent the 
chessboard segmentation grouping pixels. The functions presented in (B) were used to 
define PSR+ve, whole tissue, and background classes using red (R), green (G), blue (B) 
(RGB) values obtained from a training sample.  
2.5.1.3 Section processing for immunofluorescence 
Following deparaffinisation and rehydration, an antigen retrieval was carried out by 
immersion and microwave heating of the slides in sodium citrate buffer (10 mM, pH6. 
Slides were allowed to cool down to RT for an hour. Slides were then rinsed twice in 
PBS for 3 min, and then mounted onto a Sequenza slide rack. 
A 
B 
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(a) Cardiomyocytes cross-sectional area (CMCSA) 
Staining. Non-specific staining was blocked by 1-hour incubation in 150 L of 10% 
normal goat serum at room temperature. Slides were incubated overnight at 4oC with 
150 L of 1/100 biotinylated Isolectin B4 (IB4) in PBS. The following day the slides 
were rinsed 3x with 1 mL of PBS and incubated with 150 L of 1/100 streptavidin 
coupled Alexa Fluor® 488 and 1/75 rhodamine-coupled wheat germ agglutinin 
(WGA) in PBS for 1h at RT in the dark. IB4 and WGA are both lectins binding to 
carbohydrates found at the cell membrane. IB4 binds to carbohydrates mainly found 
on endothelial cells’ membrane whilst WGA binds to all membranes. Slides were 
rinsed 3x with 1 mL of PBS. Slides were then stained with DAPI (nuclei) for 5 min at 
RT, rinsed and mounted with Fluoromount G and coverslips. Slides were left to dry 
overnight in the dark at RT and subsequently stored in the dark at 4oC.  
Analysis. Pictures were then taken using either a Zeiss Axiovert200 microscope or a 
Zeiss slide scanner at magnification x40. Four fields of view within the outer 
myocardium were obtained as it is where the cardiomyocytes lay perpendicular to the 
short axis view. This view allows measurement of CMCSA. In each field of view, 10 
cardiomyocytes’ cross sectional area were measured using Adobe Photoshop CS6 
software. 
(b) Coronary vasculature 
Staining. Non-specific staining was blocked by 1-hour incubation in 150 L of 10% 
normal goat serum at room temperature. Slides were incubated overnight at 4oC with 
150 L of 1/100 biotinylated IB4 in PBS. The following day the slides were rinsed 3x 
with 1 mL of PBS and incubated with 150 L of 1/100 streptavidin coupled Alexa 
Fluor® 488 and 1/75 Cyanin3 (Cy3) coupled anti- smooth muscle actin (SMA) 
antibody in PBS for 1h at RT in the dark. Slides were rinsed 3x with 1 mL of PBS. 
Slides were then stained with DAPI (nuclei) for 5 min at RT, rinsed and mounted with 
Fluoromount G and coverslips. Slides were left to dry overnight in the dark at RT and 
subsequently stored in the dark at 4oC.  
Analysis. Pictures were then taken using either a Zeiss Axiovert200 microscope or a 
Zeiss slide scanner at magnification x40. Five fields of view within the outer 
myocardium were obtained. Neonatal outer myocardium is not entirely compacted 
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leading to regions without tissues. In comparison, the adult outer myocardium is dense. 
For the quantification of vascular density, regions only containing myocardium were 
drawn around and their areas measured. Counting of vessels was then performed 
within each region and normalised to its respective area. This allows quantification of 
vascular density, expressed in vessels per mm2, and avoids skewing the result by 
including regions empty of myocardium. Vessels diameter were also measured within 
the selected regions. The number of SMA+ve vessels was counted within the whole 
left ventricle. All measurements were performed in Adobe Photoshop CS6 software. 
(c) Cardiomyocytes proliferation 
Staining. Cell membranes were permeabilised by incubating the slides with 150 L of 
0.2% triton x-100 in PBS for 10 min at RT, slides rinsed 3x with 1 mL of PBS, and 
incubated with 150 L of blocking solution, 20% normal goat serum and 5% bovine 
serum albumin (BSA) in TBS, for 1h at RT. Slides were then incubated overnight at 
4oC with 150 L of 1/200 of mouse anti-cardiac troponin T (cTnT) and 1/200 of rabbit 
anti-Ki67 in blocking solution with 0.1% Tween. The following day the slides were 
rinsed 3x with 1 mL of TBS and incubated with 150 L of goat anti-rabbit and goat 
anti-mouse secondary antibodies coupled with Alexa Fluor® 555 and Alexa Fluor® 
488 respectively in TBS for 1h in the dark at RT. Slides were rinsed 3x with 1 mL of 
TBS. Slides were then stained with DAPI (nuclei) for 5 min at RT, rinsed and mounted 
with Fluoromount G and coverslips. Slides were left to dry overnight in the dark at RT 
and subsequently stored in the dark at 4oC.  
Analysis. Pictures were then taken using either a Zeiss Axiovert200 microscope or a 
Zeiss slide scanner at magnification x40. For hearts from the C57BL/6Jola and Csf1r-
null mouse lines, regions only containing myocardium were drawn around and their 
areas measured, as explained in (b)2.5.1.3(b). Counting of the number of Ki67+ve 
nuclei within cTnT+ve cardiomyocytes was performed within each region and 
normalised to its area. This analysis was performed on Adobe Photoshop CS6.   
For hearts from the Porcupine mouse line, whole section images obtained with the 
Zeiss slide scanner were exported into Definiens tissue studio v2.4 software and ROIs 
manually selected encompassing the whole LV. Within each ROI, nuclei were detected 
at 10x using a built-in nuclear detection algorithm based on size and shape. Nuclei 
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detection was refined by indicating to the software ‘real’ and ‘not real’ nuclei. The 
workspace was then opened in Definiens Developer XD v2.4 software. An image with 
the widest colour variation was chosen for sample training.  Cells cytoplasm were 
simulated by growing nuclei by 3 pixels (pix) at 10x. Ki67+ve cells were identified as 
having a nuclear to cytoplasmic ratio of Ki67 staining intensity of > 1.6 and a nuclear 
Ki67 intensity 1.3-fold brighter than the average of all cells. This allows elimination 
of the immediate background staining around the nucleus. The area positive for cTnT 
was identified using a thresholding method. Ki67+ve and Ki67-ve nuclei were counted 
within the cTnT+ve area and data exported for statistical analysis.  
2.5.2 Immunofluorescence on frozen sections 
Tissues embedded in OCT compound were cut into 10 m sequential sections on a 
Leitz cryostat with disposable blades. Sections were orientated to achieve a short axis, 
2 chamber view of the heart. Sections were carefully placed onto electrostatic slides, 
labelled and stored at -80oC until further use. On the day of the staining, the slides 
were taken out of the -80oC freezer and placed in the dark on the bench top at room 
temperature for 1h. Slides were then rinsed twice in PBS for 3 min in the dark, excess 
PBS dabbed with tissue and hydrophobic pen was used to draw around the section. 
2.5.2.1 Identification of macrophages 
Staining. Non-specific staining was blocked by 1-hour incubation in 70 L of 10% 
normal goat serum at room temperature in the dark. Slides were briefly rinsed in PBS 
1x to remove excess blocking solution and incubated overnight at 4oC with 150 L of 
1/1000 rabbit anti-GFP antibody in PBS. The following day the slides were rinsed 3x 
in PBS and incubated with 150 L of 1/200 goat anti-rabbit secondary antibody 
coupled with Alexa Fluor® 488 in PBS for 1h at RT in the dark. Slides were rinsed 3x 
in PBS. Slides were then stained with DAPI (nuclei) for 5 min at RT, rinsed and 
mounted with Fluoromount G and coverslips. Slides were left to dry overnight in the 
dark at RT and subsequently stored in the dark at 4oC.  
Analysis. Pictures were then taken using either a Zeiss slide scanner at magnification 
x40. Areas measuring 200 m x 200 m were selected within 5 different fields of 
view. The number of GFP+ve cells were counted within each area. This analysis was 
performed on Adobe Photoshop CS6. 
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2.6 Statistical analysis 
 
Statistical analysis was performed using GraphPad Prism 5 software. Data are either 
expressed as mean SEM or median interquartile range depending on the observed 
distribution of the samples. Comparison between 2 samples was done using unpaired 
Student’s t-test or Mann-Whitney test. Comparison between more than 2 samples was 
done using either 1 or 2-way ANOVA with post-hoc Bonferroni multi-comparison 
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2.7 List of reagents, consumables and equipment 
 
Table 2-5: List of reagents and their suppliers.
 Reagents Supplier Catalogue number 
10X buffer with Magnesium Sigma-Aldrich P2192 
16% PFA Alfa Aesar 43368 
20% SDS ThermoFisher scientific AM9820 
Acquasonic 100 ultrasound 
transmission gel 
Parker Labs N/A 
Agarose Bioline BIO41025 
Agilent reagents and chips Agilent technologies 5067-1511 
anti-Ly6C PerCP Cy5.5 Biolegend 128012 
anti-mouse CD11b AF700 Biolegend 101222 
anti-mouse CD45 PE/Cy7 Biolegend 109830 
anti-mouse F4/80 PE Biolegend 123110 
anti-mouse Ly6G Pacific 
blue 
Biolegend 127612 
Biomix Bioline BI025012 
Biotinylated Isolectin B4 ThermoFisher Scientific I21414 
b-mercaptoethanol Merck Millipore 444203 
Bovine serum albumin 
(BSA) 
Sigma-Aldrich A7906 
Calcium chloride (CaCL2) Sigma-Aldrich C3306 
Cardiac Troponin I ELISA 
kit 
Life Diagnostics CTNI-1-HSP 
Chloroform ThermoFisher Scientific C/4960/17 
Collagenase D Sigma-Aldrich COLLD-RO 
Conductive ultrasound gel Parker Labs N/A 
Csf1r-null mouse 
genotyping primers 
ThermoFisher scientific N/A 
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Cyanine 3 couple anti-a-
smooth muscle actin 
Sigma-Aldrich C6198 
DAPI Sigma-Aldrich 11284932001 ROCH
E 
Direct red Sigma-Aldrich 365548 
DMEM ThermoFisher Scientific 31053028 
DNase I for FACS Sigma-Aldrich 11284932001 ROCH
E 
DNeasy Blood and Tissue 
kit 
Qiagen 69504 
dNTPs (2.5mM) ThermoFisher scientific R72501 
EDTA Sigma-Aldrich E8008 
Eosin ThermoFisher Scientific 6766009 
Ethanol VWR Chemicals 20821330 
Fluoromount G Southern Biotech 0100-01 
Foetal bovine serum (FBS) ThermoFisher Scientific 10500064 
Formalin (10%) Sigma-Aldrich HT501128 
Gapdh gene expression 
assay 
ThermoFisher Scientific Hs02786624 
Gel red dye Biotium 41003 
Glycerol Sigma-Aldrich C5516 
Goat anti-mouse AF488 ThermoFisher Scientific A11001 
Goat anti-rabbit AF555 ThermoFisher Scientific A32727 
Haematoxylin (Harris) Pioneer Research 
Chemicals Limited 
PRC/R/51 
HBSS ThermoFisher Scientific 14180046 
Heparin ThermoFisher Scientific 10639163 
Hydrochloric acid (HCl-1N) ThermoFisher Scientific SA48-4 
Isoflurane Merial animal health ltd N/A 
Isopropanol VWR Chemicals 20821330 
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MacGreen mouse EGFP 
genotyping primers 
ThermoFisher scientific N/A 
MacGreen mouse Fabpi 
genotyping primers 
ThermoFisher scientific N/A 
Marcaine (bupivacaine) 
Polyamp Steripack 0.25% 
AstraZeneca N/A 
Medical O2 BOC Medical N/A 
Mouse anti-cardiac troponin 
T 
Abcam Ab10214 
Mouse serum Biosera MO-340/500 
Sodium chloride (NaCl) Sigma-Aldrich S3014 
Normal Goat Serum Biosera GO605/500 
Nuclease free water Qiagen 1039480 
Optimal cutting temperature 
(OCT) compound 
Cell Path KMA-0100-00A 
PBS (tablets) Sigma-Aldrich P-4417 
PBS without calcium 
without magnesium 
ThermoFisher Scientific 14190-094 
Porcupine mouse 
genotyping primers 
ThermoFisher scientific N/A 
Proteinase K ThermoFisher scientific 25530-015 




Rabbit anti-GFP Abcam Ab290 
Rabbit anti-Ki67 Abcam Ab15580 
RNase free water Qiagen N/A 
RNase Zap ThermoFisher scientific AM9780 
RNeasy micro kit Qiagen 74004 
RT2 PCR Profiler array 
(Mouse Wnt signalling) 
Qiagen PAMM-043ZG-4 
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Scott's tap water Sigma-Aldrich S5134  
Sex genotyping primers ThermoFisher scientific N/A 
Sodium acetate ThermoFisher scientific R1181 
Sodium citrate  Sigma-Aldrich W302600 
Sterile Saline 0.9% B Braun 362 7632 
Streptavidin AF488 ThermoFisher Scientific S32354 
Sucrose Scientific Laboratory 
Supplies 
CHE3650 
Sucrose gel loading dye ThermoFisher scientific 10725104 
TaKaRa Taq polymerase TaKaRa R001 
Taqman universal Master 
Mix II 
ThermoFisher Scientific 4364103 
Tattooing dye Scream Ink (the tattoo 
shop) 
N/A 
Tris base ThermoFisher Scientific BP152-1 
Tris borate EDTA (TBE) National Diagnostics EC860 
Tris HCl Sigma-Aldrich 10812846001 
Triton X-100 Sigma T-8787 
Tween 20 Sigma P-2287 
WGA - Rhodamine Vectors laboratories RL-1022 
Wnt5a gene expression 
assay 
ThermoFisher Scientific Hs00998537 
Xylene VWR Chemicals 28975-360 
 
Table 2-6: List of consumable and their suppliers.
 Consumable Supplier Catalogue number 
27G needle BD Microlance 3 300635 
Coverslips Leica Biosystems 3800171G 
Disposable blades ThermoFisher scientific 3050835 
Eppendorf tubes ThermoFisher scientific N/A 
Ethilon 9-0 Ethicon W2813 
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Falcon tubes ThermoFisher scientific N/A 
gentleMACS C-tube Miltenyi biotec 130-093-237 
Prolene 8-0 Ethicon W2777 
Slides (electrostatic) VWR 100501-220 
Surgical sheet (sterile) Vet direct VGSD001 
Tissue homogenizing tubes OMNI international SKU 19-627 
 
Table 2-7: List of equipment and their suppliers.
 Equipment Supplier Catalogue number 
7900HT Fast Real-Time 
PCR System  
ThermoFisher Scientific N/A 
Agilent 2100 Bioanalyzer Agilent Technologies N/A 
Animal scale Ohaus Traveller TA301 
AxioVert 200 Zeiss N/A 
Bench top centrifuge ThermoFisher Scientific Heraeus Fresco 17 
Bent blunt forceps Fine Science Tools FST 11052-10 
Copper tape BQLZR N/A 
FACS Aria II BD biosciences N/A 
FACS fusion BD biosciences N/A 
Genotyping thermocycler MJ Research PTC-200 
gentleMACS Dissociator Miltenyi biotec 130-093-235 
Large centrifuge (used for 
FACS protocol) 
ThermoFisher Scientific Heraeus Megafuge 
16R 
Lighcycler® 480 Roche N/A 
Microtome Leica Leitz 1512 
Nanodrop 1000 ThermoFisher Scientific N/A 
Needle holder Fine Science Tools FST 12075-12 
Nikon Eclipse E800 Nikon N/A 
Precelly 24 tissue 
homogeniser 
Bertin instruments N/A 
Prior proscan II Prior scientific N/A 
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Sequenza slide rack ThermoFisher Scientific 73-310-017 
Sharp bent forceps Fine Science Tools FST 11251-35 
Slide scanner Zeiss Axio Scan Z1 
Small Scissors Fine Science Tools FST 15003-08 
Straight blunt forceps Fine Science Tools FST 11064-07 
Thermometer - Adult Physitemp RET-3 
Thermometer - Neonates Physitemp RET-4 
Vevo 770 preclinical 
ultrasound 
Visualsonics N/A 
Water bath Sakura Finetek Europe N/A 
 
2.8 In-house buffer recipes 
 
In-house buffers Composition 
3.2% sodium citrate 
buffer 
32.06 g sodium citrate in 1 L deionised water (pH6) 
Acid alcohol 1% hydrochloric acid in 70% ethanol 
Heparinised saline 10 U for 1 mL of PBS 
Proteinase K solution Proteinase K powder with 200 mL 1 M Tris HCl, 800 mL 
0.5 M CaCl2, 10 mL glycerol, 9 mL deionised water 
Sodium citrate buffer 
(antigen retrieval) 
2.94 g sodium citrate in 1 L deionised water (pH6) 
Tail buffer 6.1 g Tris base, 5 mL EDTA, 5 mL 20% SDS, 5.8 g NaCl 
in 500 mL deionised water 
Tris-buffered saline 
(TBS) 






Chapter 3: Normal growth and 
function of the postnatal murine 
heart 
  




In mammals, there is clear evidence that cardiac regeneration is age-dependent. Both 
the human and mouse neonates have potent cardiac regenerative capacities whilst 
adults do not (Section 1.3.1). In mice, these capacities are limited to the first postnatal 
week (Fratz et al., 2011; Porrello et al., 2011, 2013, Haubner et al., 2012, 2016). 
Understanding the changes occurring in the neonatal period that could contribute to 
the loss of cardiac regenerative capacities therefore appears crucial. Embryonic cardiac 
organogenesis has been extensively studied (Section 1.3.2). Comparatively, studies 
focusing on neonatal cardiac functional and structural maturation are relatively sparse.  
Cardiac structure is defined by morphometric measurements but also by the cellular 
content and architecture. The three major cell types present in the myocardium are 
cardiomyocytes, endothelial cells, and fibroblasts (Pinto et al., 2016). 
Cardiomyocytes, making up most of the tissue volume, are known to rapidly lose their 
proliferative capacities after birth and to mostly grow through hypertrophy in the 
postnatal mouse (Soonpaa and Field, 1998; Leu et al., 2001; Hirschy et al., 2006). 
Early proliferative capacity has been linked to cardiac regeneration in the neonatal 
mouse (Haubner et al., 2012; Porrello et al., 2013). A recent report by Pinto et al. 
(2016) identified endothelial cells as the most abundant non-myocyte cell type in the 
heart. Angiogenesis is essential for the delivery of oxygen and nutrients to the growing 
cardiac muscle. At the start of this PhD the origin and development of the coronary 
vasculature in the embryo had been widely studied as described in Section 1.3.2.2(b). 
In the postnatal animal, coronary vasculature growth was thought to be achieved 
through angiogenesis of vessels formed in the embryo. Formal proof of this concept 
was however lacking. Angiogenesis defects have also been linked to failure of the 
neonatal mouse heart to regenerate (Aurora et al., 2014). 
Due to the size of neonatal mice, the literature linking cardiac functional and structural 
maturation is sparse. Trans-mitral Doppler imaging had been used to characterise 
diastolic function in the mouse embryo in-utero (Phoon and Turnbull, 2003; Yu et al., 
2008) and also postnatally (Zhou et al., 2003b). It had also provided functional 
assessment following coronary artery ligation (CAL) induced MI in adult and neonatal 
mice (Haubner et al., 2012; Moran et al., 2013; Porrello et al., 2013). In neonatal mice, 
however, only non-electrocardiogram (ECG) gated measurements were possible. This 
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made functional read-outs of fractional area change (FAC) and ejection fraction (EF) 
as well as structural information on cavity size, average wall thickness, and ventricular 
mass impossible.  
A systematic analysis relating neonatal cardiac structural and functional maturation 
was thereby missing.  
 
3.2 Hypothesis and aims 
 
Hypothesis: 
‘New insights on structural and functional maturation of the postnatal murine 
heart will be provided by a combination of electrocardiogram-gated high 
resolution in vivo ultrasound and histological techniques’ 
Aims: 
(i) To establish a method to permit collection of structural and 
functional data in vivo in neonatal mice using 
electrocardiogram-gated high-resolution ultrasound  
(ii) To characterise cardiac structural and functional growth in mice 














All mice used in this chapter were wild-type male C57BL/6J bred in-house from 
animals originally bought from Harlan, UK. Mice were aged between P2 and P42. 
3.3.2 Histology 
All tissues were formalin-fixed, paraffin embedded, cut into 4 m thick sections. 
Cardiomyocyte cross-sectional area (CMCSA), cardiomyocyte proliferation as well as 
vessel size, density, and maturation were measured using immuno-fluorescence as 
described in Section 2.5. Picrosirius red (PSR) staining for collagen content was 
performed by Miss Melanie McMillan at the Queen’s Medical Research Institute 
histology facility using a standardised protocol. 
3.3.3 Image acquisition and analysis 
Images used for calculation of CMCSA, vessel size, density and maturation were 
acquired on a Zeiss Axiovert200, magnification x 40. Images used for measurement 
of cardiomyocyte proliferation were imaged on a Zeiss slide scanner Axio Scan Z1, 
magnification x 40. Images used for quantification of collagen content were obtained 
on Nikon Eclipse E800 microscope using a Prior proscan II stage at magnification x 
10. All image analysis was performed on Photoshop CS6 as described in Section 2.5. 
3.3.4 Ultrasound 
Ultrasound was carried out as described in Section 2.2.1. All ultrasound imaging 
within this chapter was performed by Mr Adrian Thompson. Ultrasound analysis was 
carried out by myself as described in Section 2.2.1. 
3.3.5 Statistical analysis 











3.4.1 Cardiac morphometric measurements from early postnatal to adult stages 
As shown on Figure 3-1A body weight significantly increased between each time 
point. Heart wet weight tended to increase but only increased significantly from P21 
onwards (Figure 3-1B). The heart wet weight to body weight ratio was significantly 
increased when comparing P2 and P21 but at no other time point (Figure 3-1C). 
Ultrasound-extracted left ventricle (LV) mass followed the same pattern as heart wet 
weight but a significant increase was observed from P8 onwards (Figure 3-1D). 
 
 
Figure 3-1: Body and heart growth from early postnatal to adult stages. Body 
weight (A) was measured prior to high-resolution in vivo ultrasound postnatal day 2 
(P2), P4, P8, P21, and P42. Heart wet weight (B) was measured immediately after 
high-resolution in vivo ultrasound imaging following dissection and used to calculate 
heart to body weight ratio (C). Left ventricle (LV) mass (D) was extracted from 
electrocardiogram-gated kilohertz visualisation (EKV) parasternal long axis (PLAX) 
B-mode. n = 3-5/group. Results are presented as mean ± SEM.  p-value determined 
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Figure 3-2 shows that LV mass obtained from electrocardiogram-gated kilohertz 
visualisation (EKV) parasternal long axis (PLAX) B-mode ultrasound correlates with 
ex vivo postnatal heart wet weight. 
 
Figure 3-2: Ultrasound-extracted left ventricle (LV) mass correlates with ex vivo 
heart wet weight. Heart wet weight was measured immediately after high-resolution 
in vivo ultrasound imaging following dissection. left ventricle (LV) mass was extracted 
from electrocardiogram-gated kilohertz visualisation (EKV) parasternal long axis 
(PLAX) B-mode. LV mass was plotted against heart wet weight for each animal and 
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LV end systolic and diastolic area (LVESA & LVEDA) were both significantly 
increased from P8 onwards (Figure 3-3B, C).  
 
 
Figure 3-3: Cardiac dimensions throughout postnatal growth. Electrocardiogram-
gated kilohertz visualisation (EKV) parasternal long axis (PLAX) B-mode (A) allowed 
calculation of left ventricle (LV) cavity size at the end of systole (LVESA-B) and 
diastole (LVEDA-C) at postnatal day 2 (P2), P4, P8, P21, and P42. n = 5/group. 
Results are presented as mean ± SEM.  p-value determined with 1-way ANOVA with 
Bonferroni post hoc test. *** p <0.001. 
3.4.2 Three phases of postnatal cardiac growth 
Cardiomyocyte cross-sectional area (CMCSA) was measured as an indicator of 
cardiomyocyte size (Figure 3-4A).  CMCSA was unchanged between P2 and P8 whilst 
ultrasound extracted left ventricular (LV) wall thickness was significantly increased. 
Proliferative cardiomyocyte (cardiac troponin T+ve, Ki67+ve, DAPI+ve) density within 
the left ventricle was shown to be highest at P2 and P4 Figure 3-5B.  
Between P8 and P21 CMCSA increased 2.4-fold whilst LV wall thickness did not 
significantly change and proliferative cardiomyocyte density rapidly decreased to 
reach practically non-detectable levels by P21 (Figure 3-5B).   
A 
B C 
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Finally, between P21 and P42 both CMCSA and LV wall thickness were significantly 
increased by 1.6-fold and 1.3-fold respectively (Figure 3-4B, C) whilst proliferative 
cardiomyocyte density was extremely low (Figure 3-5B). 
 
Figure 3-4: Myocardial growth patterns identified by combining high-resolution 
in vivo ultrasound with histological techniques. Cardiomyocytes cross sectional area 
(CMCSA) was investigated on Wheat Germ Agglutinin (WGA-red-membrane 
marker), isolectin B4 (IB4-green-endothelial cells marker), and DAPI (blue) stained 
4m thick sections at postnatal day 2 (P2), P4, P8, P21, and P42. Vessels appear yellow 
as double positive for IB4 and WGA. Quantification of CMCSA was performed on 5 
different fields of view within the outer layer of the myocardium where 
cardiomyocytes are perpendicular to the plan of section. Representative images (A), 
scale bars = 20m. Upper right corners are zooms, scale bars = 10m. CMCSA 
quantification (B). Left ventricular (LV) wall thickness (C) was extracted from 
electrocardiogram-gated kilohertz visualisation (EKV) parasternal long axis (PLAX) 
B-mode. n = 3-5/group. Results are presented as mean ± SEM.  p-value determined 










Figure 3-5: Cardiomyocyte proliferation is at its highest in the neonate and 
rapidly decrease to low levels in the adult. Proliferative cardiomyocytes (cm) were 
identified as positive for cardiac troponin T (green-cm marker) and containing a 
nucleus, DAPI (blue), positive for Ki67 (red-proliferation maker). Double positive 
nuclei appear pink. Quantification was performed on 5 different field of views across 
the whole left ventricle of 4 m thick cardiac sections at postnatal day 2 (P2), P4, P8, 
P21, and P42.  Representative images (A), scale bars = 20m. Upper right corners are 
zooms, scale bars = 10m. Cardiomyocytes proliferation quantification (B). n = 3-
5/group. Results are presented as mean ± SEM.  p-value determined with 1-way 
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3.4.3 Vessel size, density, and maturation in the postnatal murine heart 
A left shift was observed in vessel size distribution from P2 to P42 (Figure 3-6A, B). 
Average vessel size was significantly reduced between P2 and P8. Vessel size was 
then unchanged between P8 and P42 (Figure 3-6B, C). On the other hand, vascular 
density was significantly increased between P2 and P8. Vascular density was not 
statistically different between P8 and P42 (Figure 3-6D). The number of smooth 
muscle actin (SMA) positive vessels was significantly increased between neonatal 















Figure 3-6: Coronary vessel size, density and maturation during postnatal 
growth. Vessel size, density, and maturation was investigated on isolectin B4 (IB4-
green-endothelial cells),  smooth muscle actin (SMA-red-mural cell coated 
vessels), and DAPI (blue). Quantification of vessel size and density was performed on 
5 different field of views within the outer layer of the left ventricle on 4 m thick 
stained sections at postnatal day 2 (P2), P8 and P42. Representative images (A), scale 
bars = 50m. Upper right corners are zooms, scale bars = 10m. Vessel size 
distribution was investigated at the 3 chosen time points (B). Average vessel size in 
m (C). Vessel density was expressed /mm2 of myocardium (D). Number of SMA+ve 
vessels within the whole left ventricle (E). n = 3-5/group. Results are presented as 
mean ± SEM.  p-value determined with 1-way ANOVA with Bonferroni post hoc test. 
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3.4.4 The heart contains stable levels of interstitial collagen throughout postnatal growth 
Left ventricle collagen content was stable from P2 to P42 (Figure 3-7). 
 
 
Figure 3-7: Cardiac interstitial collagen content is unchanged throughout growth. 
Interstitial collagen content was evaluated on picrosirius red (PSR-collagen marker) 
across the whole left ventricle on 4 m thick section at postnatal day 2 (P2), P4, P8, 
P21, P42 with Photoshop CS6. Collagen fibres appear red, remaining tissue yellow. 
Representative images of PSR stained heart (A). Quantification of PSR+ve area (B). 
Black scale bars = 50 m. n = 3-5/group. Results are presented as mean ± SEM.  p-
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3.4.5 Cardiac systolic function is maintained throughout all phases of murine myocardial 
growth. 
The systolic function read-outs of fractional area change (FAC), ejection fraction (EF), 
and fractional shortening (FS) were unchanged from P2 to P42 (Figure 3-8A, B, C). 
Myocardial performance index (MPI) was also unchanged except between P2 and P8 
when it was decreased.  
 
Figure 3-8: Cardiac systolic function is stable throughout postnatal cardiac 
structural changes. Cardiac systolic function was investigated using high-resolution 
in vivo ultrasound at postnatal day 2 (P2), P4, P8, P21, P42. Electrocardiogram-gated 
kilohertz visualisation (EKV) parasternal long axis (PLAX) B-mode allowed 
calculation of fractional area change (FAC-A) and ejection fraction (EF-B). PLAX 
motion-mode (m-mode) was used to obtain fractional shortening (FS-C). Trans-mitral 
pulse-wave Doppler allowed calculation of the myocardial performance index (MPI-
D). n = 3-5/group. Results are presented as mean ± SEM.  p-value determined with 1-
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3.4.6 Cardiac diastolic function increases drastically during the first postnatal week 
Figure 3-9 shows that at P2, the E to A wave ratio is < 1, it then significantly increases 
in P8 animals which have a ratio > 1. This reversal of the E to A wave ratio is then 
maintained between P8, P21 and P42 with no significant changes. 
 
Figure 3-9: Cardiac diastolic function matures over the first postnatal week. 
Cardiac diastolic function was investigated using high-resolution in vivo ultrasound at 
postnatal day 2 (P2), P8, P21, P42. Trans-mitral pulse-wave Doppler allowed 
calculation of the E wave to A wave ratio. Red line represents a ratio of 1. A ratio < 1 
is typical of foetal cardiac diastolic function. A ratio > 1 is typical of adult cardiac 
diastolic function. n = 3-5/group. Results are presented as mean ± SEM.  p-value 



















Whilst foetal cardiac development has been extensively investigated in mice, relatively 
few have investigated postnatal structural and functional maturation. In this chapter a 
combination of high-resolution in vivo ultrasound and histological techniques were 
used to characterise murine postnatal cardiac growth and function. 
Growth pattern of the postnatal murine heart 
In this chapter, comparison of histological data with ultrasound assessment suggests 
three distinct phases of postnatal cardiac growth. First, between P2 and P8. This phase 
was characterised by unchanged CMCSA, increased cardiomyocyte proliferation and 
a small but significant increase in wall thickness. Consistent with observations of this 
chapter, the width of murine cardiomyocyte freshly isolated from the heart was 
previously reported to be unchanged in this period, (Leu et al., 2001). The neonatal 
period is also known to characterised by high levels of cardiomyocyte proliferation, 
P1 mice contain a significant portion of cm in the G2/M phase of the cell cycle (Walsh 
et al., 2010). This proportion decreases between P1 and P4 whilst proportion of cm in 
S-phase increases (Walsh et al., 2010). Increased DNA synthesis without completion 
of mitosis has been linked to cm binucleation occurring within this time frame in 
rodents (Li et al., 1996; Soonpaa et al., 1996). Here, the density of cm positive for 
Ki67 is highest between P2 and P8 which correlates with the data from the literature 
as Ki67 is present at all active phases of the cell cycle (Gerdes et al., 1984). EKV 
PLAX B-mode ultrasound allowed calculation of average LV wall thickness between 
P2 and P8 which was shown to significantly increase indicating myocardial tissue 
expansion. This observation along with active cm proliferation during the first 
postnatal week characterise a hyperplastic phase of growth of the postnatal murine 
heart. This can be linked to the ability of the neonatal mouse to regenerate its 
myocardium following injury (see Chapter 5) while the myocardium retains the ability 
to expand through cardiomyocyte proliferation (Porrello et al., 2011, 2013; Haubner 
et al., 2012; Porrello and Olson, 2014). Interestingly though, Leu et al. (2001) have 
demonstrated that mouse cardiomyocytes increase in length during the early postnatal 
period, suggesting that not all growth can be attributed to proliferation. Since the onset 
of this PhD considerable advances have been made in the understanding of the 
mechanisms behind early postnatal cardiomyocyte proliferation. Those have included 
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miRNAs, the transcription factors MEIS1, growth factor receptor ERB2, hypoxia, and 
the Hippo and Wnt signalling pathways (Heallen et al., 2011; Chen et al., 2013; 
Mahmoud et al., 2013; Xin et al., 2013; Puente et al., 2014; H. Ma et al., 2016). 
Modulation of these pathways have yielded promising translational results to the adult 
mouse by inducing cardiomyocyte proliferation. This highlights the benefits of 
understanding the mechanism of early postnatal growth for recapitulation in the adult. 
Following the first postnatal week, cardiomyocyte volume, length, and width are 
known to increase whilst DNA synthesis decreases (Leu et al., 2001; Walsh et al., 
2010). This is consistent with data from this chapter showing a decrease in the density 
of cardiomyocytes positive for Ki67 between P8 and P21 and a significant increase in 
CMCSA. The mouse heart has therefore switched from a hyperplastic to a 
hypertrophic mode of growth. Interestingly, ultrasound-extracted LV wall thickness 
did not significantly change between P8 and P21. This is unexpected considering the 
increase in CMCSA observed in that same time period. EKV PLAX B-mode 
ultrasound also allowed calculation of left ventricular end systolic and diastolic area 
(LVESA, LVEDA) which were both significantly increased between P8 and P21. The 
overall LV size is therefore increasing along with CMCSA but this does not translate 
into increased LV wall thickness. A possible explanation for this observation is the 
structural reorganisation of cardiomyocytes within the LV which could lead to a bigger 
chamber without significant increase in wall thickness. Investigating the cellular 
architecture of the myocardium across the whole tissue is however a challenging 
endeavour. In the myocardium, no anatomical structure matching the distinct fibres of 
skeletal muscle can indeed be observed. Instead cardiomyocytes are bound to each 
other in a mesh like structure (Jouk et al., 2007). Groups of cardiomyocytes can be 
tracked along their long axis and have been proposed to form a spiralling structure 
called the ‘helical ventricular myocardial band’ (Stephenson et al., 2016). To this day, 
the precise organisation of cardiomyocytes within the myocardium remains a source 
of debate and investigation (Stephenson et al., 2016). Recently, Bensley et al. (2016) 
have been able to obtain precise information on cardiomyocyte size and bi or mono-
nucleation status using 40 m thick cardiac sections stained with wheat germ 
agglutinin (WGA) and DAPI in combination with confocal imaging. A similar 
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approach could be envisaged here to investigate the architecture of the myocardium 
from early postnatal to adult stages.   
The biological significance of a phase of cardiomyocytes re-organisation is elusive. 
Intracellularly, cardiomyocytes are known to mature postnatally to achieve more 
efficient delivery of adenosine tri-phosphate (ATP) to myofibrils (Piquereau et al., 
2010). In this thesis, Heart to body weight ratio was shown to be constant between 
most time point studied albeit a significant increase at P21. Piquereau et al. (2010) 
have reported a similar change and a subsequent decrease in the ratio between P21 and 
2 months old mice. They propose a link between this observation and an increased 
efficiency of cardiomyocyte contraction after P21. Whether intracellular changes are 
mirrored with changes in tissue architecture is less clear. 
Finally, both CMCSA and LV wall thickness significantly increased between P21 and 
P42, in the absence of cardiomyocyte proliferation, indicative of a purely hypertrophic 
mode of growth.  At the same time point Leu et al. (2001) have observed increased 
volume and width in cardiomyocytes freshly isolated from mouse heart. 
Coronary vasculature maturation in the postnatal mouse 
Angiogenesis is essential in supporting organ growth (Section 1.4.3.1(a)). At the onset 
of this PhD, the pattern of coronary vascular growth in postnatal mammals was 
relatively poorly characterised. Since then an elegant report on the origin and 
formation of the postnatal coronary vasculature was published  by Tian et al. (2014). 
Their study used a tamoxifen inducible Cre driven reporter targeted to endothelial cells 
via the Apelin promoter, specifically expressed by endothelial cells, and not 
endocardial cells (Red-Horse et al., 2010). A single injection of tamoxifen at E10.5 
permanently labelled foetal coronary endothelial cells mostly derived from the sinus 
venosus and their progeny (Section 1.3.2.2(b)). Using this approach the authors 
identitied a ‘first coronary vascular population’ present throughout foetal and postnatal 
life, and observed only within the outermost layer of the myocardium (compact 
myocardium). During foetal life and until P0, the remaining inner myocardium 
receives nutrients and oxygen directly from the ventricular cavity. This trabeculated 
myocardium is characterised by finger-like projections into the ventricular cavity. Data 
from this chapter has shown that the average vessel size within the compact 
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myocardium decreases whilst vessel density increases during the first postnatal week, 
Interestingly, Tian et al. (2014) observed that as the heart grows from P0 to P7, the 
proportion of myocardium irrigated by the first coronary vascular population remains 
unchanged. This observation and the data from this chapter therefore suggests that 
vascularisation of the outermost layer of the myocardium is achieved through the 
expansion of pre-existing vessels: angiogenesis (Carmeliet 2000).  
As for the trabeculated myocardium, part of it undergoes compaction shortly after birth 
which was associated with the appearance of new blood vessels (Tian et al., 2014). 
Those vessels were not derived from the expansion of those present in the compact 
myocardium. The authors argued for an endocardial origin of those vessel through 
epicardial-to-mesenchymal transition (EMT). As the heart grows between P7 and P28, 
showed a moderate increase 
Postnatal vascularisation of the myocardium is therefore not only achieved through 
expansion of pre-existing vessels but also de novo vessel formation. Whether vessels 
composed of endothelial cells from the sinus venosus or of endocardial origin have 
different biological functions is less clear. 
Mural cells which include pericytes and smooth muscle cells provide structural support 
in the maturation of vascular beds (Carmeliet, 2003; Jain, 2003). They are also known 
to regulate angiogenesis by modulating endothelial cell proliferation and migration 
(Carmeliet, 2000; Cai and Schaper, 2008). Here we investigated the coating of the 
postnatal coronary vasculature by smooth muscle cells using  smooth muscle cell 
actin (SMA) as marker. The number of SMA+ve vessels within the whole LV was 
shown to be highest in P42 mice when compared to neonatal mice (P2, P8). As the 
mouse grows, blood pressure increases which has previously been linked to mural cell 
coating of the vasculature (Cai and Schaper, 2008). This would therefore correlate well 
with the pattern observed here. Vessels positive for SMA were sparsely distributed 
throughout the LV. Quantification was therefore performed within the whole LV as 
opposed to selecting fields of view in order to accurately represent the total number of 
SMA+ve vessels.  As hearts are larger in P42 mice compared to neonatal mice, this 
quantification means that SMA+ve vessels were counted across a bigger surface area 
in P42 mice which can skew the quantification. Further investigation would consider 
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another method of quantification, potentially normalising the amount of SMA+ve 
vessels to the area of the LV thereby giving a paramter expressed per mm2. 
Cardiac functional maturation of the postnatal mouse 
Trans-mitral pulse wave Doppler is used to determine the pattern of LV filling by 
comparing the ratio of the passive phase due to LV relaxation (E-wave) to the active 
phase of atrial contraction (A-wave). This ratio reflects diastolic function by indicating 
the portion of ventricular filling performed by ventricular relaxation as opposed to 
atrial contraction (Zhou et al., 2003b; Corrigan et al., 2010). In foetal mice and 
humans, atrial contraction filling of the left ventricle predominates over passive filling. 
This ratio was shown by (Zhou et al., 2003b) to reverse over the course of the first 
postnatal week in mice. The data presented in this chapter supports this observation as 
the E:A wave ratio reverses between P2 and P8 when it acquires the typical adult 
pattern of E > A. 
EKV PLAX B-mode ultrasound was performed for the first time in neonatal mice to 
our knowledge. This allowed measurements of left ventricular end systolic and 
diastolic area (LVESA, LVEDA) across all postnatal stages which increased 
synchronously with body and heart weights. LVESA and LVEDA are used for the 
calculation of the systolic functional read-outs of fractional area change (FAC) and 
ejection fraction (EF). Kulandavelu et al. (2006) had previously reported the recording 
of ECG signal in neonatal mice but not in combination with high-resolution in vivo 
ultrasound. Cardiac systolic function was also assessed on PLAX M-mode and 
transmitral Doppler and showed to be mostly unchanged at the time point studied. A 
significant decrease in myocardial performance index (MPI), collected from pulse-
wave Doppler ultrasound, was however observed when comparing P2 and P8 mice. A 
decreased MPI is indicative of better systolic function. This increased systolic function 
was not observed in any of the 3 other measurements. Corrigan et al. (2010) performed 
a similar study where MPI was measured from foetal to adult stages and saw no 
significant difference between the late foetal stage of E18.5 and 1 week old mice. An 
outlier with a clearly high MPI can be identified in the P2 group. Removal of this 
outlier eliminates the significant difference previously observed between P2 and P8. 
Overall, cardiac systolic function therefore seems unchanged from neonatal to adult 
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stages, despite the significant changes in cardiomyocyte growth and arrangement 
taking place during this period. 
Overall data from this chapter, from both in vivo ultrasound and ex vivo histology, have 
suggested three phases of postnatal growth of the mouse heart. Whilst cardiomyocytes 
had been shown to undergo different phases of growth in the postnatal mouse heart 
(Soonpaa et al., 1996; Leu et al., 2001), how it related to the growth of the whole heart 
was previously unclear. The phases identified here were: a first hyperplasic phase 
characterised by cardiomyocyte proliferation and increased wall thickness between P2 
and P8; a second phase between P8 and P21 of hypertrophic growth in association with 
potential structural rearrangement characterised by CMCSA increase, low 
cardiomyocyte proliferation, and no change in LV wall thickness; and finally, a 
hypertrophic phase characterised by CMCSA and LV wall thickness increase and low 
cm proliferation between P21 and P42. This was allowed with the use of 
Electrocardiogram-gated kilohertz visualisation (EKV) parasternal long axis (PLAX) 
B-mode ultrasound for the first time to our knowledge in neonatal mice. It was also 
shown to provide reliable structural measurements as LV mass obtained using this 
method were shown to strongly correlate with ex vivo measured heart wet weight. This 
technique therefore constitutes a strong tool that can be used in the study of cardiac 
structure and function from early postnatal stages. 
Chapter 4: The role of 
macrophages and macrophage-
secreted WNTs in normal cardiac 
postnatal growth and function 
  
Chapter 4: The role of macrophages and macrophage-derived WNTs in postnatal 




Macrophages (MФ) are found in all adult mammalian tissues where they exert known 
roles in homeostasis (Davies et al., 2013; Wynn et al., 2013). MФ progenitors first 
arise during development as early as E7.5 in the yolk-sac. These progenitors then 
populate various organs including the foetal liver where definitive haematopoiesis is 
established from E12.5 (Schulz et al., 2012). Until birth, the foetal liver remains the 
primary source of circulating monocytes which can give rise to tissue MФ. After birth 
haematopoiesis relocates from the liver to the bone marrow making it the main 
haematopoietic organ in mammals (Ginhoux and Guilliams, 2016). Depending on their 
origin, tissue MФ have also been shown through fate mapping experiments to 
differentially express the canonical MФ marker F4/80 and leukocyte marker CD11b. 
Yolk-sac derived and foetal liver/bone marrow derived MФ are typically F4/80hi, 
CD11blo and F4/80lo, CD11bhi respectively (Schulz et al., 2012).  
In mammals, each organ contains phenotypically distinct subsets of tissue MФ thought 
to have various origin (Ginhoux and Guilliams, 2016). For example, brain tissue MФ, 
microglia, are primarily yolk-sac derived whereas the gut epithelium is populated 
almost entirely with bone-marrow derived MФs in the adult. At the outset of this PhD 
cardiac MФ origin and dynamic in the steady state was unclear. 
The importance of MФ in growth has been in part demonstrated using a mouse model 
homozygous for a null mutation of the colony stimulating factor -1 (Csf1op/op) (Wiktor-
Jedrzejczak et al., 1990; Yoshida et al., 1990). CSF-1 and its receptor CSF1R are 
essential in the differentiation and survival of MФ. The Csf1op/op mouse lacks many 
tissue MФ populations and present a range of developmental abnormalities including 
growth retardation (Chitu and Stanley, 2006). At the start of this PhD project it was 
however unknown whether MФ played specific roles in the postnatal maturation of 
the heart discussed in Section 3.5. 
The highly conserved Wnt signalling pathway is known to play crucial roles during 
development (Wynn et al., 2013) (Section 1.5.2). WNT ligands are secreted proteins 
that are acylated by the member of the membrane bound O-acyltransferase (MBOAT) 
family: porcupine (PORCN). Without acylation, WNTs cannot bind the cargo protein 
wntless (Wls) which is essential for their secretion into the extracellular space (Mikels 
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and Nusse, 2006). WNTs act on the receiving cell by binding to their receptors, 
members of the frizzled (FZD) family. By involving different partners at the 
membrane and intracellularly, WNTs can act through 3 major pathways described in 
Section 1.5.1.1. The most well characterised and so called canonical Wnt signalling 
pathway acts through stabilisation of cytoplasmic -catenin that can then translocate 
to the nucleus and regulate gene expression. 
In the embryonic heart, the Wnt signalling pathway has been shown to play stage 
specific roles in cardiac specification (Gessert and Kühl, 2010). In the adult 
myocardium it is however thought to be quiescent and only re-activated upon injury 
(as reviewed by Dawson et al. 2013). The activity of the Wnt signalling pathway in 
the neonatal heart is however unknown. At the onset of this PhD a brief analysis of 
RNAseq data kindly provided by Prof. Tim Aitman showed that naïve hearts 
differentially expressed Wnt signalling related genes between postnatal day 1 and 10. 
This may indicate a role of the pathway in early postnatal growth. 
Formation of an adequate vasculature is known to be essential in normal organ growth. 
As shown in the previous chapter, vessel size, density and maturation change during 
postnatal growth. Evidence has shown over the years that the Wnt signalling pathway 
is a modulator of angiogenesis (Dejana, 2010). Indeed, endothelial cells express a wide 
range of Fzd receptors at their surface (Goodwin et al., 2006). Additionally, loss of 
function of FZD4 is associated with decreased vascularisation of  the heart and kidney 
(Descamps et al., 2012). Interestingly, MФ-derived WNTs were shown to modulate 
vascular patterning of the retina by controlling apoptosis of endothelial cells (James A 
Stefater et al., 2011). MФ-derived WNTs were also shown to regulate angiogenesis 
by titrating local VEGF (Stefater et al., 2013). Whether they play a role in postnatal 
vascular expansion and patterning in the myocardium is unclear. 
Collectively, the studies presented above argue for a role of both macrophages and 
WNTs during cardiac growth and its associated mechanisms. 
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4.2 Hypothesis and aims 
 
Hypothesis: 
‘Macrophage depletion and preventing secretion of WNTs from macrophages 
through specific deletion of Porcupine will impair normal cardiac growth and 
function’ 
Aims: 
(i) Characterise the presence of cardiac macrophages and their behaviour during 
cardiac postnatal growth. 
(ii) Characterise the impact of constitutive macrophage depletion on normal cardiac 
postnatal growth with a focus on the neonatal period 
(iii)  Study the mRNA expression profile of Wnt signalling pathway genes in cardiac 
mononuclear phagocytes in the steady state 
(iv)  Characterise the effect of macrophage specific deletion of Porcn on normal 
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Three mouse lines were used in the studies reported in this chapter: 
• Tg(Csf1r-Egfp) mice express enhanced green fluorescent protein under the 
control of the colony-stimulating factor 1 receptor gene (Csf1r) promoter. 
Animals expressing the transgene were noted as GFP+ve. This mouse line is 
referred to as the MacGreen mouse and is on an incomplete C57BL/6J 
background. Male and female mice aged between P2 and P42 were used. 
Further details on the mouse line can be found in Section 2.1.1.2. 
These were bred and housed in Edinburgh in the Central Bioresearch Services local 
facility. 
• Male and female mice homozygous for an inactivating deletion of exon 5 of 
Csf1r (further details in Section 2.1.2.1) were used and referred to as Csf1r-
null animals. Wild-type (WT) littermates were used as controls and compared 
to Csf1r-null animals aged between P1 and P20. Those mice were on a 
C57BL/6J background. Genotyping as well as body and heart weight 
measurements were carried out by Dr Liyin Zhu at the Albert Einstein College 
of Medicine, NY. 
• Male and female mice homozygous for a floxed allele of the Porcupine gene 
(Porcnfl/fl) were used for breeding and generation of experimental animals. The 
male breeders were heterozygous for a transgene containing the cre-
recombinase under the control of the Csf1r promoter (Tg(Csf1r-icre)). The off-
spring of such breeding are homozygous for Porcnfl/fl, and a subset also express 
cre-recombinase in Csf1r-expressing cells. This mouse line is referred to as the 
Porcupine mouse. Cre-expressing animals were referred to as Cre+ve and 
compared to cre-deficient (Cre-ve) animals as littermate controls. These mice 
are on an incomplete FVB background. Further details on the mouse line can 
be found in Section 2.1.2.2. Both male and female mice aged between P1 and 
P41 were used in this chapter. Breeding and part of the genotyping and weight 
measurements were carried out by Mr Mark Thompson.  
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These animals were bred and housed at the Einstein College of Medicine (New York, 
Bronx). 
4.3.2 FACS 
Cardiac leukocytes including, granulocytes, monocytes and macrophages were 
measured in heart digest of P2 and P8 GFP+ve MacGreen animals. Hearts of GFP+ve 
animals of the same litter, typically 3-4, were pooled in an effort to increase yield. 
Heart digests were stained with DAPI, CD45 PE-Cy7, Ly6G Pacific blue, CD11b 
Alexa fluor 700, F4/80 PE, and Ly6C PerCP Cy5.5 and assessed as described in 
Section 2.3.2. Gating strategy is shown in Section 2.3.2. 
4.3.3 Histology 
10 m thick frozen sections of male and female MacGreen tissues were stained with 
anti-GFP antibody for MФ visualisation. All other tissues were formalin-fixed paraffin 
embedded and cut into 4 m thick sections as described in Section 2.5. Cardiomyocyte 
cross-sectional area (CMCSA), cardiomyocyte proliferation as well as vessel size, 
density, and maturation were measured using immuno-fluorescence as described in 
Section 2.5. Both male and females were used in the histological characterisation of 
the Csf1r-null and their wild-type littermates. Only males were used in the histological 
characterisation of the Porcupine mouse. Picrosirius red (PSR) staining for 
identification of collagen content was performed by Miss Melanie McMillan at the 
Queen’s Medical Research Institute histology facility using a standardised protocol. 
4.3.4 Ultrasound 
Ultrasound was carried out as described in Section 2.2.1 on male and female Porcupine 
mice aged between P1 and P41 to assess cardiac structure and function. All ultrasound 
measurements within this chapter were acquired by myself. 
4.3.5 Image acquisition and analysis 
Images were acquired on a Zeiss slide scanner Axio Scan Z1, magnification x 40 for 
heart sections of MacGreen and Porcupine mice as well as P1 Csf1r-null mice and 
their corresponding WT littermates. Images were acquired on a Zeiss Axiovert200, 
magnification x 40 for heart sections of P7 Csf1r-null mice and their WT littermates. 
All image analysis was performed on Adobe Photoshop CS6 except cardiomyocyte 
proliferation quantification in Porcupine mice which was performed using Definiens 
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software as described in Section 2.5. The algorithm was written and performed by Dr 
Daniel Soong. 
4.3.6 Statistical analysis 
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4.4.1 Cardiac mononuclear phagocytes during postnatal growth 
Image analysis of heart frozen sections from GFP+ve MacGreen mice showed that the 
density of Csf1r-expressing cardiac mononuclear phagocytes was constant between 
postnatal day 2 (P2) and P42 (Figure 4-1). 
 
Figure 4-1: The density of Csf1r-GFP expressing cells is stable throughout growth 
in the myocardium of MacGreen mice. Representative images (A) of 4m thick 
cardiac sections from GFP+ve MacGreen mice stained for GFP (green) at postnatal day 
2 (P2), P4, P8, P21, P42. Quantification of the number of GFP+ve cells was performed 
on 5 different fields of view across the whole left ventricle (B). Scale bars = 50 m. 
Upper right corners are zooms, scale bars = 10 m. Results are presented as mean ± 
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Flow cytometry analysis in hearts from GFP+ve MacGreen mice revealed 3 distinct 
populations of mononuclear phagocytes at both P2 and P8. Those 3 populations 
differentially expressed F4/80, CD11b and Ly6C. A first population of F4/80hi, 
CD11blo, Ly6C-ve mononuclear phagocyte. A second of F4/80lo, CD11bhi, Ly6C-ve and 
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Figure 4-2: The neonatal heart contains distinct mononuclear phagocyte 
populations. Single, Live, CD45+ve cells were gated on. Neutrophils (N) were 
identified as GFP+ve, Ly6G+ve. The Csf1r+ve, Ly6G-ve population was then gated on 
CD11b and F4/80 in order to identify total mononuclear phagocytes (labelled M) as 
(F4/80, CD11b)+ve. Mononuclear phagocytes could be subdivided into F4/80lo, 
CD11bhi and F4/80hi, CD11blo subsets. F4/80hi, CD11blo contained a single Ly6C-ve 
population whereas F4/80lo, CD11bhi contained both a Ly6C-ve and Ly6C+ve population 
(A). Differential expression of F4/80 and CD11b by flow cytometry of the two 
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The proportion of F4/80hi, CD11blo, Ly6C-ve mononuclear phagocyte within the total 
mononuclear phagocyte population ((F4/80, CD11b)+ve) was unchanged between P2 
and P8. F4/80lo, CD11bhi, Ly6C-ve and F4/80lo, CD11bhi, Ly6C+ve cells’ proportion of 
total mononuclear phagocyte was not significantly changed. However, a trend to an 
increased proportion of F4/80lo, CD11bhi, Ly6C-ve cells and decreased proportion of 
F4/80lo, CD11bhi, Ly6C+ve cells can be noted. 
As shown on Figure 4-3C, the proportion of total leukocytes, as measured using CD45 
(pan-leukocyte marker) and expressed as a percentage of live cells, was unchanged 
between P2 and P8. This was also true of neutrophils, identified as (Csf1r, Ly6G)+ve 
(Figure 4-3D).  
 
 
Figure 4-3: Cardiac mononuclear phagocyte populations during the first 
postnatal week. Gating strategy on Figure 4-2A was used to quantify the frequency 
of F4/80hi, CD11blo, Ly6C-ve - F4/80lo, CD11bhi, Ly6C-ve - F4/80lo, CD11bhi, Ly6C+ve 
mononuclear phagocytes as a proportion of total mononuclear phagocytes each subset 
is expressed as a proportion of the total mononuclear phagocyte ((F4/80, CD11b)+ve) 
in GFP+ve MacGreen mice hearts at postnatal day 2 (P2) and P8 (A). Summary of 
subsets frequencies (B) Total CD45+ve (C) and GFP+ve, Ly6G+ve (D) cells were 
expressed as a proportion of live cells. n=3-4/group. Data are expressed as median ± 
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4.4.2 Constitutive genetic depletion of macrophages impairs body and cardiac growth 
Body and heart wet weight were not significantly different prior to P7 between groups 
(Figure 4-4A, B). However, in P7 and P20 animals both body and heart wet weight 
were significantly reduced in Csf1r-null animals when compared to WT littermates. 
Heart wet weight to body weight ratio (Figure 4-4C) was not significantly different 
between groups at any age, apart from P1, when heart weight was significantly 
increased relative to body weight in Csf1r-null compared to WT littermates. 
 
Figure 4-4: Body and cardiac growth impairment of Csf1r-null animals. Body 
weight (A) as well as heart wet weight (B) were recorded in Csf1r-null animals and 
WT littermates used as controls. Heart wet weight to body weight ratio was then 
calculated (C). Results are presented as mean ± SEM.  p-value determined with 2-way 
ANOVA with Bonferroni post hoc test. * p <0.05, ** p <0.01 *** p <0.001. 
 
4.4.3 Constitutive genetic depletion of macrophages does not impair cardiomyocytes cross 
sectional area or proliferation in the neonatal mouse 
Cardiomyocyte cross sectional area (CMCSA) wasn’t significantly different in Csf1r-
null mice relative to WT during the neonatal period within (P1) and outside (P7) of the 
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Figure 4-5: Constitutive genetic depletion of macrophages does not influence 
CMCSA in the neonatal mouse. Cardiomyocytes cross sectional area (CMCSA) was 
investigated on Wheat Germ Agglutinin (WGA-red-membrane marker), isolectin B4 
(IB4-green-endothelial cells marker), and DAPI (blue) stained 4 m thick sections at 
postnatal day 1 (P1) and P7. Vessels appear yellow as double positive for IB4 and 
WGA. Quantification of CMCSA was performed on 5 different fields of view within 
the outer layer of the myocardium where cardiomyocytes are perpendicular to the plan 
of section. Representative images (A), scale bars = 50m. Upper right corners are 
zooms, scale bars = 10m. CMCSA quantification (B). Clear bars are WT and black 
bars Csf1r-null animals. Results are presented as mean ± SEM.  p-value determined 
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Proliferative cardiomyocyte (cardiac troponin T+ve, Ki67+ve, DAPI+ve) density within 
the left ventricle of Csf1r-null animals and their WT littermates was significantly 
increased between mice aged P1 and P7 (Figure 4-6B). Density of proliferative 
cardiomyocytes was not significantly different between Csf1r-null animals and their 




Chapter 4: The role of macrophages and macrophage-derived WNTs in postnatal 




Figure 4-6: Constitutive genetic depletion of macrophages does not influence 
cardiomyocyte proliferation in the neonatal mouse.  Proliferative cardiomyocytes 
(cm) were identified as positive for cardiac troponin T (green-cm marker) and 
containing a nucleus, DAPI (blue), positive for Ki67 (red-proliferation maker). Double 
positive nuclei appear pink (white arrows). Quantification was performed on 5 
different field of views across the whole left ventricle of 4 m thick cardiac sections 
at postnatal day 1 (P1) and P7 in Csf1r-null mice and compared to their wild-type 
littermates as controls. Representative images (A), scale bars = 50m. Upper right 
corners are zooms, scale bars = 10m. Cardiomyocytes proliferation quantification 
(B). Clear bars are WT and black bars Csf1r-null animals. Results are presented as 
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4.4.4 Constitutive genetic depletion of macrophages does not impair vessel density or size in 
neonatal mice 
A left shift was observed in vessel size distribution from P1 to P7 (Figure 4-7D). 
Average vessel size was significantly reduced between those time points (Figure 4-
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Figure 4-7: Constitutive genetic depletion of macrophages does not influence 
vessel size or density in the neonatal mouse. Vessel size and density was investigated 
on isolectin B4 (IB4-green-endothelial cells),  smooth muscle actin (SMA-red-
mural cell coated vessels), and DAPI (blue). Quantification of vessel size and density 
was performed on 5 different field of views within the outer layer of the left ventricle 
on 4m thick stained sections at postnatal day 1 (P1) and P7 in Csf1r-null mice and 
compared to their wild-type littermates as controls. Representative images (A), scale 
bars = 50m. Upper right corners are zooms, scale bars = 10m. Average vessel size 
in m (B). Vessel density was shown as expressed per mm2 of myocardium (C). Vessel 
size distribution was investigated at the 2 chosen time points (D). Clear bars are WT 
animals and black bars are Csf1r-null. Results are presented as mean ± SEM.  p-value 
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4.4.5 Does Csf1r-icre mediated depletion of Porcn affect normal postnatal cardiac growth 
and function? 
4.4.5.1 Csf1r-icre mediated depletion of Porcn does not influence normal postnatal cardiac 
growth 
Body and heart weight increased from P1 to P41 in Cre-expressing (Cre+ve) and Cre-
deficient (Cre-ve) Porcupine mice (Figure 4-8A, B). Body weight was significantly 
increased in Cre+ve animals at P41 when compared to age-matched Cre-ve littermates 
(Figure 4-8A). No effect of the genotype on body weight at earlier time points could 
be seen. Neither heart wet weight nor the heart to body weight ratio were significantly 
affected by the genotype (Figure 4-8B, C). Although LV mass determined by high-
resolution in vivo ultrasound was significantly increased in Cre+ve animals at P41 when 
compared to age-matched Cre-ve littermates (Figure 4-8D), this is not reflected in actual 
heart weight. 
 
Figure 4-8: Csf1r-icre mediated depletion of Porcn does not impair body or 
cardiac growth. Body weight (A) was measured prior to high-resolution in vivo 
ultrasound. Heart wet weight (B) was measured immediately after high-resolution in 
vivo ultrasound imaging following dissection and used to calculate heart to body 
weight ratio (C). Left ventricle (LV) mass (D) was extracted from electrocardiogram-
gated kilohertz visualisation (EKV) parasternal long axis (PLAX) B-mode. 
Measurements were performed at postnatal day 1 (P1), P3, P7, P20, and P41 in Cre-
expressing (Cre+ve - black bars) and Cre-deficient (Cre-ve - clear bars) Porcupine mice. 
Results are presented as mean ± SEM.  p-value determined with 2-way ANOVA with 
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4.4.5.2 Csf1r-icre mediated depletion of Porcn does not impair cardiomyocyte size or 
proliferation 
CMCSA was significantly increased in Cre+ve mice at P41 when compared to age-
matched Cre-ve littermates as controls. No effect of the genotype on CMCSA at earlier 
time points could be seen (Figure 4-9B). High-resolution in vivo ultrasound extracted 
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Figure 4-9: Csf1r-icre mediated depletion of Porcn does not impair CMCSA. 
Cardiomyocytes cross sectional area (CMCSA) was investigated on Wheat Germ 
Agglutinin (WGA-red-membrane marker), isolectin B4 (IB4-green-endothelial cells 
marker), and DAPI (blue) stained 4 m thick sections at postnatal day 1 (P1), P3, P7, 
P20, and P41 in Cre-expressing (Cre+ve - black bars) and Cre-deficient (Cre-ve - clear 
bars) Porcupine mice. Representative images (A), scale bars = 50m. Upper right 
corners are zooms, scale bars = 10m. CMCSA quantification (B). Left ventricular 
(LV) wall thickness (C) was extracted from electrocardiogram-gated kilohertz 
visualisation (EKV) parasternal long axis (PLAX) B-mode. Results are presented as 
mean ± SEM.  p-value determined with 2-way ANOVA with Bonferroni post hoc test. 








Chapter 4: The role of macrophages and macrophage-derived WNTs in postnatal 
cardiac growth and function 
114 
 
Proliferative cardiomyocyte (cardiac troponin T+ve, Ki67+ve, DAPI+ve) density within 
the left ventricle of Porcupine mice was highest in mice aged P1, P3, and P7 (Figure 
4-10B). This density drops to low levels at P20 and P41 (Figure 4-10B). No significant 
difference between Cre+ve mice and their Cre-ve control littermates was observed.  
 
 
Figure 4-10: Csf1r-icre mediated depletion of Porcn does not influence 
cardiomyocytes proliferation. Proliferative cardiomyocytes (cm) were identified as 
positive for cardiac troponin T (green-cm marker) and containing a nucleus, DAPI 
(blue), positive for Ki67 (red-proliferation maker). Double positive nuclei appear pink. 
Quantification was performed across the whole left ventricle of 4 m thick cardiac 
sections at postnatal day 1 (P1), P3, P7, P20, and P41 in Cre-expressing (Cre+ve - black 
bars) and Cre-deficient (Cre-ve - clear bars) Porcupine mice. Representative images (A), 
scale bars = 50m. Upper right corners are zooms, scale bars = 10m. Cardiomyocytes 
proliferation quantification (B). Results are presented as mean ± SEM.  p-value 
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4.4.5.3 Csf1r-icre mediated depletion of Porcn does not influence vessel size, density, or 
maturation 
Vessel size distribution was not significantly affected by the genotype at any of the 3 
time points investigated (Figure 4-11B). Average vessel size was decreased and vessel 
density increased from P1 to P7 and P41 with no effect of the genotype (Figure 4-11C-
D). As shown on Figure 4-11E the number of SMA+ve vessels throughout the LV was 
drastically increased in adult animals (P41) when compared to neonates (P1, P7). No 
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Figure 4-11: Csf1r-icre mediated depletion Porcn does not influence cardiac vessel 
size, density, or maturation. Vessel size, density, and maturation was investigated on 
isolectin B4 (IB4-green-endothelial cells),  smooth muscle actin (SMA-red-mural 
cell coated vessels), and DAPI (blue). Quantification of vessel size and density was 
performed on 5 different field of views within the outer layer of the left ventricle on 4 
m thick stained sections at postnatal day 1 (P1), P7, and P41 in Cre-expressing (Cre+ve 
- black bars) and Cre-deficient (Cre-ve - clear bars) Porcupine mice.  Representative 
images (A), scale bars = 50m. Upper right corners are zooms, scale bars = 10m. 
Vessel size distribution was investigated at the 3 chosen time points (B). Average 
vessel size in m (C). Vessel density was shown as expressed /mm2 of myocardium 
(D). Number of SMA+ve vessels within the whole left ventricle (E). Results are 
presented as mean ± SEM.  p-value determined with 2-way ANOVA with Bonferroni 
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4.4.5.4 Csf1r-icre mediated depletion of Porcn does not influence cardiac interstitial fibrosis 
Cardiac interstitial fibrosis was investigated on picrosirius red (PSR) stained sections. 
The amount of fibrosis appeared stable across all time-point studied. The genotype did 
not have an effect (Figure 4-12B). 
 
 
Figure 4-12: Csf1r-icre mediated depletion of Porcn does not influence cardiac 
interstitial collagen content. Interstitial collagen content was evaluated on picrosirius 
red (PSR-collagen marker) across the whole left ventricle on 4 m thick section at 
postnatal day 1 (P1), P3, P7, P20, P41 in Cre-expressing (Cre+ve - black bars) and Cre-
deficient (Cre-ve - clear bars) Porcupine mice with Photoshop CS6. Collagen fibres 
appear red, remaining tissue yellow. Representative images of PSR stained heart (A). 
Quantification of PSR+ve area (B). Scale bars = 50 m. Results are presented as mean 




































Chapter 4: The role of macrophages and macrophage-derived WNTs in postnatal 
cardiac growth and function 
118 
 
4.4.5.5 Csf1r-icre mediated depletion of Porcn does not influence cardiac dimensions at systole 
or diastole 
LV end systolic area (LVESA) was increased from P1 to P41 with no effect of 
genotype (Figure 4-13B). LV end diastolic area (LVEDA) was increased from P1 to 
P41. LVEDA was significantly increased in Cre+ve animals at P41 when compared to 
age-matched Cre-ve control littermates No effect of the genotype on LVEDA at earlier 
time points could be seen (Figure 4-13C). 
 
 
Figure 4-13: Csf1r-icre mediated depletion of Porcn does not impair cardiac 
dimensions. Electrocardiogram-gated kilohertz visualisation (EKV) parasternal long 
axis (PLAX) B-mode (A) allowed calculation of left ventricle (LV) cavity size at the 
end of systole (LVESA-B) and diastole (LVEDA-C) at postnatal day 1 (P1), P3, P7, 
P20, P41 in Cre-expressing (Cre+ve - black bars) and Cre-deficient (Cre-ve - clear bars) 
Porcupine mice. Results are presented as mean ± SEM.  p-value determined with 2-
way ANOVA with Bonferroni post hoc test. *** p <0.001. 
 
4.4.5.6 Csf1r-icre mediated depletion of Porcn does not impair cardiac diastolic function 
Both functional measurements of fractional area change (FAC) and ejection fraction 
(EF), obtained with electrocardiogram-gated kilohertz visualisation (EKV) parasternal 
long axis (PLAX) B-mode ultrasound, were similar at all time points up to P20 
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significantly increased in Cre+ve animals when compared to Cre-ve control littermates.  
No effect of the genotype on FAC or EF at earlier time points could be seen (Figure 
4-14A, B). No effect of the genotype could be observed at any time point with the 
additional functional measurements of fractional shortening (FS) and myocardial 
performance index (MPI) obtained from PLAX M-mode and pulse-wave Doppler 
respectively (Figure 4-14C, D).  
 
Figure 4-14: Csf1r-icre mediated depletion of Porcn does not impair cardiac 
systolic function. Cardiac systolic function was investigated using high-resolution in 
vivo ultrasound at postnatal day 2 (P2), P4, P8, P21, P42 in Cre-expressing (Cre+ve - 
black bars) and Cre-deficient (Cre-ve - clear bars) Porcupine mice. Electrocardiogram-
gated kilohertz visualisation (EKV) parasternal long axis (PLAX) B-mode allowed 
calculation of fractional area change (FAC-A) and ejection fraction (EF-B). PLAX 
motion-mode (m-mode) was used to obtain fractional shortening (FS-C). Trans-mitral 
Doppler allowed calculation of the myocardial performance index (MPI-D). Results 
are presented as mean ± SEM.  p-value determined with 2-way ANOVA with 
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4.4.5.7 Csf1r-icre mediated depletion of Porcn does not influence cardiac diastolic function 
A normal pattern of E to A wave ratio reversal was observed in Porcupine mice. Mice 
prior to P7 had a ratio below 1, and mice from P7 had a ratio above 1 (Figure 4-15). 
No significant difference between the two genotypes could be noted. 
 
Figure 4-15: Csf1r-icre mediated depletion of Porcn does not impair cardiac 
diastolic function. Cardiac diastolic function was investigated using high-resolution 
in vivo ultrasound at postnatal day 2 (P2), P8, P21, P42 in Cre-expressing (Cre+ve - 
black bars) and Cre-deficient (Cre-ve - clear bars) Porcupine mice. Trans-mitral pulse-
wave Doppler allowed calculation of the E wave to A wave ratio. Red line represents 
a ratio of 1. A ratio < 1 is typical of foetal cardiac diastolic function. A ratio > 1 is 
typical of adult cardiac diastolic function. Results are presented as mean ± SEM.  p-
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Macrophages have well described roles in tissue homeostasis (Davies et al., 2013; 
Wynn et al., 2013). In the heart, they have mostly been described in the context of 
injury such as myocardial infarction (MI) (Frangogiannis, 2014) and their role during 
normal cardiac growth remains unclear (Pinto et al., 2014). Whilst the Wnt signalling 
pathway has been demonstrated to play key roles during foetal cardiac development 
and following injury in adults (Gessert and Kühl, 2010; Dawson et al., 2013), its role 
during early postnatal cardiac growth is unknown. It is becoming increasingly clear 
that macrophages express and secrete WNTs that are then able to modulate 
angiogenesis (James A Stefater et al., 2011; Stefater et al., 2013). The present study 
therefore aimed at shedding light on the role of macrophages and macrophage-secreted 
WNTs on murine postnatal cardiac growth.  
Mononuclear phagocyte populations in the murine heart 
In this chapter the MacGreen mouse, that expresses GFP under the control of the Csf1r 
promoter (Sasmono et al., 2003), was used to visualise the mononuclear phagocyte 
population within the myocardium. Csf1r mRNA can also be found in neutrophils but 
is not translated (Sasmono et al., 2007). Nevertheless, this indicates an active Csf1r 
promoter in neutrophil which also express GFP in the MacGreen mouse model. Flow 
cytometric analysis allowed to determine that, on average, 30% of GFP+ve cells are 
neutrophils based on their expression of Ly6G. The density of Csf1r-expressing cells 
within the myocardium of MacGreen mice was shown to be constant between P2 and 
P42 averaging at 170 GFP+ve cells/mm2. The average mononuclear phagocytes content 
of the murine myocardium can therefore be estimated at 120 cells/mm2 excluding 
neutrophils. Lavine et al. (2014) had identified an approximate number of 125 
mononuclear phagocytes per milligram of heart tissue in neonatal mice. How this 
compares to our findings is less clear. The neonatal population of Csf1r-expressing 
cells was evenly distributed across the myocardium. Consistent with this data, 
Mylonas et al. (2015) previously reported that cardiac macrophages were also evenly 
distributed in the adult mouse. 
Flow cytometric analysis of neonatal hearts revealed 3 clearly distinct populations of 
mononuclear phagocytes: F4/80hi, CD11blo, Ly6C-ve - F4/80lo, CD11bhi, Ly6C-ve - 
F4/80lo, CD11bhi, Ly6C+ve.  
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The foetal heart contains multiple cardiac mononuclear phagocyte populations that are 
ontologically distinct. F4/80hi, CD11blo macrophages are detected in the heart at E10.5 
(Epelman et al., 2014) and E12.5 (Leid et al., 2016), and are believed to be yolk-sac 
derived as they appear prior to the formal establishment of foetal liver haematopoiesis 
(Schulz et al., 2012). From E12.5 to E16.5 (Epelman et al., 2014) and at E14.5 (Leid 
et al., 2016), data from the literature shows the appearance of a second population with 
the characteristic foetal liver F4/80lo, CD11bhi pattern. This latter population was also 
shown to be positive for C-C chemokine receptor type 2 (CCR2) suggesting a 
monocytic origin (Leid et al., 2016). F4/80hi, CD11blo macrophages were however 
CCR2-ve (Leid et al., 2016). Leid et al. (2016) showed that in the foetal heart both 
CCR2+ve and CCR2-ve populations co-expressed MER proto-oncogene tyrosine kinase 
(MertTK) indicating their macrophage identity. Lavine et al. (2014) however showed 
that in the neonatal heart the CCR2+ve population did not co-express MerTK and 
classed this population as monocytes. In the present study, cells with characteristics of 
yolk-sac and foetal liver derived macrophages were found in neonatal hearts. 
Data from this chapter showed that in the neonatal mouse heart, the F4/80lo, CD11bhi 
population of mononuclear phagocytes contains both Ly6C-ve and Ly6C+ve cells. 
Additional markers such as CCR2 and MerTK would help formally compare this 
population with the published literature. It however possesses the typical foetal 
liver/bone marrow derived pattern of F4/80lo, CD11bhi (Epelman et al., 2014; Lavine 
et al., 2014; Leid et al., 2016). Whether the Ly6C-ve population correspond to the 
CCR2+ve, MerTK+ve population (Leid et al., 2016); and the Ly6C+ve population to the 
CCR2+ve, MerTK-ve population (Lavine et al., 2014) is unclear but should be 
investigated further for better comprehension of the present data. The F4/80hi, CD11blo 
population of mononuclear phagocytes observed in this chapter only contained Ly6C-
ve cells. Yolk-sac derived, F4/80hi, CD11blo cardiac macrophages were shown by Leid 
et al. (2016) to also be Ly6C-ve. This may indicate that the population observed in this 
chapter arise from the yolk-sac. Lineage tracing experiments should be considered as 
formal proof of the origin of the mononuclear phagocyte populations observed in this 
chapter. The precise identification of different cardiac resident mononuclear 
phagocyte population is crucial as they have been shown to play different roles during 
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normal cardiac growth and following injury (Epelman et al., 2014; Lavine et al., 2014; 
Leid et al., 2016). 
Furthermore, the data presented here suggests that the population of yolk-sac derived 
macrophages is stable at least during the first week after birth which is in accordance 
to the literature showing that yolk-sac derived macrophages can still be found in the 
myocardium of adult mice (Epelman et al., 2014). Even though it didn’t reach 
significance some trends are worth noting in the F4/80lo, CD11bhi population. Ly6C+ve 
cells, which likely represent bone-marrow derived monocytes, seemed present in a 
higher proportion at P2 when compared to P8. The opposite was true for Ly6C-ve cells, 
likely to be macrophages. This could indicate that following birth, monocytes are 
recruited to the myocardium where they will then differentiate into macrophages. This 
indeed coincides with a time where the heart undergoes important changes as described 
in Chapter 3. A formal investigation of those populations in the first days after birth 
including the CCR2 marker would help understand their dynamics and provide better 
understanding of the published literature. Measuring levels of chemokines and 
chemokine receptor as well as performing lineage tracing would also provide further 
proof of the recruitment of monocytes to the myocardium shortly after birth. Having 
established this phenotype would then provide a basis for the role of those newly 
recruited macrophages in early postnatal cardiac growth. 
Macrophages in cardiac growth 
In this chapter, the effect of macrophage depletion was investigated using a murine 
model lacking exon 5 of the Csf1r gene. This has previously been shown to reduce 
tissue macrophages numbers (Dai et al., 2002) including microglia in the brain, a prime 
example of yolk-sac derived tissue resident macrophages (Erblich et al., 2011). In the 
heart, tissue macrophages were also reduced using a similar genetic depletion model; 
the Csf1op/op mouse which presents an inactivating mutation within the Csf1 gene (Leid 
et al., 2016). Both ablation of the Csf1r gene and its ligand CSF1 are associated with 
osteopetrosis and reproductive deficiencies along with other defects leading to global 
growth retardation (Dai et al., 2002; Pollard, 2009). 
Consistent with these observation, Csf1r-null animals presented with both body and 
cardiac growth impairment from P7. Heart wet weight to body weight ratio was 
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comparable between Csf1r-null and WT littermates except at P1 where it appeared to 
be increased in mice depleted of macrophages. Further investigation at this time point 
showed that neither CMCSA or cardiomyocyte proliferation were increased which 
could have participated in an increased heart weight via hypertrophy and hyperplasia 
respectively. This correlates with data from Lavine et al. (2014) showing that 
clodronate mediated depletion of cardiac macrophages in the neonatal mouse does not 
affect either CMCSA or cardiomyocyte proliferation. The mechanism behind 
increased heart to body weight ratio at P1 is therefore unclear. It may be due to oedema 
or accumulation of another cell type not investigated. This however needs to be studied 
in a larger cohort of mice. The heart largely continues to grow in proportion to the 
body in these mice.  
There is substantial amount of evidence showing an involvement of macrophages in 
angiogenesis during development and in pathology (Pollard, 2009; Nucera et al., 
2011). In the foetal heart, Csf1op/op mice contain significantly more vessels of a larger 
size compared to WT littermates at E17.5 (Leid et al., 2016). In this chapter, Csf1r-
null mice showed a trend to an increased proportion of larger vessels at P2 although 
this failed to reach statistical significance, due to the small number of hearts that were 
available to use for analysis. Vessel size distribution and density were normal at P8 in 
Csf1r-null compared to WT littermates. (Leid et al., 2016) also observed that their 
phenotype of increased vessel size and density in the foetal heart at E17.5 disappears 
in P21 animals. This suggests that the effect of constitutive macrophage depletion may 
be compensated by alternative mechanisms that allow normal vessel development 
postnatally. Leid et al. (2016) argued for a role of IGF1 as a macrophage secreted 
factor that was shown by them and others to regulate angiogenesis (Bach, 2015). 
Interestingly IGF1 is also known to be produced by cardiac fibroblasts in vitro (Takeda 
et al., 2010) and these cells could represent an alternative compensatory source of the 
growth factor in the absence of macrophages. Further investigation on the role of 
macrophages during coronary vasculature formation would greatly benefit from the 
use of inducible models; that would allow temporal control over macrophage 
depletion, which appears crucial in their function.  
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Interestingly, Leid et al. (2016) saw that foetal liver-derived CCR2+ve macrophage 
primarily localised within the trabeculated myocardium in the foetal heart. The 
phenotype observed in Csf1op/op mice of increased vessel size and density in the foetal 
heart at E17.5 was however not reproduced in a CCR2 KO mouse model (Leid et al., 
2016). Nevertheless, Tian et al. (2014) have shown that prior to P3 the trabecular 
myocardium does not contain any vessels and is supplied in nutrients and oxygen 
through exchange with the blood present in the ventricular cavity. Following birth and 
the increased pressure and demand on the LV, compaction of the trabecular 
myocardium occurs (Sedmera et al., 2000). This is concurrent to the formation of a 
new coronary vasculature to supply the newly compacted myocardium (Tian et al., 
2014). Whether CCR2+ve macrophages play a role in the postnatal vascularisation of 
the newly compacted myocardium is less clear. Using an inducible CCR2 KO mouse 
model could help investigate this further by preventing recruitment of monocytes and 
macrophages to the myocardium at this key time point. 
Even though Csf1op/op mice were shown by Leid et al. (2016) to lack cardiac 
macrophages, and that Csf1op/op and Csf1r-null mice are phenotypically close, a formal 
proof of cardiac macrophages ablation in Csf1r-null animals is lacking the present 
study and prevents conclusive statements to be drawn. Cardiac macrophages 
visualisation on sections has been endeavoured throughout this PhD using the specific 
marker F4/80. This was however inconclusive in our hands. Other markers that may 
be envisaged for immunostainings include Mac-3 or CD68 (Aurora et al., 2014; Lavine 
et al., 2014). Alternatively flow cytometry could also be carried out to confirm cardiac 
macrophage ablation.   
Altogether evidence in the literature suggests that macrophages play a role in 
patterning and maturation of the coronary vasculature during foetal development. 
Their role postnatally is however less clear and may necessitate more refined ablation 
approaches. Their constitutive ablation indeed seems to induce compensatory 
mechanisms.  
Macrophages-derived WNTs and cardiac growth 
The Wnt signalling pathway is known to play and essential biphasic role during cardiac 
organogenesis promoting proliferation and then differentiation of cardiac precursors 
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(Section 1.5.2.1). WNT ligands are secreted proteins that are acylated by the member 
of the membrane bound O-acyltransferase (MBOAT) family: porcupine (PORCN). 
Without acylation, WNTs cannot bind the cargo protein wntless (Wls) which is 
essential for their secretion into the extracellular space (Mikels and Nusse, 2006).  
Macrophages have been identified as a source of WNTs in several organs following 
injury in the adult mouse. These have included the kidney (Lin et al., 2010), the liver 
(Boulter et al., 2012; Irvine et al., 2015; Planas-Paz et al., 2016), the gut (Saha et al., 
2016), and recently in the heart (Palevski et al., 2017). Whether macrophage-derived 
WNTs play a role in normal postnatal heart growth was however less clear. 
Identifying whether cardiac mononuclear phagocytes express WNTs in the steady state 
is evidently crucial to our understanding of their potential role and has been 
endeavoured throughout this PhD. It was however not possible to collect sufficient 
RNA due to the low number of cells collected by FACS for analysis as described in 
Section 2.4.2. Detecting expression of Wnts from cells is notoriously difficult. The 
ability of tissue MФ to express Wnts has previously been shown using nested PCR on 
freshly FACS isolated cells (Lin et al. 2010) or laser capture of F4/80+ve MФ followed 
by total RNA amplification and qRT-PCR (Boulter et al., 2012). Saha et al. (2016) 
were also able to show that culture medium from bone marrow derived MФ (BMMФ) 
is able to induce a positive response in a reporter that is activated when stimulated by 
the WNT/-catenin pathway (Jho et al., 2002).   
One avenue that could be considered for future work is the amplification of the RNA 
collected from sorted mononuclear phagocytes. Nevertheless, mRNA expression does 
not necessarily mean protein expression or secretion. Another way to assess WNTs 
presence and secretion is the use of the reporter cell line mentioned above. This was 
not pursued in the current study due to time constraints but should be revisited. The 
literature shows that for extraction of tissue MФ for cell culture, the preferred method 
is column extraction (Meznarich et al., 2013). If this method is to be envisaged for 
future work, optimisation for cardiac MФ will be necessary in order to confirm purity 
and yield of the population extracted. 
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WNT ligands family consist of 19 members in mammals (Section 1.5.1.1). As no 
specific candidate could be identified with cardiac mononuclear phagocyte expression 
data, a general depletion approached was chosen. As mentioned above, secretion of 
WNTs is dependent on their acylation by PORCN and transport to the membrane by 
Wls (Willert et al., 2003; Port et al., 2008; Herr and Basler, 2012; Saha et al., 2016; 
Palevski et al., 2017). Without either protein, WNTs are not secreted into the 
extracellular space. Two mouse models of mononuclear phagocyte-targeted depletion 
of Porcn, the Porcupine mouse, and Wls, the Wntless mouse, exist using cre-
recombinase expressed from the Csf1r promoter. Both models have been shown to 
effectively delete their targeted genes specifically in macrophages which prevented 
secretion of WNTs into the extracellular space (Saha et al., 2016; Palevski et al., 
2017). However, as mentioned above, neutrophils express Csf1r mRNA indicative of 
an active promoter (Sasmono et al., 2007). They would therefore also be targeted by 
the Csf1r-icre. Neutrophils have been shown to express a number of Fzd receptors and 
to respond to Wnt signals (Y. S. Jung et al., 2013)  but unlike MФ, whether they 
produce WNTs is unclear. As the Porcupine mouse could be kindly provided by Prof 
J.W Pollard’s lab at the Einstein College of Medicine, New York, it was chosen in 
order to investigate the role of macrophage-derived WNTs on normal postnatal growth 
(Biechele et al., 2013; Saha et al., 2016).  
In this chapter, the Porcupine mouse had normal heart and body weight, CMCSA, 
cardiac vascular size and density, ultrasound extracted cardiac dimensions and normal 
function up until P41 when body weight, LV mass, CMCSA, and LV end diastolic 
area were increased in Cre+ve mice compared to the Cre-ve control littermates. This may 
suggest cardiac hypertrophy (Maillet et al., 2013). This phenotype was also associated 
with increased cardiac function measured with electrocardiogram-gated high-
resolution ultrasound which might be suggesting physiological hypertrophy (Maillet 
et al., 2013). A similar trend of increased cardiac function was observed in adult 
Wntless mice, albeit not statistically significant (Palevski et al., 2017). However, 
further characterisation would be required investigating the molecular pathways 
typically involved with cardiac hypertrophy such as increased expression of Igf1, and 
phosphorylation of AKT and GSK3   . Atrial natriuretic 
peptide (ANP) and brain natriuretic peptide (BNP) are two proteins encoded by Nppa 
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and NppB respectively that are known to be up-regulated during cardiac hypertrophy 
(Rohini et al., 2010); determination of their expression should also be envisaged. 
Contrary to the original hypothesis, the Porcupine mouse has a mostly normal 
postnatal growth suggesting little role for macrophage-derived WNTs in the changes 
described in Chapter 3. Even though literature has shown that macrophages are able to 
express and secrete WNTs (Lin et al., 2010; Boulter et al., 2012; Saha et al., 2016), it 
has not been possible in our hands to show their expression in cardiac macrophages. 
Saha et al. (2016) have however shown that Csf1r-iCre mediated depletion of 
Porcupine in the same mouse used in this chapter specifically depleted Porcupine in 
bone-marrow derived macrophages and prevented activation of a Wnt signalling 
reporter cell line. Direct evidence of expression and secretion of WNTs from cardiac 
macrophages, and confirmation of Porcupine depletion in cardiac macrophages as well 
as its effect on WNTs secretion is lacking from this thesis. This represents a major 
challenge experienced during this PhD. 
Altogether data from this chapter has suggested a role for macrophages in normal 
postnatal growth of the whole animal. No specific link between macrophage depletion 
and a heart phenotype could however be established. Even though macrophage 
depletion had been shown to be associated with increased vessel size and density in 
the foetal heart, compensatory mechanisms seem put in place postnatally (Leid et al., 
2016). No effect of macrophage-derived WNTs on cardiac vessel size and density 
could be observed either. However, preventing secretion of WNTs from macrophages 
increases vascular density and branching in the postnatal retina (James A Stefater et 
al., 2011). This may suggest a potential role for macrophage-derived WNTs in the 
effect of macrophage depletion on vascular maturation in the foetal heart. 
 
Chapter 5: The role of 
macrophage-secreted WNTs in 
neonatal cardiac regeneration 
  




Unlike other organs such as the liver (Forbes and Newsome, 2016) that are capable of 
a well-described regenerative response, the adult mammalian heart has thus far been 
considered largely non-regenerative. Following injury such as myocardial infarction 
(MI) a non-contractile scar is therefore formed to replace lost myocardium leading to 
remodelling of the remaining healthy tissue (Cohn et al., 2000; Frangogiannis, 2014). 
Remodelling can in turn become maladaptive and lead to the development of heart 
failure (Section 1.1).   
In contrast, neonatal humans and mice have been shown to retain potent regenerative 
capacities (Fratz et al., 2011; Porrello et al., 2011, 2013, Haubner et al., 2012, 2016). 
Briefly, following induction of MI by permanently ligating the left anterior descending 
(LAD) coronary artery the neonatal mouse is able of full functional recovery and 
regeneration of the lost myocardium following 21 days (Haubner et al., 2012; Porrello 
et al., 2013). For further details see Section 1.3.1. 
In other organs, macrophages (MФ) are key to provision of a suitable environment for 
regeneration (Forbes and Rosenthal, 2014).At the outset of this PhD project a role for 
macrophages in neonatal heart regeneration had been proposed by the Olson lab (ISHR 
conference 2013) based on the detrimental effect of MФ depletion on neonatal heart 
regeneration. This work has subsequently been published (Aurora et al. 2014) and 
presented a role of MФ in angiogenesis post-MI in the neonate. Distinct populations 
of MФ were also shown to participate in the response to cardiac injury in the adult and 
neonatal mouse (Lavine et al., 2014). These studies demonstrate a pivotal role of MФ 
in scar free neonatal cardiac regeneration, but the signalling pathways involved are not 
yet clear. 
Importantly, MФ-secreted WNTs were shown prior to the start of this PhD to be 
essential in regeneration of the kidney. MФ-specific deletion of Wnt7b was indeed 
associated with increased interstitial fibrosis following hypoxia-induced injury of the 
kidney (Lin et al., 2010). Since then a role of MФ-secreted WNTs has been shown in 
the liver where prevention of secretion of WNTs from MФ was also associated with 
increased fibrosis following thioacetamide-induced injury (Irvine et al., 2015); and in 
the gut where prevention of secretion of WNTs from MФ prevented stem cell 
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proliferation in the crypt villi regeneration following radiation-induced injury (Saha et 
al., 2016). 
The Wnt signalling pathway (Section 1.5) is known to be crucial during cardiac 
development (Gessert and Kühl, 2010) and is also involved in mechanisms essential 
to regeneration such as cell proliferation, angiogenesis (Dejana, 2010), and fibrosis 
(Henderson et al., 2010; Laeremans et al., 2010). Of specific interest, WNT5a was 
shown to participate in vascular patterning in a skin wound model (Stefater et al., 
2013) whilst loss of function of the WNT receptor FZD4 diminished vascular networks 
in the heart and kidney (Descamps et al., 2012). WNT5a and WNT3a were also shown 
to regulate proliferation and differentiation of immortalised cardiac fibroblasts into 
myofibroblasts (Laeremans et al., 2010). 
WNTs are highly hydrophobic secreted proteins. Acylation by the member of the 
membrane bound O-acyltransferase (MBOAT) family: porcupine (PORCN), is 
essential to their secretion into the extracellular space (Mikels and Nusse, 2006). 
PORCN, encoded by the gene Porcn, has therefore been used as a tool to prevent 
secretion of WNTs from selected cell populations using cell-type specific cre 
recombinase expression. Notably, macrophage-specific deletion of Porcn was shown 
to prevent secretion of WNTs using expression of cre-recombinase from the colony 
stimulating factor – 1 receptor (Csf1r) promoter (Saha et al., 2016).  
Altogether these observations support a positive role of MФ and specifically MФ-
derived WNTs during organ regeneration. WNT5a could indeed promote adequate 
vascular patterning following MI in the neonate thereby supporting regeneration. This 
ligand along with WNT3a could also regulate proliferation and differentiation of 
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5.2 Hypothesis and aims 
 
Hypothesis: 
‘Preventing secretion of WNTs from macrophages through specific deletion of 
Porcupine will impair scar free cardiac regeneration in neonatal mice’ 
Aims: 
(i) Investigate the impact of MI on the cardiac mononuclear 
phagocyte populations described in Chapter 4. 
(ii) Study the mRNA expression profile of Wnt signalling genes in 
the steady state and post-MI in cardiac macrophages and whole 
heart tissue. 
(iii)Characterise the effect of macrophage-specific abrogation of 























Three mouse lines were used in this chapter: 
• Tg(Csf1r-Egfp) mice express enhanced green fluorescent protein under the 
control of the colony-stimulating factor 1 receptor gene (Csf1r) promoter. 
Animals expressing the transgene were noted as GFP+ve. This mouse line is 
referred to as the MacGreen mouse and is on an incomplete C57BL/6J 
background. Male and female mice aged P8 (naïve or day 7 post-MI). Further 
details on the mouse line can be found in Section 2.1.1.2. 
• C57BL/6J in-house male and female mice aged P8 (naïve and day 7 post-MI). 
(Section 2.1.1.1) 
Both MacGreen and C57BL/6J mouse lines were bred and housed in Edinburgh in the 
Central Bioresearch Services local facility. 
• Male and female mice homozygous for a floxed allele of the Porcupine gene 
(Porcnfl/fl) were used for breeding and generation of experimental animals. The 
male breeders were heterozygous for a transgene containing the cre-
recombinase under the control of the Csf1r promoter (Tg(Csf1r-icre)). The off-
spring of such breeding are homozygous for Porcnfl/fl, and a subset also express 
cre-recombinase in Csf1r-expressing cells. This mouse line is referred to as the 
Porcupine mouse. Cre-expressing animals were referred to as Cre+ve and 
compared to cre-deficient (Cre-ve) animals as littermate controls. These mice 
are on an incomplete FVB background. Further details on the mouse line can 
be found in Section 2.1.2.2. Both male and female mice aged between P1 and 
P22 were used in this chapter. Breeding and part of the genotyping and weight 
measurements were carried out by Mr Mark Thompson.  
These animals were bred and housed at the Einstein College of Medicine (New York, 
Bronx). 
5.3.2 Coronary Artery Ligation (CAL) surgery in neonatal mice 
Animals at postnatal day 1 (P1) underwent CAL surgery to induce MI with naïve 
animals serving as controls as described in Section 2.2.2.  




In order to confirm effective ligation of the LAD, high-resolution in vivo ultrasound 
was carried out at day 1 post-MI as described in Section 2.2.1. Animals that did not 
show functional decrease at day 1 were excluded from the study. Body weights were 
recorded at this time. Before termination, each animal underwent ultrasound at day 21 
post-MI. Body and heart weights were recorded at this time. All ultrasound 
measurement within this chapter were acquired by myself. 
5.3.4 FACS 
Cardiac leukocytes including, granulocytes, monocytes and macrophages were 
measured in heart digest of age-matched naïve and post-MI GFP+ve MacGreen animals 
at day 7. Naïve hearts of GFP+ve animals of the same litter were pooled in an effort to 
increase yield. Hearts of GFP+ve animals at day 7 post-MI were not pooled. Heart 
digests were stained with DAPI, CD45 PE-Cy7, Ly6G Pacific blue, CD11b Alexa 
fluor 700, F4/80 PE, and Ly6C PerCP Cy5.5 and assessed as described in Section 
2.3.2.  
5.3.5 mRNA extraction and expression analysis 
Whole heart total RNA of neonatal C57BL/6J was extracted using the 
Qiazol™/chloroform technique as described in Section 2.4.1.2. mRNA was then 
reverse transcribed and RT-qPCR was performed using the kits provided with the RT2 
Profiler™ PCR array mouse WNT signalling pathway from Qiagen (Section 2.4.2.2). 
Total RNA from adult C57BL/6J at day 7 post-MI were donated by Dr Katie Mylonas 
who performed the adult CAL surgery and RNA extraction. 
5.3.6 Histology 
10 m thick frozen sections of MacGreen tissues were stained with anti-GFP for MФ 
visualisation. All other tissues were formalin-fixed paraffin embedded and cut into 4 
m thick sections as described in Section 2.5. Sections at 3 different levels below the 
ligation were collected at regular interval. At least 2 levels were used for image 
analysis. Picrosirius red (PSR) staining for identification of collagen content was 
performed by Miss Melanie McMillan at the Queen’s Medical Research Institute 
histology facility using a standardised protocol. 
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5.3.7 Image acquisition and analysis 
Images were acquired on a Zeiss slide scanner Axio Scan Z1, magnification x 40 and 
analysed as described in Section 2.5 using either Definiens Developer XD or Adobe 
Photoshop CS6. Analysis using Definiens Developer XD was performed by Dr Daniel 
Soong. 
5.3.8 Statistical analysis 























5.4.1 Changes in mononuclear phagocytes subsets post-MI 
Csf1r-expressing cells were shown to accumulate in the regenerating area of the 
myocardium at day 1 and 7 post-MI in heart sections from MacGreen mice (Figure 5-
1A, B).  
 
Figure 5-1: Csf1r-expressing cells accumulate in the regenerating myocardium 
during the first week post-MI.  MacGreen mice underwent CAL surgery at postnatal 
day 1 (P1), 10 m thick cardiac sections below the ligature were obtained and stained 
with an anti-GFP antibody (green) and DAPI (nuclei-blue) at day 1 (A), and day 7 (B) 
thereby identifying Csf1r-expressing cells. Gold outline marks the regenerating area. 
Scale bars = 100 m. Upper right corners are zooms, scale bars 20 m. 
 
Flow cytometric analysis revealed that at day 7 post-MI the F4/80hi, CD11blo, Ly6C-ve 
population of cardiac mononuclear phagocytes appears to have greatly diminished as 
shown on Figure 5-2B. Contrastingly, the F4/80lo, CD11bhi, Ly6C-ve and F4/80lo, 
CD11bhi, Ly6C+ve populations could still be observed within the neonatal heart at day 
7 post-MI (Figure 5-2B).  
 




Figure 5-2: Cardiac mononuclear phagocyte populations at day 7 post-MI.  
Single, Live, CD45+ve cells were gated as described. Neutrophils (N) were identified 
as GFP+ve, Ly6G+ve. The Csf1r+ve, Ly6G-ve population was then gated on CD11b and 
F4/80 in order to identify total mononuclear phagocytes (labelled M) as (F4/80, 
CD11b)+ve. Mononuclear phagocytes could be subdivided into F4/80lo, CD11bhi and 
F4/80hi, CD11blo subsets. F4/80hi, CD11blo contained a single Ly6C-ve population 
whereas F4/80lo, CD11bhi contained both a Ly6C-ve and Ly6C+ve population. Flow 
charts of neonatal heart digest of naïve postnatal day 8 (P8) (A) and day 7 post-MI 
animals (B).  Differential expression of F4/80 and CD11b by flow cytometry of the 
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As shown on Figure 5-3A, the proportion of total leukocytes, as measured using CD45 
(pan-leukocyte marker) and expressed as a percentage of live cells, was significantly 
increased in the myocardium at day 7 post-MI when compared to age-matched naïve 
hearts. This was also true of neutrophils, identified as (Csf1r, Ly6G)+ve (Figure 5-3B). 
Quantification also showed that the proportion of the F4/80hi, CD11blo, Ly6C-ve 
population of cardiac mononuclear phagocytes is diminished at day 7 post-MI (Figure 
5-3C) whereas that of the F4/80lo, CD11bhi, Ly6C-ve and F4/80lo, CD11bhi, Ly6C+ve 
populations are expanded (Figure 5-3D, E) 




Figure 5-3: Increased immune infiltrate at day 7 post-MI. Quantification of the 
frequency of each immune cell population in the neonatal heart at day 7 following MI 
and in aged-matched naïve postnatal day 8 (P8) animals. Population size was 
expressed as a percentage of live cells. Populations are: total leukocytes as CD45+ve 
(A), neutrophils (B) as well as F4/80hi, CD11blo, Ly6C-ve (C), F4/80lo, CD11bhi, Ly6C-
ve (D), and F4/80lo, CD11bhi, Ly6C+ve (E) mononuclear phagocytes. n=4/group. Data 
are expressed as median ± interquartile range. p-value was determined with two-tailed 
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5.4.2 Assessment of Wnt signalling pathway gene expression 
mRNA expression was assessed on a RT2 Profiler™ PCR array specific to the mouse 
Wnt signalling pathway. Whole neonatal heart tissue at day 7 post-MI in neonatal mice 
was compared to age-matched naïve animals as reference. 9 genes were shown to be 
significantly up-regulated post-MI (Figure 5-4). The upregulated gene expression 
included the Wnt16 and 5b, the receptor Fzd2, and the pathway inhibitors Sfrp1 and 




Figure 5-4: Cardiac mRNA expression of Wnt signalling genes in neonatal mice 
at day 7 post-MI compared to age-matched naïve mice. mRNA expression of 84 
genes was assessed on a RT2 Profiler™ PCR array specific for the mouse Wnt 
signalling pathway. mRNA expression levels in whole heart tissue at day 7 post-MI 
was expressed as a fold-change compared to expression levels in age-matched naïve 
whole heart tissue as the reference. A volcano plot was used to present differentially 
expressed genes (A). Significantly differentially expressed genes are listed in (B). 
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Using the same approach, whole neonatal heart tissue was compared to adult infarct 
plus border zone tissue (reference) at day 7 post-MI. Over 40 genes were significantly 
up-regulated and only 2 genes significantly down-regulated in the neonatal mouse 
compared to the adult following MI. Up-regulated genes included Wnt2b and 5b, the 
receptors Fzd1, 2, 3, 4, 5, 6, and 8, and pathway inhibitors Dkk3, Ctnnbip1 and Sox17. 
Out of the target genes, Bcl9, Axin2, and Jun were all significantly up-regulated in the 
neonate relative to the adult. Expression the pathway inhibitors Sfrp1 and Sfrp2 was 
significantly down-regulated in neonatal mice. Notably, Sfrp2 was the most 
differentially expressed gene between the two groups being down 180.18-fold in 
neonatal mice when compared to adults at day 7 post-MI. 




Figure 5-5: Cardiac mRNA expression of Wnt signalling genes at day 7 post-MI 
in neonatal mice compared to adult. mRNA expression of 84 genes was assessed on 
a RT2 Profiler™ PCR array specific for the mouse Wnt signalling pathway. mRNA 
expression levels in neonatal whole heart tissue at day 7 post-MI was expressed as a 
fold-change compared to expression levels in infarct and border zone of adult mice at 
day-7 post-MI as the reference. A volcano plot was used to present differentially 
expressed genes (A). Significantly up-regulated genes are listed in (B) and down-
regulated genes in (C). Boundaries were set at ±1.5 fold-change and significance at p-
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5.4.3 Csf1r-icre mediated depletion of Porcn impairs scar free cardiac regeneration post-MI 
in the neonatal mouse 
Out of 26 Porcupine mice operated 3 mice did not present any signs of systolic 
dysfunction and 2 could not be classified at day 1 post-MI. This represents an 81% 
success rate of the surgery. 
5.4.3.1 Csf1r-icre mediated depletion of Porcn does not affect body weight, LV mass or wall 
thickness at day 1 post-MI. 
At day 1 post MI (P2) both body weight and ultrasound extracted LV mass were 
significantly increased respectively by 30 and 20% when compared to naïve animals 
at P1 (Figure 5-6 A, B). LV wall thickness did not significantly change between those 
two time points (Figure 5-6 C). No effect of the genotype could be noted. 
 
Figure 5-6: Csf1r-icre mediated depletion of Porcn does not influence body 
weight, LV mass or wall thickness at day 1 post-MI.  Body weight (A) was measured 
prior to in vivo high-resolution ultrasound imaging. Both left ventricle (LV) mass (B) 
and wall thickness (C) were extracted from electrocardiogram-gated kilohertz 
visualisation (EKV) parasternal long axis (PLAX) B-mode in naïve animals at 
postnatal day 1 (P1) and at day 1 post-MI (P2) in Cre-expressing (Cre+ve - black bars) 
and Cre-deficient (Cre-ve - clear bars) Porcupine mice. Results are presented as mean 
± SEM.  p-value determined with 2-way ANOVA with Bonferroni post hoc test. * p < 
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5.4.3.2 Cardiac function dramatically decreases at day 1 post-MI 
Left ventricular end systolic and diastolic areas (LVESA, LVEDA) were respectively 
increased by around 100% and 40% between P1 and P2 (day 1 post-MI) (Figure 5-7 
A, B). Cardiac function as evaluated by fractional area change (FAC), ejection fraction 
(EF), and fractional shortening (FS) was decreased by half at day 1 post-MI when 
compared to P1 naïve animals (Figure 5-7 C, D, E). Motion mode (M-mode) stills 
show a clear lack of movement from both anterior and posterior LV walls at day 1 
post-MI (P2) when compared to naïve P1 animals (Figure 5-7 F). No effect of the 









Figure 5-7: CAL surgery results in functional impairment at day 1 post-MI with 
no effect of the genotype. Cardiac function was assessed using in vivo high-resolution 
ultrasound in Cre-expressing (Cre+ve - black bars) and Cre-deficient (Cre-ve - clear bars) 
Porcupine mice. Electrocardiogram-gated kilohertz visualisation (EKV) parasternal 
long axis (PLAX) B-mode (A) allowed calculation of left ventricular end systole 
(LVESA-B) and diastole (LVEDA-C) area. These were used to calculate cardiac 
function with fractional area change (FAC-D) and ejection fraction (EF-E). Function 
was also assessed with fractional shortening (FS-F) using motion-mode (M-mode). M-
mode stills showing akinetic anterior and posterior walls at day 1 post-MI (G). Results 
are presented as mean ± SEM.  P-value determined with 2-way ANOVA with 
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5.4.3.3 Normal cardiac and body growth at day 21 post-MI 
As shown on Figure 5-8 A, no effect of the genotype on survival after MI could be 
noted. Body weight, heart wet weight, and their ratio at day 21 post-MI (P22) were 
normal when compared to naïve animals at P20 (Figure 5-8 B, C, D). Ultrasound 
extracted LV wall thickness was also identical between those groups whereas LV mass 
was decreased by 20% (Figure 5-8 E, F).  No effect of the genotype could be noted on 










Figure 5-8: CAL surgery at P1 does not impair survival or normal growth at day 
21 post-MI with no effect of the genotype.  Survival at day 1 and day 21 following 
CAL surgery at postnatal day 1 (P1) in Cre-expressing (Cre+ve - black bars and circles) 
and Cre-deficient (Cre-ve - clear bars and circles) Porcupine mice (A) at day 21 
following MI (postnatal day 22 -P22-) and in naïve P20 animals. Body weight (B) was 
measured prior to in vivo high-resolution ultrasound imaging. Heart wet weight (C) 
was measured immediately after in vivo high-resolution ultrasound imaging following 
dissection and used to calculate heart to body weight ratio (D). Both wall thickness (E) 
and LV mass (F) were extracted from electrocardiogram-gated kilohertz visualisation 
(EKV) parasternal long axis (PLAX) B-mode. Results are presented as mean ± SEM.  
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5.4.3.4 Csf1r-icre mediated depletion of Porcn does not influence cardiac function recovery at 
day 21 post-MI 
Cardiac function as measured by FAC, EF, and FS was dramatically increased between 
day 1 and day 21 post-MI by over 100% (Figure 5-9 A, B, C). M-mode stills show 
recovery of movement of both LV anterior and posterior walls by day 21 post-MI 
(Figure 5-9 D). No effect of the genotype could be noted.  
 
Figure 5-9: Cardiac function is increased at day 21 when compared to day 1 post-
MI at P1 with no effect of the genotype. Cardiac function was assessed using in vivo 
high-resolution ultrasound in Cre-expressing (Cre+ve - black bars) and Cre-deficient 
(Cre-ve - clear bars) Porcupine mice at day 1 and 21 post-MI. Electrocardiogram-gated 
kilohertz visualisation (EKV) parasternal long axis (PLAX) B-mode allowed 
calculation of fractional area change (FAC-A) and ejection fraction (EF-B). Function 
was also assessed with fractional shortening (FS-C) using motion-mode (M-mode). 
M-mode stills showing recovery of movement of the anterior and posterior walls at 
day 21 post-MI (D). Results are presented as mean ± SEM.  p-value determined with 
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5.4.3.5 Complete recovery of cardiac function by day 21 post-MI 
LVESA and LVEDA were marginally, but significantly lower in animals at day 21 
post-MI (P22) when compared to naïve animals of a similar age (P20) (Figure 5-10 A, 
B). However, cardiac function as assessed by FAC, EF and FS were identical between 
those two groups (Figure 5-10 C, D). No effect of the genotype could be noted on 
either cardiac dimensions or in functional recovery at day 21 post-MI. 
 
Figure 5-10: Cardiac function is completely recovered by day 21 post-MI at P1 
with a slight decrease in LV cavity size but no effect of the genotype. Cardiac 
function was assessed using in vivo high-resolution ultrasound in Cre-expressing 
(Cre+ve - black bars) and Cre-deficient (Cre-ve - clear bars) Porcupine mice at day 21 
following MI (postnatal day 22 -P22-) and in naïve P20 animals. Electrocardiogram-
gated kilohertz visualisation (EKV) parasternal long axis (PLAX) B-mode allowed 
calculation of left ventricular end systole (LVESA-A) and diastole (LVEDA-B) area, 
and cardiac function with fractional area change (FAC-C) and ejection fraction (EF-
D). Results are presented as mean ± SEM.  P-value determined with 2-way ANOVA 
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5.4.3.6 Macrophage-specific deletion of Porcn does not influence vascularisation of the 
infarcted area at day 21 post-MI 
As shown on Figure 5-11 both Cre+ve and Cre-ve control littermates had normal looking 
myocardial vascularisation at day 21 post-MI. 
 
Figure 5-11: Myocardial vascularisation is not influenced by macrophage-specific 
deletion of Porcn at day 21 post-MI. Myocardial vascularisation was investigated on 
isolectin B4 (IB4-green-endothelial cells),  smooth muscle actin (SMA-red-mural 
cell coated vessels), and DAPI (blue). DAPI was left out of above representative 
images for clarity. Staining was performed on 4m thick stained sections at day 21 
post-MI in Cre-expressing (Cre+ve - black bars) and Cre-deficient (Cre-ve - clear bars) 
Porcupine mice. Scale bars = 100 m.  
 
5.4.3.7 Csf1r-icre mediated depletion of Porcn resulted in increased myocardial fibrosis at day 
21 post-MI 
All animals that had undergone surgery presented with an expanded pericardium as 
shown by the blue arrows on Figure 5-12A, B. Picrosirius red (PSR) staining identified 
a clear fibrotic area in the direct vicinity of the ligation in Cre-ve animals with limited 
interstitial fibrosis Figure 5-12A. On the other hand, fibrotic tissue also infiltrated the 
myocardium away from the suture in Cre+ve animals which presented with increased 
fibrotic area Figure 5-12B, C, D. It is important to note that the percentage of tissue 
detected as PSR+ve is much higher when using Definiens than in Photoshop. This is 
true for both Cre-ve and Cre+ve groups and did not affect the level of significance. 




Figure 5-12: Macrophage-specific abrogation of WNTs secretion increases 
fibrosis at day 21 post-MI at P1. Collagen accumulation was evaluated on picrosirius 
red (PSR-collagen marker) across the whole left ventricle below the suture excluding 
the pericardium on 4 m thick section at postnatal day 20 (P20) and at day 21 post-MI 
in Cre-deficient (Cre-ve - clear circles) (A) and Cre-expressing (Cre+ve - black circles) 
(B) Porcupine mice. Collagen fibres appear red, remaining tissue yellow. Fibrotic area 
was evaluated with Definiens software (C) and Adobe Photoshop CS6 (D) at day 21 
post-MI (P22) and Cre+ve animals compared to Cre-ve control littermates. Black arrows 
indicate location of suture, green arrows indicate myocardial fibrosis, blue arrows 
indicate expanded pericardium. Grey scale bar = 500m, black scale bar = 100m. 
Results are presented as median ± inter-quartile range.  P-value determined with 




















It is becoming increasingly clear that macrophages and macrophage-derived WNTs 
play a central role in the regeneration of organs such as the kidney (Lin et al., 2010), 
the liver (Boulter et al., 2012), and the gut (Saha et al., 2016). Although Aurora et al. 
(2014) have shown that macrophage depletion prevented neonatal cardiac regeneration 
it is not clear whether macrophage-derived WNTs are part of this process. The present 
study aimed to investigate the effect of MI on the neonatal cardiac mononuclear 
phagocyte populations described in chapter 4. Determining the expression profile at 
the mRNA level of Wnt signalling related genes in both cardiac macrophages and 
whole heart tissues was also endeavoured.  The final aim of this study was to 
characterise the impact of preventing WNTs secretion from macrophages on neonatal 
cardiac regeneration. This was achieved through a macrophage-specific (Csf1r 
promoter driven cre recombinase) deletion of Porcn. Porcn encodes for the O-
acyltransferase porcupine (PORCN) which is essential in the secretion of all WNTs 
(Mikels and Nusse, 2006). 
The role of immune cells following induction of MI in neonatal mice 
In this chapter, Csf1r-expressing cells were shown to accumulate within the 
regenerating myocardium at day 1 and day 7 post-MI using the MacGreen mouse. Day 
7 was previously identified by Aurora et al. (2014) as the peak abundance of 
mononuclear phagocytes in the myocardium following MI in neonatal mice. This is 
consistent with the data from this chapter. This experiment was however designed as 
a pilot study to provide supporting evidence of the interaction between Csf1r-
expressing cells and the regenerating myocardium. Further work should involve a full 
size investigation of the distribution and density of Csf1r-expressing cells at both day 
1 and day 7 post-MI. This work should also incorporate double staining with a more 
specific mononuclear phagocyte marker. As discussed in Chapter 4 Csf1r-expressing 
cells are a mixed population of mononuclear phagocytes and neutrophils. Double 
staining for GFP and F4/80 in MacGreen mice has been attempted under multiple 
conditions during this PhD but has not worked. Other makers that could be used in the 
future include Mac-3 and CD68 as they have been shown to identify macrophages and 
monocytes on heart sections (Aurora et al., 2014; Lavine et al., 2014).  
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In the adult mouse, inflammatory cells content is increased following MI primarily as 
a result of recruitment of neutrophil and monocytes from the bone marrow and spleen 
(Frangogiannis, 2014; Chen and Frangogiannis, 2016). In the present study, total 
leukocytes (CD45+ve) proportion was increased relative to live cells by approximately 
2-fold at day 7 post-MI. This correlates with the published literature showing a crucial 
involvement of the immune system in the response to MI in the neonatal mouse 
(Aurora et al., 2014).  
In the adult, neutrophils are the first leukocyte population to accumulate in the 
myocardium after MI. Their number peaks 24h-48h post-MI to then decline to very 
low levels at day 6 post-MI (McSweeney et al., 2010; Nahrendorf and Swirski, 2013). 
As presented in further detail in Section 1.1.1.1, this decline of neutrophils is known 
as a hallmark of inflammation resolution (reviewed in Frangogiannis 2014). The time 
course of inflammation and its subsequent resolution is however less clear in the 
neonatal mouse following MI. Data from this chapter has showed that neutrophils 
((Csf1r, Ly6G)+ve) were more abundant within the myocardium at day 7 post-MI when 
compared to naïve hearts. This correlates with data from Aurora et al. (2014) which 
showed that neutrophils were significantly more abundant at day 7 in mice that 
underwent CAL surgery at P1 compared to those operated at P14. Induction of MI in 
P14 mice yielded similar response to adult with formation of a non-contractile scar 
and no functional recovery at day 21 post MI. It therefore appears that a prolonged 
presence of neutrophils correlates with the capacity to regenerate a scar free 
myocardium.  
Neutrophils are known to express proteases following MI in the adult (Ma et al., 2013). 
This particular property may participate in regulating scar free regeneration of the 
neonatal heart. Neutrophils have also been shown to exhibit distinct phenotypes 
depending on the time post-MI in the adult (Y. Ma et al., 2016). At day 1, they 
expressed high levels of IL1 and Tnf which are classical pro-inflammatory markers. 
Whereas, at day 7, they expressed high levels of IL10 and Cd206 and low levels of 
IL1 and Tnf which would indicate a more anti-inflammatory phenotype. The 
presence and dynamics of these two phenotypes following MI in the neonatal mouse 
is unknown. Their balance could however be important in scar free regeneration and 
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should be included in further investigations. Ma et al (2016) have indeed shown that 
the pro-inflammatory phenotype correlates with wall thinning and thereby matrix 
degradation. 
In the present study, cardiac mononuclear phagocyte populations behaviour was also 
investigated following MI in neonatal mice. The data has suggested that the F4/80hi, 
CD11blo, Ly6C-ve population disappears from the heart at day 7 post-MI. As discussed 
in Chapter 4, this population may reflect yolk-sac derived macrophages (MФ) 
observed by (Lavine et al., 2014) in the neonatal heart. In their paper, Lavine et al. 
(2014) demonstrate that this population of MФ expands immediately after genetic 
ablation of cardiomyocytes in the neonatal mouse. They were also shown to promote 
cardiomyocyte proliferation, angiogenesis, and have anti-fibrotic capacities. As 
discussed in Chapter 4, a more comprehensive investigation of the different cardiac 
mononuclear phagocyte populations would be required for a better comparison to the 
literature. It is also not clear whether the different types of injury, cardiomyocyte 
depletion vs. MI, has a significant influence on the ensuing immune response. A time 
course experiment of the immune response following MI would therefore be required 
to determine whether yolk-sac derived macrophages also expand immediately after 
injury as observed by Lavine et al. (2014), and then reduce by day 7 as suggested here.  
The data showed in this chapter suggests an expansion in both F4/80lo, CD11bhi, Ly6C-
ve and F4/80lo, CD11bhi, Ly6C+ve populations at day 7 post-MI in the neonate when 
compared to naïve mice. This failed to reach statistical significance due to the low 
sample size. As discussed in Chapter 4, these populations may correspond to the 
CCR2+ve mononuclear phagocytes of foetal liver/bone marrow origin described by 
Lavine et al. (2014) and Leid et al. (2016). It therefore may suggest that recruitment 
of cells of monocytic origin may be required later on during neonatal cardiac 
regeneration. Further investigation of this should be incorporated in the time course 
experiment of the immune response following MI. 
Interestingly, neutrophil recruitment to the myocardium was recently shown to be 
dependent on resident CCR2+ve cardiac MФ following syngeneic cardiac transplant in 
the adult mouse (Li et al., 2016). Lavine et al. (2014) also reported a decreased 
neutrophil influx following cardiac injury in mice treated with CCR2 inhibitor. Aurora 
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et al. (2014) did not report any effect of macrophage depletion using clodronate-loaded 
liposomes on neutrophil presence in the heart following CAL at P1. The specific 
cardiac MФ population that was depleted in this model is however unknown. Lavine 
et al. (2014) suggest that in their model, clodronate specifically depletes CCR2-ve 
cardiac MФ. Using an inducible CCR2 KO model could help understanding the role 
of CCR2+ve cardiac MФ in the recruitment of neutrophils following neonatal MI. As 
discussed above, neutrophils may indeed play a key role in scar free regeneration of 
the neonatal heart. 
Together, data from this chapter and published studies have highlighted differences in 
the immune response following MI between the neonatal and adult mouse (Epelman 
et al., 2014). Neonatal mice, compared to adult, appear to be utilising a population of 
yolk-sac derived resident MФ which have better pro-angiogenic and anti-fibrotic 
capacities in the first days following injury (Lavine et al., 2014). Our data may suggest 
that this population then subsides in favour of the expansion of a bone-marrow derived 
population, although more work is required. Neutrophils were then hypothesised as 
crucial regulators of scar free regeneration through their expression of proteases. 
Further work should investigate the relationship between bone-marrow derived MФ 
and neutrophil recruitment following MI in the neonatal mouse. Neutrophil phenotype 
and protease expression dynamics should also be part of such study. 
Wnt signalling genes expression in MФ and whole heart tissue 
The second aim was to show that cardiac MФ express Wnts and to identify changes 
post-MI in the neonatal mouse. However, as discussed in Section 4.5, extraction from 
neonatal hearts and mRNA expression analysis of cardiac mononuclear phagocytes 
proved extremely challenging. The amount of total RNA obtained from the low 
number of cells collected by FACS was unfortunately not sufficient to use on the RT2 
Profiler™ PCR array specific to the mouse Wnt signalling pathway, or for regular RT-
qPCR.  
Aurora et al. (2014) performed microarray analysis on cardiac MФ isolated at day 3 
post-MI in the neonate. The data did not show any significant differential expression 
of Wnts between the MI and sham group. This however does not constitute a proof that 
neonatal cardiac MФ do not express Wnts. Macrophages have however been shown to 
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be a source of WNTs in several organs following injury in the adult mouse. These have 
included the kidney (Lin et al., 2010), the liver (Boulter et al., 2012; Irvine et al., 2015; 
Planas-Paz et al., 2016), the gut (Saha et al., 2016), and recently in the heart (Palevski 
et al., 2017). Whether neonatal cardiac macrophages express and secrete WNTs is 
however less clear. 
Identifying the exact set of Wnts expressed and secreted following neonatal MI by 
cardiac MФ populations would provide insight on their potential effect on the immune 
response described in the previous section. The avenues that could be undertaken are 
described in Section 4.5. 
It was however possible to study mRNA expression on the RT2 Profiler™ PCR array 
specific to the mouse Wnt signalling pathway using whole tissue samples. First, day 7 
post-MI (P8) was compared to age-matched naïve tissue as reference. Out of 84 genes 
tested only 9 were significantly differentially expressed between the two groups. These 
included 1 target gene: Axin2. Axin2 is commonly used as a reporter of Wnt signalling 
as it lies downstream of WNT/-catenin/TCF/LEF elements (Jho et al., 2002). It has 
notably been used to show pathway activation following MI in adult mice (Oerlemans 
et al. 2010; Palevski et al. 2017; Mizutani et al. 2016). AXIN2 is also a potent negative 
regulator of the canonical Wnt signalling pathway by promoting phosphorylation and 
degradation of -catenin (Stamos and Weis, 2013). No other target genes were 
significantly up-regulated in the neonate at day 7 post-MI relative to naive mice, 
suggesting that pathway activity may not be particularly increased post-MI relative to 
normal Wnt pathway activation in the growing neonatal heart.  
In contrast, expression of pathway inhibitors Dkk3 and Sfrp1 were up-regulated post-
MI in the neonate. To date, no studies have investigated their role in neonatal cardiac 
regeneration. In the adult, it is however known that overexpression of Sfrp1 as well as 
Dkk3 reduces inflammation and improves function following MI (Barandon et al., 
2003, 2011; Bao et al., 2015). Contrastingly to the neonatal mouse, Dkk3 expression 
was reduced in adult mice post-MI (Bao et al., 2015). Up-regulation of those inhibitors 
may therefore be associated with the regenerative response of the neonate to MI and 
could be investigated further using KO models.  
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Out of the 19 mammalian Wnt genes, only 2 were significantly up-regulated after 
neonatal MI relative to naïve controls: Wnt16 and the prototypical non-canonical 
Wnt5b (Hardy et al., 2009; Bradley and Drissi, 2011). Wnt16 preferential pathway is 
less clear. It has been shown to be both a weak activator of the canonical pathway 
whilst also being able to act through the non-canonical pathway (Clements et al., 2011; 
Movérare-Skrtic et al., 2014). Interestingly Wnt5b is up-regulated in human bone 
marrow derived macrophages, when stimulated with IL-4 (Derlindati et al., 2015), a 
stimulus that promotes alternative activation (Gordon, 2003). WNT5b also reduces 
collagen X production in chondrocytes, a type of mesenchymal cell related to 
fibroblasts (Bradley and Drissi, 2011). Interestingly, Fzd2, which encodes a receptor 
known to interact with WNT5b (Gujral et al., 2015), was also up-regulated in the 
neonatal heart post-MI. Fzd2 is also known to be up-regulated on fibroblasts following 
adult MI (Blankesteijn et al., 1997). Those genes are thus upregulated at a time where 
fibrotic tissue has accumulated within the myocardium and prior to scar regression 
which is thought to largely take place between day 7 and day 14 post-MI (Porrello et 
al., 2013). Whether WNT5b secreted by cardiac macrophages following MI in the 
neonate interacts with FZD2 on fibroblasts to regulate collagen deposition/removal is 
not clear but should be investigated further. 
Wnt activity is essential to cardiac development (Ueno et al., 2007) but is thought to 
be quiescent in the adult myocardium (Dawson et al., 2013; Palevski et al., 2017). The 
exact time course of Wnt activity decrease is not clear in the heart. It is however 
thought to be higher in growing organs. It is therefore likely that Wnt activity is higher 
in neonatal mice than it is in adults at baseline. Upon a stressor such as injury, the 
pathway is however re-activated in the adult mouse  (Dawson et al., 2013; Palevski et 
al., 2017) and inhibition has been generally shown as beneficial following MI 
(Barandon et al., 2003, 2011; Zelarayán et al., 2008; He et al., 2010; Laeremans et al., 
2010).  
The second comparison of Wnt pathway genes that was performed in this thesis was 
between neonatal and adult hearts at day 7 post-MI. This comparison revealed 
significant upregulation of over 40 genes in neonates relative to adults and 
downregulation of 2. The stronger contributor to these differential expression levels is 
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however most likely to be the age of the animal. As mentioned above, the Wnt pathway 
is most active in growing organs. 
The up-regulated genes included the target genes Axin2, Bcl-9, and Jun, but also 
various suppressors of the pathway including Ctnnbip1. Genes encoding a number of 
receptors (FZD) and co-receptors (LRP5/6) were also up-regulated in neonatal mice 
post-MI consistent with increased Wnt activity. However, of the ligands only Wnt2b 
(5.1 fold) and Wnt5b (5.8 fold) were differentially expressed in neonatal mice relative 
to adults following injury. This consolidate the potentially important role of Wnt5b in 
regulating fibrosis. Interestingly, Wnt2b has recently been linked to epithelial to 
mesenchymal transition (EMT) of epicardial cells into cardiac fibroblasts (Mizutani et 
al. 2016). Altogether these observations are consistent with a stronger Wnt pathway 
activity at neonatal stages compared to the adult. 
The only two down-regulated genes both encoded SFRPs which bind to WNTs 
extracellularly therefore competitively inhibiting their interaction with FZD receptors 
at the target cell membrane. Notably, Sfrp2 was the most differentially expressed gene 
of the 84 tested with a down-regulation of 180.2-fold in neonates relative to adults 
post-MI. Interestingly, Sfrp2 was shown to be up-regulated 2.3-fold at day 4 post-MI 
in the adult mouse (Palevski et al., 2017). Sfrp2 was not significantly differentially 
expressed in neonates at day 7 post-MI when compared to naïve controls but was 
significantly down-regulated in neonates relative to adults post-MI. This suggests that 
neonatal mice express considerably less Sfrp2 at basal state and do not utilise it in the 
response to MI; whereas adults express higher levels of Sfrp2 in the steady state and 
further increase its expression following MI. In adults, the role of SFRP2 in fibrosis 
has been receiving attention but remains unclear and highly dependent on the 
experimental design. Thus while fibrosis was reduced in Sfrp2-deficient mice 
following MI, resulting in improved systolic function (Kobayashi et al., 2009), 
administration of SFRP2 2 days post-MI in the adult rat decreased fibrosis 14 days 
later (He et al., 2010). Incubation of cardiac fibroblasts with SFRP2 in vitro promoted 
proliferation whilst increasing expression levels of Mmp13, consistent with promotion 
of ECM turn-over (Lin et al., 2016). Those contradictory observation could be due to 
a concentration dependent effect of SFRP2 (He et al., 2010). In their study, He et al. 
(2010) proposed that low concentrations of SFRP2 could promote deposition and 
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maturation of collagen whereas higher concentrations would inhibit it. It is however 
not clear what role SFRP2 plays in the response following neonatal MI. According to 
He et al. (2010) biphasic model, neonatal mice would therefore promote deposition 
and maturation of collagen which correlates with the scarring observed by Porrello et 
al. (2013) at day 7 post-MI. This scar is however then removed. Neonatal mice low 
levels of Sfrp2 expression could also be better compared to Sfrp2-deficient mice and 
their lack of fibrosis following MI in the adult (Kobayashi et al., 2009). SFRP2 
injection following neonatal MI would help determine whether its absence is necessary 
to scar-free regeneration of the myocardium. 
Altogether the data presented in this chapter suggests that, at day 7 following MI, the 
neonatal mouse presents a higher Wnt pathway activity when compared to adult mice 
which may not be solely due to the developmental stage. Indeed, neonatal mice did 
appear to utilise the Wnt pathway following MI as shown by up-regulation of Wnt5b 
and its receptor Fzd2 as well as the target gene Axin2 relative to naïve neonate. This 
data was also proposed as a potential link between regulation of fibrosis and the Wnt 
pathway following neonatal MI. Further investigation is however needed to determine 
the validity of this link. In order to gain insight on the contribution of cardiac 
macrophages to these changes in gene expression, alternative approach for their 
isolation should also be considered 
Csf1r-icre mediated depletion of Porcn does not influence functional loss at day 1 or 
recovery at day 21 post-MI 
In order to study the role of macrophage-secreted WNTs a mouse line with 
mononuclear phagocyte targeted depletion of the Porcn gene using cre-recombinase 
expression from the Csf1r promoter. Porcn encodes Porcupine (PORCN) which is 
essential in the secretion of WNTs (Section 1.5.1.1). As discussed in Section 4.5, 
conditional gene depletion from the Csf1r promoter would also target neutrophils. 
Neutrophils have however scarcely been described as WNTs producers. Moreover, 
recent work from the Pollard lab has shown that this results in specific Porcn deletion 
and prevention of WNT secretion by adult bone marrow derived macrophages (Saha 
et al., 2016). 
Prior to surgery, Cre+ve mice were shown to be normal up until P41 where they 
exhibited mild cardiomyocyte hypertrophy with slightly increased cardiac function 
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when compared to Cre-ve control littermates Section 4.4. No difference in any of the 
parameters tested could be noted prior to P41. No difference in mortality was observed 
between Cre+ve mice and Cre-ve littermates at either day 1 or day 21 post-MI 
At day 1 post-MI, both Cre+ve and Cre-ve control littermates experienced significant 
functional decrease when compared to naïve P1 mice. The genotype did not have any 
statistical significance on the functional decrease observed at day 1. This suggests 
similar extent of injuries in both Cre-ve and Cre+ve animals as well. However, the exact 
degree of injury at day 1 post-MI in those mice could not be evaluated in vivo. This is 
classically done by measuring plasma troponin but it is impossible to sample sufficient 
blood in neonatal mice in vivo for analysis using current methods of detection. As 
shown in Section 2.2.2.3, functional decrease however correlated with signs of 
myocardial injury and increased plasma troponin in terminal blood at day 1 post-MI 
in neonatal C57BL/6J mice. In an effort to gather sufficient numbers and because of a 
limited access to these mice while in New York, all animals were assigned to a study 
looking at the effect of MФ-specific deletion of Porcn on regeneration at day 21 post-
MI. No animals were therefore pulled out of this study at day 1 to investigate the exact 
injury size.  
Full recovery of function was observed at day 21 to levels comparable to un-operated 
mice (P20), consistent with regeneration, as previously reported (Haubner et al., 2012; 
Porrello et al., 2013). Again, no effect of the genotype was observed on recovery of 
cardiac function following MI. A decreased LV mass was suggested with no LV wall 
thinning by ultrasound in all post-MI mice. This was accompanied by a reduction in 
LVESA and LVEDA which can indicate smaller hearts. However, since heart wet 
weight and heart to body weight ratio were not significantly different between post-
MI animals (P22) and mice of a similar age (P20) it is unclear whether it has 
significance. 
Due to the limited access to the mouse line, it was decided to use the animals generated 
in the study presented in Chapter 4 as un-injured, naïve controls to the MI groups of 
Chapter 5. Time-points are therefore not exactly matching which represents a 
limitation to the interpretation of the results presented here. The study in Chapter 4 has 
however shown that cardiac function was not significantly changing at least between 
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P1 and P20. The differences observed in this chapter are therefore most likely due to 
the treatment rather than an age difference (1-2 days). This small age difference is 
likely to have an effect on structural measurements such as LVESA, LVEDA, and LV 
mass. The data presented here however suggests that mice at P22, that received MI at 
P1, have smaller hearts as measured on the ultrasound when compared to slightly 
younger naïve animals (P20). Considering that cardiac dimensions have been shown 
to increase between P20 and P41 in Chapter 4 it is also unlikely that this effect is due 
to the age difference. Exactly matching time-points however represent a more robust 
control group and should be envisaged for publication of this thesis’ work 
Csf1r-icre mediated depletion of Porcupine results in increased interstitial fibrosis 
following regeneration 
Even though cardiac function was not changed between the naïve and MI groups 21 
days after induction of MI, clear histological differences could be observed in tissue 
sections. Notably, the location of suture could be identified as a clear depression in the 
LV wall on the epicardial side, accompanied by scarring irrespective of the genotype, 
which has been reported by other groups using this model (Porrello et al., 2013; 
Konfino et al., 2015). Within the myocardium,  Porrello et al. (2013) reported 
significant scar formation at day 7 post-MI, that is largely regressed by day 21 when 
regeneration is complete. Furthermore, MФ were shown to play a central role in the 
scar-free regeneration of the myocardium following injury (Aurora et al., 2014; Lavine 
et al., 2014). In the present study, interstitial fibrosis distant from the ligature site in 
Cre-ve animals was largely similar to naïve animals at 21 days, although there was 
evidence of very limited residual fibrosis in the myocardium. Importantly, the extent 
of this interstitial fibrosis was significantly greater in Cre+ve mice, suggesting that MФ-
derived WNTs may participate in MФ-mediated promotion of scar-free regeneration 
following neonatal MI.  
As reported by (Konfino et al., 2015), the type and extant of injury is likely to play a 
role on cardiac repair and regeneration following MI in the neonate. There is therefore 
a need to determine the time course of scar formation and regression following 
neonatal MI in our hands; this will also allow further understanding on the role of MФ-
derived WNTs on this process. Starting with the readily available day 21 samples this 
would be the opportunity to evaluate the presence of proteases MMP12 and MMP13 
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as well as protease inhibitor TIMP1 in the regenerating myocardium as they were 
shown to be affected in a model of liver injury in mice unable to secrete WNTs from 
MФ (Irvine et al., 2015). Furthermore, expression analysis has identified two fibrosis 
related genes: Wnt5b and Fzd2 (Laeremans et al., 2010; Bradley and Drissi, 2011) as 
being up-regulated at day 7 post-MI when compared to naïve controls. WNT5b has 
also been shown to be produced by MФ (Derlindati et al., 2015) and FZD2 present on 
migrating myofibroblasts (Blankesteijn et al., 1997). Studying the expression levels of 
those Wnt pathway genes in MФ as well as fibroblasts would provide preliminary data 
on their involvement in scar free regeneration of the neonatal heart post-MI. Specific 
KO models could then be envisaged to further our understanding of their role if the 
expression data supports additional experiments. Altogether this would provide clues 
on the potential mechanism behind the fibrotic phenotype of mice with a Csf1r-icre 
mediated depletion of Porcn. This study could also provide tissue to investigate the 
time course of fibroblast activation, proliferation and matrix deposition/removal 
following MI in the neonatal mouse. This would provide further insights on the 
specific aspects of scar free regeneration that MФ-secreted WNTs may be involved in. 
Interestingly, Palevski et al. (2017) showed that macrophages polarised towards an 
M2 phenotype were more abundant in mice unable to secrete WNTs from 
macrophages following MI in the adult. The Wnt signalling is indeed known to act in 
an autocrine manner and influence macrophage phenotype (Pereira et al., 2009). 
Further investigation should include the influence of the Csf1r-icre mediated Porcn 
depletion on the cardiac mononuclear subsets following MI. 
Clodronate MФ depletion was shown by both Aurora et al. (2014) and Lavine et al. 
(2014) to diminish vascularisation of the myocardium following cardiac injury. In this 
chapter, MФ-specific deletion of Porcn did not appear to have a notable effect on 
vessel density at day 21 post-MI. This suggest that MФ-derived WNTs may not play 
a central role in the angiogenic response to MI in the neonatal mouse. This should 
however be investigated further along with the time course of scar formation and 
regression to confirm the absence of effect. Lavine et al. (2014) but not Aurora et al. 
(2014) describe a deleterious effect of MФ depletion on cardiomyocyte proliferation 
following cardiac injury. Moreover, Wnt signalling activity was shown to be necessary 
for promotion of cardiomyocyte proliferation by the Yes-associated protein (YAP) 
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during development and following neonatal injury (Heallen et al., 2011; Xin et al., 
2013). The study presented here did not evaluate the effect of the genotype on 
proliferation due to the limited access to the mouse line in New York. This could 
however be investigated along with the time course of scar formation by injecting 
BrdU and studying its incorporation in proliferating cardiomyocytes. Cardiomyocyte 
cross sectional area (CMCSA) could also help determine whether MФ-specific 
deletion of Porcn is associated with hypertrophic remodelling at day 21. This would 
suggest a diminished proliferative response of cardiomyocytes to MI  
Further investigations of the mechanisms involved will be highly relevant. These 
should involve the study of earlier time points throughout the regeneration process 
including expression of genes involved in collagen deposition and removal. Looking 
at earlier time points would also allow confirmation of cell death and extent of injury 
at 1 day post-MI, investigation of re-vascularisation, cardiomyocytes proliferation and 
growth, and immune cells content and phenotype.  
Altogether, these results present the first evidence of the involvement of the Wnt 
signalling pathway in the regulation of fibrosis following MI in the neonatal mouse. 
Using a Csf1r-icre mediated Porcn depletion model has pointed at a positive role of 
MФ-derived WNTs in neonatal cardiac regeneration. This shed a new light on the 
involvement of the pathway following MI as the data thus far has mostly pointed at a 
detrimental role of the Wnt signalling pathway in the adult post-MI (Barandon et al., 
2003, 2011; Zelarayán et al., 2008; He et al., 2010; Laeremans et al., 2010; Dawson 
et al., 2013; Palevski et al., 2017). Nevertheless, as it was described in this chapter the 
Wnt signalling pathway is highly complex and tightly regulated which can explain the 
discrepancies noted in the literature.  
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Following injury such as myocardial infarction (MI) the adult mammalian heart fails 
to regenerate the lost tissue. Instead, a non-contractile fibrous scar forms that in the 
longer term can lead to the development of heart failure Neonatal mammals however 
retain potent regenerative capacities (Porrello et al., 2011; Haubner et al., 2012, 2016) 
which are dependent on the presence of macrophages (Aurora et al., 2014). In the adult 
mouse, macrophage-derived WNTs have been shown to promote regeneration of the 
kidney (Lin et al., 2010), the liver (Boulter et al., 2012; Irvine et al., 2015; Planas-Paz 
et al., 2016), and the gut (Saha et al., 2016). WNTs are secreted lipophilic proteins 
essential in development (Section 1.5.1). The primary aim of this thesis was to 
investigate the role of macrophages and macrophage-secreted WNTs on normal 
cardiac growth from neonatal to adult as well as in regeneration of the neonatal heart 
following injury in the mouse model. 
6.1 Study of the neonatal myocardium 
Cardiac structure and function during postnatal growth 
The set-up of ECG-gated ultrasound methods established by research reported in this 
thesis has allowed measurement of cardiac systolic function using 2-D and 3-D 
measurements in neonates. This has provided important structural information such as 
cavity size, left ventricle (LV) wall thickness, and LV mass. Together with histological 
techniques it has allowed the identification of 3-distinct phases of myocardial growth.  
A first hyperplastic phase, between postnatal day 2 (P2) and P8 characterised by 
increased density of Ki67+ve, proliferative, cardiomyocytes and increasing left 
ventricle (LV) wall thickness on the ECG-gated ultrasound. Prior to the onset of this 
PhD, cardiomyocytes were known to rapidly lose their ability to proliferate during the 
first post-natal week in mammals (Soonpaa et al., 1996; Leu et al., 2001; Hirschy et 
al., 2006); the mechanisms controlling postnatal cardiomyocyte proliferation were 
however less clear. Since then, several pathways have been identified including 
miRNAs, the transcription factors MEIS1, growth factor receptor ERB2, hypoxia, and 
the Hippo and Wnt signalling pathways (Heallen et al., 2011; Chen et al., 2013; 
Mahmoud et al., 2013; Xin et al., 2013; Puente et al., 2014; H. Ma et al., 2016). 
Interestingly, the Yes-associated protein (YAP) necessitates the nuclear localisation of 
-catenin, and thereby Wnt pathway activity, in order to promote cardiomyocyte 
proliferation in the postnatal mouse (Heallen et al., 2011; Xin et al., 2013). Data from 
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this thesis has suggested that, in the steady state, macrophage directed depletion of the 
Porcupine gene (Porcn) does not influence the density of proliferative cardiomyocyte 
in the mouse neonatal heart. Macrophage-derived WNTs are therefore not likely to be 
the main source of Wnt activity required for YAP during this period of development. 
Identifying the source and identity of WNTs able to trigger pathway activation in 
cardiomyocytes should be envisaged as future work. Isolation and gene expression 
analysis of cardiomyocytes, endothelial cells, and fibroblasts, the three major cell types 
in the mouse heart (Pinto et al., 2016), would help determine targets for manipulation 
of the pathway to promote cardiomyocyte proliferation in the adult. 
A second hypertrophic/reorganisation phase was identified in C57BL/6Jola mice 
between P8 and P21 characterised by increasing cardiomyocyte size without change 
in LV wall thickness. The significance and mechanism behind cardiomyocyte 
reorganisation in normal cardiac growth is unclear and hasn’t been investigated in vivo 
to the best of our knowledge. Using serial, thick, histological sections may allow 
investigation of tissue architecture in a 3-D manner which will be envisaged as future 
work. 
And finally, a third, purely hypertrophic phase between P21 and P42 with increasing 
cardiomyocyte and LV wall thickness. 
Postnatal myocardial vascularisation 
Whilst considerable advances have been made in the understanding of coronary 
vasculature origin and development, the cellular pathways controlling it remain less 
clear (Smart, 2016). Postnatal myocardial vascularisation was originally thought to be 
achieved through angiogenic sprouting of blood vessels established during foetal life. 
Agreeing with this idea, work carried out in this thesis showed that, during the first 
postnatal week, vascular density increases in the outer myocardium whilst vessel size 
decreases. Those vessels were also shown to be expanding from those established in 
the foetus (Tian et al., 2014). Whilst macrophages were shown to participate in the 
patterning of the coronary vasculature in the foetus (Leid et al., 2016), data from this 
thesis has suggested that a constitutive depletion of macrophages does not influence 
postnatal vascularisation of  the compact myocardium. Shortly after birth, part of the 
trabeculated myocardium undergoes compaction which is accompanied by de novo 
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formation of blood vessels from the endocardium (Tian et al., 2014). Different 
myocardial compartments are thereby vascularised through different mechanisms. 
Since the onset of this PhD it has become clear that the mouse heart contains 
macrophage populations of distinct origin (Epelman et al., 2014; Lavine et al., 2014; 
Leid et al., 2016). Interestingly, foetal liver/bone marrow derived macrophages 
expressing the C-C chemokine receptor type 2 (CCR2), indicative of their monocytic 
origin, were shown to preferentially localise within the trabeculated myocardium in 
the foetal mouse heart. Whether those CCR2+ve macrophages play a role in de novo 
myocardial vascularisation is unknown but could be envisaged as future work. An 
inducible CCR2 knock-out (KO) model would allow precise depletion of those 
macrophages to study their involvement in early postnatal de novo vascularisation of 
the compacting trabeculated myocardium. 
6.2 Neonatal myocardial regeneration 
Models 
Several groups have now succeeded in reproducing Porrello et al.’s observations on 
both the apical resection and MI model of neonatal injury (Haubner et al., 2012; Xin 
et al., 2013; Aurora et al., 2014; Han et al., 2015; Konfino et al., 2015). However, 
substantial variability in the surgical and analytical methodologies as well as the 
regenerative outcome can be noted. Source of variability include, the type of injury 
model, the surgical method, and the genetic background of the mice used. 
For example, Porrello et al. (2013) exteriorised the heart before placing a 6-0 Prolene 
suture through the left ventricle on top of the LAD; Haubner et al. (2012) ligate the 
LAD without exteriorising the heart using a 10-0 Ehtilon suture. 6-0 Prolene is 3.5 
times larger than 10-0 Ethilon. Using a larger suture alters the structure of the LV 
which may lead to more collateral damage and mechanical injury. Konfino et al. 
(2015) observed an average survival rate of 40% following MI using an 8-0 Prolene 
suture after exteriorising the heart. This was associated with important transmural 
scarring at the site of the ligation. The survival rate observed across this thesis using 
9-0 Ethilon sutures without exteriorising the heart averaged around 80% with minimal 
scarring around the suture. This might suggest that the size of the suture may play a 
role in the recovery following MI. 
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A report by Andersen et al. (2014) failed to replicate Porrello et al. observations on 
regeneration following apical resection. Andersen et al. experiments were however 
carried out in C57BL/6 mice whilst Porrello et al. were performed on mice with a CD-
1 background. This may highlight a strain dependency of neonatal cardiac 
regeneration, at least for the apical resection model. In this thesis, the two genetic 
backgrounds used were C57BL/6J and FVB and both showed functional recovery by 
day 21 post-MI with limited interstitial fibrosis distal of the ligation. Konfino et al. 
(2015) observed functional recovery at day 28 post-MI with mice on a CD-1 
background but did not comment on fibrosis distal of the suture. Background strain 
therefore does not seem to influence functional recovery following MI. Survival rates 
may be affected, however. Konfino et al. (2015) observed a survival rate of 40% in 
CD-1 mice following MI whilst work from this thesis suggests a survival rate around 
70% for C57BL/6 and 90% for FVB mice.  
In a multi-author letter, Sadek et al. (2014), also pointed out that Andersen et al. had 
potentially resected a greater portion of the LV which could impair regeneration. The 
regenerative response indeed seems to be dependent on the extent and type of initial 
injury (Konfino et al., 2015; Sen and Sadek, 2015). 
Assessment of the presence and extent of injury 
In this thesis, high-resolution in vivo ultrasound was used to confirm presence of injury 
following LAD ligation at day 1 (P2). Decreased systolic function at day 1 correlated 
with signs of myocardial injury on histological cardiac sections and increased plasma 
cardiac troponin levels (Section 2.2.2.3). Other groups have also reported myocardial 
damage following MI in the neonate on cardiac histological sections (Haubner et al., 
2012; Porrello et al., 2013; Xin et al., 2013; Konfino et al., 2015). Ultrasound provides 
a valuable tool in the longitudinal study of cardiac systolic function decrease (day 1) 
and recovery (day 21). Currently published work assessed functional decrease at day 
1 using 1-D M-mode visualisation. Following MI, part of the LV below the ligature is 
akinetic due to cardiomyocyte death whereas the remaining viable myocardium retains 
movement. Performing ECG-gated 2-D or 3-D measurements of systolic function 
presented in this thesis considers both parts of the myocardium following MI leading 
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to a more accurate reading of cardiac systolic function. Neither method of ultrasound 
is however able to assess the exact extent of initial myocardial damage. 
In the adult mouse, the extent of initial injury is routinely measured in the Gray lab by 
quantifying in vivo plasma cardiac troponin levels 24h following permanent LAD 
ligation (Zhao et al., 2015). This allows longitudinal follow up of animals. Whilst it 
was possible to obtain sufficient blood post-mortem from neonatal mice post-MI, it is 
unlikely that it will be possible in-vivo. A method able to accurately assess the extent 
of initial injury following MI in the neonatal mouse and allow longitudinal assessment 
of the animal is therefore lacking. 
Whilst magnetic resonance imaging (MRI) and positron emission tomography (PET) 
have been used to evaluate the extent of cardiac injury in adult mice following MI 
(Stegger et al., 2006; Zhao et al., 2015), no currently published work describes their 
use in the neonate. Whilst costly, they may provide accurate measurements of extent 
of initial injury. 
When performing neonatal coronary artery ligation, it is important to perform identical 
surgeries on all pups of a litter. Disparities in the recovery or behaviour of the pups 
can enhance maternal stress and increase the risk of cannibalisation. It is therefore 
preferred not to perform sham and MI surgeries on the same litter. Due to the limited 
access to the mouse line, it was decided to use the animals generated in the study 
presented in Chapter 4 as un-injured, naïve controls to the MI groups of Chapter 5. 
This allowed for higher numbers in the experimental groups and thereof more reliable 
statistical analysis. However, having another control group consisting of sham 
operated animals would have benefited this study. This would rule out any potential 
contribution of the hypothermia and thoracotomy in the fibrotic phenotype observed 
in Chapter 5.  
A collaborative effort with the aim to investigate the differences in the surgical 
techniques and their influence on the regenerative response is therefore required. A 
thorough comparison of the influence of background strain, surgical method, and 
analytical protocol on the extent of initial injury and regenerative response appears 
critical steps that the field needs to investigate. This can provide answers on the 
mechanisms behind neonatal cardiac regeneration and uncover potential therapies. 
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Mechanisms of neonatal myocardial regeneration 
Achieving successful cardiac regeneration necessitate three key phenomena: 
cardiomyocyte replenishment, removal of interstitial fibrosis, and normal 
vascularisation of the regenerated myocardium. 
Cardiomyocyte replenishment following neonatal MI is mostly achieved through pre-
existing cardiomyocytes’ de-differentiation and proliferation as opposed to a stem cell 
based mechanism (Haubner et al., 2012; Porrello et al., 2013). Whilst in the kidney, 
liver, and gut, macrophage-derived WNTs appeared to promote proliferation of 
progenitor cells to replenish the lost tissue following injury (Lin et al., 2010; Boulter 
et al., 2012; Planas-Paz et al., 2016; Saha et al., 2016); deletion of Porcn from 
macrophages has not affected functional recovery at day 21 post-MI in the neonate, it 
is therefore unlikely that it will have had a significant impact on cardiomyocyte 
replenishment. However, formal proof of this will be required and is currently being 
considered as further experiment using cardiomyocyte cross sectional area and 
proliferation markers on cardiac sections. 
Macrophages have been highlighted as having a key role in neonatal cardiac 
regeneration (Aurora et al., 2014). Yolk-sac derived macrophages were suggested by 
Lavine et al. (2014) to be mobilised shortly after genetic ablation of cardiomyocytes 
in the neonate and to participate in the regenerative response. Data from this thesis 
however suggested that this population may be replaced later on, at day 7 post-MI, by 
macrophages of monocytic origin. The precise identity of these macrophages and their 
role is however less clear in the MI model. CCR2 is essential in the recruitment of 
blood derived monocytes to the site of injury (Dewald et al., 2005; Nahrendorf et al., 
2007). Using an inducible CCR2 KO models would allow us to understand the precise 
role of macrophages of monocytic origin following neonatal MI. Future experiments 
should include a comprehensive analysis of the time line of the immune response along 
with the various cell types involved with the injury model used in this thesis. As 
described in 0, the response is likely to be dependent on the type and extent of injury 
and any finding should always be placed in this context. A further understanding of 
the mediators of the immune response following neonatal MI would help design 
strategies to manipulate to promote regeneration in the adult. 
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In both the kidney and the liver, preventing secretion of WNTs from macrophages was 
associated with increased fibrosis following injury (Lin et al., 2010; Irvine et al., 
2015). Consistent with those findings, data from this thesis has suggested that 
macrophage-directed depletion of Porcn was associated with increased interstitial 
fibrosis at day 21 post-MI in neonatal mice. In the liver, mice unable to secrete WNTs 
from macrophages down-regulate the anti-fibrotic Mmp12 and Mmp13 (Irvine et al., 
2015). Investigating expression of Mmps in a time course experiment following MI in 
the Porcupine mouse would help determine if a similar mechanism is employed in the 
neonatal heart during regeneration. This thesis has identified Wnt5b and its receptor 
Fzd2 as being up-regulated in the regenerating myocardium. Wnt5b expression was 
shown to reduce collagen X production in chondrocytes whilst Fzd2 is known to be 
expressed on cardiac fibroblast following MI in the adult (Blankesteijn et al., 1997). 
Whether these interact in the neonatal mouse to control fibrosis is less clear but present 
a potential mechanism for further investigation. Interestingly, preventing secretion of 
WNTs from macrophages was shown to be associated with acquisition of an M2-like 
phenotype following adult MI (Palevski et al., 2017). M2-like macrophages are known 
to promote angiogenesis, which is beneficial following adult MI, but also matrix 
deposition to enhance scar stabilisation, (Nahrendorf et al., 2007; Murray and Wynn, 
2011). Whether preventing secretion of WNTs from macrophages influences their 
phenotype in neonatal mice is less clear but also present a potential mechanism to be 
investigated. It is indeed known that WNTs possess autocrine properties able to 
influence macrophage phenotype (Pereira et al., 2008; Schaale et al., 2011; Maiti et 
al., 2012).   
Re-vascularisation of the myocardium following neonatal MI was shown by Aurora et 
al (2014) to require macrophages. Of interest, macrophage-derived WNTs have indeed 
been shown to participate in patterning of the vasculature in the retina (Lobov et al., 
2005; James A Stefater et al., 2011; Stefater et al., 2013). In this thesis however, 
macrophage-directed depletion of Porcn does not seem to have influenced re-
vascularisation of the myocardium at day 21 post-MI. A more thorough analysis of the 
re-vascularisation process is however necessary by investigating earlier time points. 
The 3-D structure of the vasculature could also be investigated using casts as described 
in (Porrello et al., 2013).  
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The recent discovery by Tian et al. that the endocardium actively participates in 
myocardial vascularisation postnatally. It is however unclear if those different vascular 
beds play distinct roles following neonatal MI compared to adult MI. Using the same 
reporter mouse could help identify the contribution of each vascular beds to the re-
vascularisation of the regenerating area in the neonate and in the peri-infarct 
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6.3 Summary of future work 
Even though considerable questions remain open, the neonatal mouse has provided the 
field with a strong model of postnatal mammalian cardiac regeneration. It has led to 
the uncovering of pathways with translational potential to achieving cardiomyocyte 
proliferation in the adult (Figure 6-1). Work from this thesis has investigated the role 
of macrophages and macrophages-derived WNTs in normal postnatal growth as well 
as regeneration following injury. A link between macrophage-derived WNTs and 
regulation of fibrosis following neonatal MI could be established. This has raised 
further questions which are considered for further experiments: 
• Do foetal liver/bone marrow derived macrophages play a role in postnatal 
vascularisation of the myocardium? This could be investigated using an 
inducible CCR2 KO mouse model.  
• What is the Wnt signalling gene expression profile in cardiac macrophages 
during normal growth and following MI in the neonatal mouse? This was 
attempted during this thesis but was unsuccessful due to low yield of cells. 
Further investigations should involve an mRNA amplification step. 
• What is the time course of immune response following our model of neonatal 
MI? The immune response is likely to differ depending on the extent and type 
of injury, as well as the background of the mouse. A time course experiment 
would benefit interpretation of our results. 
• What is the role of macrophage-derived WNTs in fibrosis following neonatal 
MI? This could be investigated using a time course experiment looking at gene 
expression and collagen content on cardiac section. This would give us the 
chance to also investigate fibroblast proliferation and differentiation into 
myofibroblasts.  
• What is the influence of macrophage-derived WNTs on the immune response 
following neonatal MI? Using the time course established above, key time 
points would be identified to perform targeted experiments on macrophage 
polarisation. 




Figure 6-1: Mechanisms of neonatal cardiac regeneration.  Cardiomyocyte (cm) 
proliferation is essential in replenishment of the myocardium during regeneration. 
Yes-associated protein (YAP) promotes cm proliferation in the neonatal mouse and in 
the adult which is mediated by -catenin. ERBB2 was also shown to promote cm 
proliferation. Both Meis1 and miR-15 family were shown to negatively regulate cm 
proliferation. Macrophages (MФ) are important in revascularisation and scar removal 
following neonatal MI. The role of vascular heterogeneity on neonatal cardiac 
regeneration is unknown, so is the role of macrophages in that process. MФ-mediated 
scar removal was suggested to be dependent on secretion of WNTs. The identity of the 
WNTs and the mechanisms employed are however less clear. Potential mechanisms 




Position Symbol Description         
1 Aes Amino-terminal enhancer of split      
2 Apc Adenomatosis polyposis coli       
3 Axin1 Axin 1        
4 Axin2 Axin2         
5 Bcl9 B-cell CLL/lymphoma 9       
6 Btrc Beta-transducin repeat containing protein      
7 Ccnd1 Cyclin D1        
8 Ccnd2 Cyclin D2        
9 Csnk1a1 Casein kinase 1, alpha 1     
10 Csnk2a1 Casein kinase 2, alpha 1 polypeptide    
11 Ctbp1 C-terminal binding protein 1      
12 Ctnnb1 Catenin (cadherin associated protein), beta 1    
13 Ctnnbip1 Catenin beta interacting protein 1     
14 Daam1 Dishevelled associated activator of morphogenesis 1    
15 Dab2 Disabled homolog 2 (Drosophila)      
16 Dixdc1 DIX domain containing 1      
17 Dkk1 Dickkopf homolog 1 (Xenopus laevis)     
18 Dkk3 Dickkopf homolog 3 (Xenopus laevis)     
19 Dvl1 Dishevelled, dsh homolog 1 (Drosophila)     
20 Dvl2 Dishevelled 2, dsh homolog (Drosophila)     
21 Ep300 E1A binding protein p300      
22 Fbxw11 F-box and WD-40 domain protein 11    
23 Fbxw4 F-box and WD-40 domain protein 4    
24 Fgf4 Fibroblast growth factor 4      
25 Fosl1 Fos-like antigen 1       
26 Foxn1 Forkhead box N1       
27 Frat1 Frequently rearranged in advanced T-cell lymphomas    
28 Frzb Frizzled-related protein        
29 Fzd1 Frizzled homolog 1 (Drosophila)      
30 Fzd2 Frizzled homolog 2 (Drosophila)      
31 Fzd3 Frizzled homolog 3 (Drosophila)      
32 Fzd4 Frizzled homolog 4 (Drosophila)      
33 Fzd5 Frizzled homolog 5 (Drosophila)      
34 Fzd6 Frizzled homolog 6 (Drosophila)      
35 Fzd7 Frizzled homolog 7 (Drosophila)      
36 Fzd8 Frizzled homolog 8 (Drosophila)      




38 Gsk3b Glycogen synthase kinase 3 beta     
39 Jun Jun oncogene        
40 Kremen1 Kringle containing transmembrane protein 1     
41 Lef1 Lymphoid enhancer binding factor 1     
42 Lrp5 Low density lipoprotein receptor-related protein 5    
43 Lrp6 Low density lipoprotein receptor-related protein 6    
44 Mapk8 Mitogen-activated protein kinase 8      
45 Mmp7 Matrix metallopeptidase 7       
46 Myc Myelocytomatosis oncogene        
47 Nfatc1 Nuclear factor of activated T-cells, cytoplasmic, calcineurin-
dependent 1  
48 Nkd1 Naked cuticle 1 homolog (Drosophila)     
49 Nlk Nemo like kinase       
50 Pitx2 Paired-like homeodomain transcription factor 2     
51 Porcn Porcupine homolog (Drosophila)       
52 Ppard Peroxisome proliferator activator receptor delta     
53 Prickle1 Prickle homolog 1 (Drosophila)      
54 Pygo1 Pygopus 1        
55 Rhoa Ras homolog gene family, member A    
56 Rhou Ras homolog gene family, member U    
57 Ruvbl1 RuvB-like protein 1       
58 Sfrp1 Secreted frizzled-related protein 1      
59 Sfrp2 Secreted frizzled-related protein 2      
60 Sfrp4 Secreted frizzled-related protein 4      
61 Sox17 SRY-box containing gene 17      
62 Tcf7 Transcription factor 7, T-cell specific     
63 Tcf7l1 Transcription factor 7-like 1 (T-cell specific, HMG box)  
64 Tle1 Transducin-like enhancer of split 1, homolog of Drosophila 
E(spl) 
65 Vangl2 Vang-like 2 (van gogh, Drosophila)     
66 Wif1 Wnt inhibitory factor 1      
67 Wisp1 WNT1 inducible signaling pathway protein 1    
68 Wnt1 Wingless-related MMTV integration site 1     
69 Wnt10a Wingless related MMTV integration site 10a    
70 Wnt11 Wingless-related MMTV integration site 11     
71 Wnt16 Wingless-related MMTV integration site 16     
72 Wnt2 Wingless-related MMTV integration site 2     
73 Wnt2b Wingless related MMTV integration site 2b    
74 Wnt3 Wingless-related MMTV integration site 3     
75 Wnt3a Wingless-related MMTV integration site 3A     
76 Wnt4 Wingless-related MMTV integration site 4     
77 Wnt5a Wingless-related MMTV integration site 5A     




79 Wnt6 Wingless-related MMTV integration site 6     
80 Wnt7a Wingless-related MMTV integration site 7A     
81 Wnt7b Wingless-related MMTV integration site 7B     
82 Wnt8a Wingless-related MMTV integration site 8A     
83 Wnt8b Wingless related MMTV integration site 8b    
84 Wnt9a Wingless-type MMTV integration site 9A     
HKG Actb Actin, beta        
HKG B2m Beta-2 microglobulin        
HKG Gapdh Glyceraldehyde-3-phosphate dehydrogenase        
HKG Gusb Glucuronidase, beta        
HKG Hsp90ab1 Heat shock protein 90 alpha (cytosolic), class B member 
GDC MGDC Mouse Genomic DNA Contamination      
RTC RTC Reverse Transcription Control       
RTC RTC Reverse Transcription Control       
RTC RTC Reverse Transcription Control       
PPC PPC Positive PCR Control       
PPC PPC Positive PCR Control       
PPC PPC Positive PCR Control       
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